PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,PHARM_CLASSES,DEASCHEDULE
0002-1200_4bd46cbe-cdc1-4329-a8e7-22816bd7fc33,0002-1200,HUMAN PRESCRIPTION DRUG,Amyvid,,Florbetapir F 18,"INJECTION, SOLUTION",INTRAVENOUS,20120601,,NDA,NDA202008,Eli Lilly and Company,FLORBETAPIR F-18,51,mCi/mL,"Radioactive Diagnostic Agent [EPC],Positron Emitting Activity [MoA]",
0002-1407_14757f9d-f641-4836-acf3-229265588d1d,0002-1407,HUMAN PRESCRIPTION DRUG,Quinidine Gluconate,,Quinidine Gluconate,SOLUTION,INTRAVENOUS,19500712,,NDA,NDA007529,Eli Lilly and Company,QUINIDINE GLUCONATE,80,mg/mL,"Antiarrhythmic [EPC],Cytochrome P450 2D6 Inhibitor [EPC],Cytochrome P450 2D6 Inhibitors [MoA]",
0002-1433_aaae85ae-9295-465f-b938-463b74b8d5bd,0002-1433,HUMAN PRESCRIPTION DRUG,Trulicity,,Dulaglutide,"INJECTION, SOLUTION",SUBCUTANEOUS,20141107,,BLA,BLA125469,Eli Lilly and Company,DULAGLUTIDE,0.75,mg/.5mL,"GLP-1 Receptor Agonist [EPC],Glucagon-Like Peptide 1 [Chemical/Ingredient],Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]",
0002-1434_aaae85ae-9295-465f-b938-463b74b8d5bd,0002-1434,HUMAN PRESCRIPTION DRUG,Trulicity,,Dulaglutide,"INJECTION, SOLUTION",SUBCUTANEOUS,20141107,,BLA,BLA125469,Eli Lilly and Company,DULAGLUTIDE,1.5,mg/.5mL,"GLP-1 Receptor Agonist [EPC],Glucagon-Like Peptide 1 [Chemical/Ingredient],Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]",
0002-1445_2ecde4c5-5128-4725-9cf5-64384857eb1c,0002-1445,HUMAN PRESCRIPTION DRUG,TALTZ,,ixekizumab,"INJECTION, SOLUTION",SUBCUTANEOUS,20160322,,BLA,BLA125521,Eli Lilly and Company,IXEKIZUMAB,80,mg/mL,"Interleukin-17A Antagonist [EPC],Interleukin-17A Antagonists [MoA]",
0002-1975_23295988-5c83-40af-99e3-67ac0b5a9562,0002-1975,HUMAN PRESCRIPTION DRUG,AXIRON,,testosterone,SOLUTION,TOPICAL,20101123,,NDA,NDA022504,Eli Lilly and Company,TESTOSTERONE,30,mg/1.5mL,"Androgen [EPC],Androgen Receptor Agonists [MoA],Androstanes [Chemical/Ingredient]",CIII
0002-1977_23295988-5c83-40af-99e3-67ac0b5a9562,0002-1977,HUMAN PRESCRIPTION DRUG,AXIRON,,testosterone,SOLUTION,TOPICAL,20101123,,NDA,NDA022504,Eli Lilly and Company,TESTOSTERONE,30,mg/1.5mL,"Androgen [EPC],Androgen Receptor Agonists [MoA],Androstanes [Chemical/Ingredient]",CIII
0002-3004_7bf36d98-220e-4e2b-8c26-8c939c6b4473,0002-3004,HUMAN PRESCRIPTION DRUG,Prozac,Weekly,Fluoxetine hydrochloride,"CAPSULE, DELAYED RELEASE",ORAL,20010316,,NDA,NDA021235,Eli Lilly and Company,FLUOXETINE HYDROCHLORIDE,90,mg/1,"Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]",
0002-3227_324a23e9-1d68-42ba-8643-85cb35d45e5d,0002-3227,HUMAN PRESCRIPTION DRUG,Strattera,,Atomoxetine hydrochloride,CAPSULE,ORAL,20021126,,NDA,NDA021411,Eli Lilly and Company,ATOMOXETINE HYDROCHLORIDE,10,mg/1,"Norepinephrine Reuptake Inhibitor [EPC],Norepinephrine Uptake Inhibitors [MoA]",
0002-3228_324a23e9-1d68-42ba-8643-85cb35d45e5d,0002-3228,HUMAN PRESCRIPTION DRUG,Strattera,,Atomoxetine hydrochloride,CAPSULE,ORAL,20021126,,NDA,NDA021411,Eli Lilly and Company,ATOMOXETINE HYDROCHLORIDE,25,mg/1,"Norepinephrine Reuptake Inhibitor [EPC],Norepinephrine Uptake Inhibitors [MoA]",
0002-3229_324a23e9-1d68-42ba-8643-85cb35d45e5d,0002-3229,HUMAN PRESCRIPTION DRUG,Strattera,,Atomoxetine hydrochloride,CAPSULE,ORAL,20021126,,NDA,NDA021411,Eli Lilly and Company,ATOMOXETINE HYDROCHLORIDE,40,mg/1,"Norepinephrine Reuptake Inhibitor [EPC],Norepinephrine Uptake Inhibitors [MoA]",
0002-3230_7de92fb4-d903-4b94-a776-f9b083fd363c,0002-3230,HUMAN PRESCRIPTION DRUG,Symbyax,,Olanzapine and Fluoxetine hydrochloride,CAPSULE,ORAL,20070409,,NDA,NDA021520,Eli Lilly and Company,OLANZAPINE; FLUOXETINE HYDROCHLORIDE,3; 25,mg/1; mg/1,"Atypical Antipsychotic [EPC],Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]",
0002-3231_7de92fb4-d903-4b94-a776-f9b083fd363c,0002-3231,HUMAN PRESCRIPTION DRUG,Symbyax,,Olanzapine and Fluoxetine hydrochloride,CAPSULE,ORAL,20031224,,NDA,NDA021520,Eli Lilly and Company,OLANZAPINE; FLUOXETINE HYDROCHLORIDE,6; 25,mg/1; mg/1,"Atypical Antipsychotic [EPC],Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]",
0002-3232_7de92fb4-d903-4b94-a776-f9b083fd363c,0002-3232,HUMAN PRESCRIPTION DRUG,Symbyax,,Olanzapine and Fluoxetine hydrochloride,CAPSULE,ORAL,20031224,,NDA,NDA021520,Eli Lilly and Company,OLANZAPINE; FLUOXETINE HYDROCHLORIDE,12; 25,mg/1; mg/1,"Atypical Antipsychotic [EPC],Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]",
0002-3233_7de92fb4-d903-4b94-a776-f9b083fd363c,0002-3233,HUMAN PRESCRIPTION DRUG,Symbyax,,Olanzapine and Fluoxetine hydrochloride,CAPSULE,ORAL,20031224,,NDA,NDA021520,Eli Lilly and Company,OLANZAPINE; FLUOXETINE HYDROCHLORIDE,6; 50,mg/1; mg/1,"Atypical Antipsychotic [EPC],Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]",
0002-3234_7de92fb4-d903-4b94-a776-f9b083fd363c,0002-3234,HUMAN PRESCRIPTION DRUG,Symbyax,,Olanzapine and Fluoxetine hydrochloride,CAPSULE,ORAL,20031224,,NDA,NDA021520,Eli Lilly and Company,OLANZAPINE; FLUOXETINE HYDROCHLORIDE,12; 50,mg/1; mg/1,"Atypical Antipsychotic [EPC],Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]",
0002-3235_16857985-b2a3-4db7-9dad-afde7ec557f9,0002-3235,HUMAN PRESCRIPTION DRUG,Cymbalta,,Duloxetine hydrochloride,"CAPSULE, DELAYED RELEASE",ORAL,20040824,,NDA,NDA021427,Eli Lilly and Company,DULOXETINE HYDROCHLORIDE,20,mg/1,"Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]",
0002-3238_324a23e9-1d68-42ba-8643-85cb35d45e5d,0002-3238,HUMAN PRESCRIPTION DRUG,Strattera,,Atomoxetine hydrochloride,CAPSULE,ORAL,20021126,,NDA,NDA021411,Eli Lilly and Company,ATOMOXETINE HYDROCHLORIDE,18,mg/1,"Norepinephrine Reuptake Inhibitor [EPC],Norepinephrine Uptake Inhibitors [MoA]",
0002-3239_324a23e9-1d68-42ba-8643-85cb35d45e5d,0002-3239,HUMAN PRESCRIPTION DRUG,Strattera,,Atomoxetine hydrochloride,CAPSULE,ORAL,20021126,,NDA,NDA021411,Eli Lilly and Company,ATOMOXETINE HYDROCHLORIDE,60,mg/1,"Norepinephrine Reuptake Inhibitor [EPC],Norepinephrine Uptake Inhibitors [MoA]",
0002-3240_16857985-b2a3-4db7-9dad-afde7ec557f9,0002-3240,HUMAN PRESCRIPTION DRUG,Cymbalta,,Duloxetine hydrochloride,"CAPSULE, DELAYED RELEASE",ORAL,20040824,,NDA,NDA021427,Eli Lilly and Company,DULOXETINE HYDROCHLORIDE,30,mg/1,"Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]",
0002-3250_324a23e9-1d68-42ba-8643-85cb35d45e5d,0002-3250,HUMAN PRESCRIPTION DRUG,Strattera,,Atomoxetine hydrochloride,CAPSULE,ORAL,20050214,,NDA,NDA021411,Eli Lilly and Company,ATOMOXETINE HYDROCHLORIDE,80,mg/1,"Norepinephrine Reuptake Inhibitor [EPC],Norepinephrine Uptake Inhibitors [MoA]",
0002-3251_324a23e9-1d68-42ba-8643-85cb35d45e5d,0002-3251,HUMAN PRESCRIPTION DRUG,Strattera,,Atomoxetine hydrochloride,CAPSULE,ORAL,20050214,,NDA,NDA021411,Eli Lilly and Company,ATOMOXETINE HYDROCHLORIDE,100,mg/1,"Norepinephrine Reuptake Inhibitor [EPC],Norepinephrine Uptake Inhibitors [MoA]",
0002-3270_16857985-b2a3-4db7-9dad-afde7ec557f9,0002-3270,HUMAN PRESCRIPTION DRUG,Cymbalta,,Duloxetine hydrochloride,"CAPSULE, DELAYED RELEASE",ORAL,20100115,,NDA,NDA021427,Eli Lilly and Company,DULOXETINE HYDROCHLORIDE,60,mg/1,"Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]",
0002-4112_fc834175-f01d-430f-9e61-3c7af669ba4b,0002-4112,HUMAN PRESCRIPTION DRUG,Zyprexa,,Olanzapine,TABLET,ORAL,19970623,,NDA,NDA020592,Eli Lilly and Company,OLANZAPINE,2.5,mg/1,Atypical Antipsychotic [EPC],
0002-4115_fc834175-f01d-430f-9e61-3c7af669ba4b,0002-4115,HUMAN PRESCRIPTION DRUG,Zyprexa,,Olanzapine,TABLET,ORAL,19961001,,NDA,NDA020592,Eli Lilly and Company,OLANZAPINE,5,mg/1,Atypical Antipsychotic [EPC],
0002-4116_fc834175-f01d-430f-9e61-3c7af669ba4b,0002-4116,HUMAN PRESCRIPTION DRUG,Zyprexa,,Olanzapine,TABLET,ORAL,19961001,,NDA,NDA020592,Eli Lilly and Company,OLANZAPINE,7.5,mg/1,Atypical Antipsychotic [EPC],
0002-4117_fc834175-f01d-430f-9e61-3c7af669ba4b,0002-4117,HUMAN PRESCRIPTION DRUG,Zyprexa,,Olanzapine,TABLET,ORAL,19961001,,NDA,NDA020592,Eli Lilly and Company,OLANZAPINE,10,mg/1,Atypical Antipsychotic [EPC],
0002-4165_b2ed517f-fb63-4558-af19-996810ef637c,0002-4165,HUMAN PRESCRIPTION DRUG,Evista,,Raloxifene hydrochloride,TABLET,ORAL,19980106,,NDA,NDA020815,Eli Lilly and Company,RALOXIFENE HYDROCHLORIDE,60,mg/1,"Estrogen Agonist/Antagonist [EPC],Selective Estrogen Receptor Modulators [MoA]",
0002-4184_b2ed517f-fb63-4558-af19-996810ef637c,0002-4184,HUMAN PRESCRIPTION DRUG,Evista,,Raloxifene hydrochloride,TABLET,ORAL,19980106,,NDA,NDA020815,Eli Lilly and Company,RALOXIFENE HYDROCHLORIDE,60,mg/1,"Estrogen Agonist/Antagonist [EPC],Selective Estrogen Receptor Modulators [MoA]",
0002-4415_fc834175-f01d-430f-9e61-3c7af669ba4b,0002-4415,HUMAN PRESCRIPTION DRUG,Zyprexa,,Olanzapine,TABLET,ORAL,20000110,,NDA,NDA020592,Eli Lilly and Company,OLANZAPINE,15,mg/1,Atypical Antipsychotic [EPC],
0002-4420_fc834175-f01d-430f-9e61-3c7af669ba4b,0002-4420,HUMAN PRESCRIPTION DRUG,Zyprexa,,Olanzapine,TABLET,ORAL,20010301,,NDA,NDA020592,Eli Lilly and Company,OLANZAPINE,20,mg/1,Atypical Antipsychotic [EPC],
0002-4453_fc834175-f01d-430f-9e61-3c7af669ba4b,0002-4453,HUMAN PRESCRIPTION DRUG,ZYPREXA,Zydis,Olanzapine,"TABLET, ORALLY DISINTEGRATING",ORAL,20000601,,NDA,NDA021086,Eli Lilly and Company,OLANZAPINE,5,mg/1,Atypical Antipsychotic [EPC],
0002-4454_fc834175-f01d-430f-9e61-3c7af669ba4b,0002-4454,HUMAN PRESCRIPTION DRUG,ZYPREXA,Zydis,Olanzapine,"TABLET, ORALLY DISINTEGRATING",ORAL,20000601,,NDA,NDA021086,Eli Lilly and Company,OLANZAPINE,10,mg/1,Atypical Antipsychotic [EPC],
0002-4455_fc834175-f01d-430f-9e61-3c7af669ba4b,0002-4455,HUMAN PRESCRIPTION DRUG,ZYPREXA,Zydis,Olanzapine,"TABLET, ORALLY DISINTEGRATING",ORAL,20010901,,NDA,NDA021086,Eli Lilly and Company,OLANZAPINE,15,mg/1,Atypical Antipsychotic [EPC],
0002-4456_fc834175-f01d-430f-9e61-3c7af669ba4b,0002-4456,HUMAN PRESCRIPTION DRUG,ZYPREXA,Zydis,Olanzapine,"TABLET, ORALLY DISINTEGRATING",ORAL,20010901,,NDA,NDA021086,Eli Lilly and Company,OLANZAPINE,20,mg/1,Atypical Antipsychotic [EPC],
0002-4462_a300bb97-176e-4771-8b31-3246d3f773f8,0002-4462,HUMAN PRESCRIPTION DRUG,Cialis,,Tadalafil,"TABLET, FILM COATED",ORAL,20031126,,NDA,NDA021368,Eli Lilly and Company,TADALAFIL,5,mg/1,"Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA]",
0002-4463_a300bb97-176e-4771-8b31-3246d3f773f8,0002-4463,HUMAN PRESCRIPTION DRUG,Cialis,,Tadalafil,"TABLET, FILM COATED",ORAL,20031126,,NDA,NDA021368,Eli Lilly and Company,TADALAFIL,10,mg/1,"Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA]",
0002-4464_a300bb97-176e-4771-8b31-3246d3f773f8,0002-4464,HUMAN PRESCRIPTION DRUG,Cialis,,Tadalafil,"TABLET, FILM COATED",ORAL,20031126,,NDA,NDA021368,Eli Lilly and Company,TADALAFIL,20,mg/1,"Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA]",
0002-4465_a300bb97-176e-4771-8b31-3246d3f773f8,0002-4465,HUMAN PRESCRIPTION DRUG,Cialis,,Tadalafil,"TABLET, FILM COATED",ORAL,20080107,,NDA,NDA021368,Eli Lilly and Company,TADALAFIL,2.5,mg/1,"Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA]",
0002-5121_dec2c4de-adab-42c6-a981-015a1a9be91b,0002-5121,HUMAN PRESCRIPTION DRUG,Effient,,Prasugrel hydrochloride,"TABLET, FILM COATED",ORAL,20090710,,NDA,NDA022307,Eli Lilly and Company,PRASUGREL HYDROCHLORIDE,5,mg/1,"Decreased Platelet Aggregation [PE],P2Y12 Platelet Inhibitor [EPC],P2Y12 Receptor Antagonists [MoA]",
0002-5123_dec2c4de-adab-42c6-a981-015a1a9be91b,0002-5123,HUMAN PRESCRIPTION DRUG,Effient,,Prasugrel hydrochloride,"TABLET, FILM COATED",ORAL,20090710,,NDA,NDA022307,Eli Lilly and Company,PRASUGREL HYDROCHLORIDE,10,mg/1,"Decreased Platelet Aggregation [PE],P2Y12 Platelet Inhibitor [EPC],P2Y12 Receptor Antagonists [MoA]",
0002-7140_a667f669-cd7e-4dc0-89b7-9be550b03b3c,0002-7140,HUMAN PRESCRIPTION DRUG,REOPRO,,abciximab,"INJECTION, SOLUTION",INTRAVENOUS,19931216,,BLA,BLA103575,Eli Lilly and Company,ABCIXIMAB,2,mg/mL,,
0002-7190_1742bd54-1adb-4528-9617-5a39f07dd957,0002-7190,HUMAN PRESCRIPTION DRUG,LARTRUVO,,olaratumab,"INJECTION, SOLUTION",INTRAVENOUS,20161019,,BLA,BLA761038,Eli Lilly and Company,OLARATUMAB,10,mg/mL,,
0002-7335_0fa2b681-937c-4f9b-a94b-dc11292bfd40,0002-7335,HUMAN PRESCRIPTION DRUG,HUMATROPE,,Somatropin,KIT,INTRAMUSCULAR; SUBCUTANEOUS,19870401,,NDA,NDA019640,Eli Lilly and Company,,,,,
0002-7501_ca20741b-2f42-40f2-90a7-7cb9e4ed22e0,0002-7501,HUMAN PRESCRIPTION DRUG,Gemzar,,Gemcitabine hydrochloride,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,19960515,,NDA,NDA020509,Eli Lilly and Company,GEMCITABINE HYDROCHLORIDE,200,mg/5mL,"Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]",
0002-7502_ca20741b-2f42-40f2-90a7-7cb9e4ed22e0,0002-7502,HUMAN PRESCRIPTION DRUG,Gemzar,,Gemcitabine hydrochloride,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,19960515,,NDA,NDA020509,Eli Lilly and Company,GEMCITABINE HYDROCHLORIDE,1,g/25mL,"Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]",
0002-7510_5b040825-3777-4cc2-a30a-34aa47a7b7d5,0002-7510,HUMAN PRESCRIPTION DRUG,Humalog,,Insulin lispro,"INJECTION, SOLUTION",INTRAVENOUS; SUBCUTANEOUS,19960614,,NDA,NDA020563,Eli Lilly and Company,INSULIN LISPRO,100,[iU]/mL,"Insulin [Chemical/Ingredient],Insulin Analog [EPC]",
0002-7511_ddb5903e-0eb4-4147-8a1b-afdae83f155f,0002-7511,HUMAN PRESCRIPTION DRUG,Humalog,Mix75/25,Insulin lispro,"INJECTION, SUSPENSION",SUBCUTANEOUS,19991222,,NDA,NDA021017,Eli Lilly and Company,INSULIN LISPRO,100,[iU]/mL,"Insulin [Chemical/Ingredient],Insulin Analog [EPC]",
0002-7512_cecf254f-646c-49ae-bc7e-80cff483c2c5,0002-7512,HUMAN PRESCRIPTION DRUG,Humalog,Mix50/50,Insulin lispro,"INJECTION, SUSPENSION",SUBCUTANEOUS,19991222,,NDA,NDA021018,Eli Lilly and Company,INSULIN LISPRO,100,[iU]/mL,"Insulin [Chemical/Ingredient],Insulin Analog [EPC]",
0002-7516_5b040825-3777-4cc2-a30a-34aa47a7b7d5,0002-7516,HUMAN PRESCRIPTION DRUG,Humalog,,Insulin lispro,"INJECTION, SOLUTION",INTRAVENOUS; SUBCUTANEOUS,19980220,,NDA,NDA020563,Eli Lilly and Company,INSULIN LISPRO,100,[iU]/mL,"Insulin [Chemical/Ingredient],Insulin Analog [EPC]",
0002-7597_fc834175-f01d-430f-9e61-3c7af669ba4b,0002-7597,HUMAN PRESCRIPTION DRUG,ZYPREXA,Intramuscular,Olanzapine,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR,20040401,,NDA,NDA021253,Eli Lilly and Company,OLANZAPINE,10,mg/2mL,Atypical Antipsychotic [EPC],
0002-7623_79c88183-a5a1-48cb-85b0-e96f0d5e95ab,0002-7623,HUMAN PRESCRIPTION DRUG,Alimta,,Pemetrexed disodium,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20040204,,NDA,NDA021462,Eli Lilly and Company,PEMETREXED DISODIUM HEPTAHYDRATE,500,mg/20mL,"Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA]",
0002-7635_30d4a0e1-0f38-450e-ba50-49d0b17e2c29,0002-7635,HUMAN PRESCRIPTION DRUG,ZYPREXA,Relprevv,Olanzapine pamoate,KIT,INTRAMUSCULAR,20091211,,NDA,NDA022173,Eli Lilly and Company,,,,,
0002-7636_30d4a0e1-0f38-450e-ba50-49d0b17e2c29,0002-7636,HUMAN PRESCRIPTION DRUG,ZYPREXA,Relprevv,Olanzapine pamoate,KIT,INTRAMUSCULAR,20091211,,NDA,NDA022173,Eli Lilly and Company,,,,,
0002-7637_30d4a0e1-0f38-450e-ba50-49d0b17e2c29,0002-7637,HUMAN PRESCRIPTION DRUG,ZYPREXA,Relprevv,Olanzapine pamoate,KIT,INTRAMUSCULAR,20091211,,NDA,NDA022173,Eli Lilly and Company,,,,,
0002-7640_79c88183-a5a1-48cb-85b0-e96f0d5e95ab,0002-7640,HUMAN PRESCRIPTION DRUG,Alimta,,Pemetrexed disodium,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20070907,,NDA,NDA021462,Eli Lilly and Company,PEMETREXED DISODIUM HEPTAHYDRATE,100,mg/4mL,"Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA]",
0002-7669_82b47bfc-57e1-4299-a915-7a3003992b4b,0002-7669,HUMAN PRESCRIPTION DRUG,CYRAMZA,,ramucirumab,SOLUTION,INTRAVENOUS,20140421,,BLA,BLA125477,Eli Lilly and Company,RAMUCIRUMAB,10,mg/mL,"Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC],VEGFR2 Inhibitors [MoA]",
0002-7678_82b47bfc-57e1-4299-a915-7a3003992b4b,0002-7678,HUMAN PRESCRIPTION DRUG,CYRAMZA,,ramucirumab,SOLUTION,INTRAVENOUS,20140421,,BLA,BLA125477,Eli Lilly and Company,RAMUCIRUMAB,10,mg/mL,"Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC],VEGFR2 Inhibitors [MoA]",
0002-7712_5b040825-3777-4cc2-a30a-34aa47a7b7d5,0002-7712,HUMAN PRESCRIPTION DRUG,Humalog,KwikPen,Insulin lispro,"INJECTION, SOLUTION",SUBCUTANEOUS,20150526,,NDA,NDA205747,Eli Lilly and Company,INSULIN LISPRO,200,[iU]/mL,"Insulin [Chemical/Ingredient],Insulin Analog [EPC]",
0002-7714_5b040825-3777-4cc2-a30a-34aa47a7b7d5,0002-7714,HUMAN PRESCRIPTION DRUG,Humalog,Junior KwikPen,Insulin lispro,"INJECTION, SOLUTION",SUBCUTANEOUS,19960614,,NDA,NDA020563,Eli Lilly and Company,INSULIN LISPRO,100,[iU]/mL,"Insulin [Chemical/Ingredient],Insulin Analog [EPC]",
0002-7715_f28edb9a-75bd-4005-8c65-eefc64770124,0002-7715,HUMAN PRESCRIPTION DRUG,BASAGLAR,,Insulin glargine,"INJECTION, SOLUTION",SUBCUTANEOUS,20151216,,NDA,NDA205692,Eli Lilly and Company,INSULIN GLARGINE,100,[iU]/mL,"Insulin [Chemical/Ingredient],Insulin Analog [EPC]",
0002-7716_62de9272-71de-4b81-8ccf-ad7806f02081,0002-7716,HUMAN PRESCRIPTION DRUG,Portrazza,,necitumumab,SOLUTION,INTRAVENOUS,20151124,,BLA,BLA125547,Eli Lilly and Company,NECITUMUMAB,16,mg/mL,"Epidermal Growth Factor Receptor Antagonist [EPC],HER1 Antagonists [MoA]",
0002-7724_2ecde4c5-5128-4725-9cf5-64384857eb1c,0002-7724,HUMAN PRESCRIPTION DRUG,TALTZ,,ixekizumab,"INJECTION, SOLUTION",SUBCUTANEOUS,20160322,,BLA,BLA125521,Eli Lilly and Company,IXEKIZUMAB,80,mg/mL,"Interleukin-17A Antagonist [EPC],Interleukin-17A Antagonists [MoA]",
0002-8031_b2922f8a-c8d3-4360-b2f6-ed46f0b00a88,0002-8031,HUMAN PRESCRIPTION DRUG,Glucagon,,glucagon,KIT,,19990301,,NDA,NDA020928,Eli Lilly and Company,,,,,
0002-8147_0fa2b681-937c-4f9b-a94b-dc11292bfd40,0002-8147,HUMAN PRESCRIPTION DRUG,HUMATROPE,,Somatropin,KIT,INTRAMUSCULAR; SUBCUTANEOUS,20060127,,NDA,NDA019640,Eli Lilly and Company,,,,,
0002-8148_0fa2b681-937c-4f9b-a94b-dc11292bfd40,0002-8148,HUMAN PRESCRIPTION DRUG,HUMATROPE,,Somatropin,KIT,INTRAMUSCULAR; SUBCUTANEOUS,20060127,,NDA,NDA019640,Eli Lilly and Company,,,,,
0002-8149_0fa2b681-937c-4f9b-a94b-dc11292bfd40,0002-8149,HUMAN PRESCRIPTION DRUG,HUMATROPE,,Somatropin,KIT,INTRAMUSCULAR; SUBCUTANEOUS,20060127,,NDA,NDA019640,Eli Lilly and Company,,,,,
0002-8215_08827443-2aa4-4cd9-9657-64a52085fd83,0002-8215,HUMAN OTC DRUG,Humulin,R,Insulin human,"INJECTION, SOLUTION",PARENTERAL,19830627,,NDA,NDA018780,Eli Lilly and Company,INSULIN HUMAN,100,[iU]/mL,,
0002-8315_96565fb7-dbd9-4048-96a7-73e9c3626f6e,0002-8315,HUMAN OTC DRUG,Humulin,N,Insulin human,"INJECTION, SUSPENSION",SUBCUTANEOUS,19830627,,NDA,NDA018781,Eli Lilly and Company,INSULIN HUMAN,100,[iU]/mL,,
0002-8400_4d0a0023-d348-41dd-a689-43971e41d26f,0002-8400,HUMAN PRESCRIPTION DRUG,Forteo,,Teriparatide,"INJECTION, SOLUTION",SUBCUTANEOUS,20021126,,NDA,NDA021318,Eli Lilly and Company,TERIPARATIDE,250,ug/mL,"Parathyroid Hormone [Chemical/Ingredient],Parathyroid Hormone Analog [EPC]",
0002-8501_78d3163c-1688-4a57-9d91-61b0a5f1a7f4,0002-8501,HUMAN PRESCRIPTION DRUG,Humulin,R U-500,Insulin human,"INJECTION, SOLUTION",SUBCUTANEOUS,19940331,,NDA,NDA018780,Eli Lilly and Company,INSULIN HUMAN,500,[iU]/mL,"Insulin [Chemical/Ingredient],Insulin [EPC]",
0002-8715_adccb1d5-7fb9-48d1-8dd9-e2a0a6a8a735,0002-8715,HUMAN OTC DRUG,Humulin,70/30,Insulin human,"INJECTION, SUSPENSION",SUBCUTANEOUS,19890626,,NDA,NDA019717,Eli Lilly and Company,INSULIN HUMAN,100,[iU]/mL,,
0002-8797_ddb5903e-0eb4-4147-8a1b-afdae83f155f,0002-8797,HUMAN PRESCRIPTION DRUG,Humalog,Mix75/25 KwikPen,Insulin lispro,"INJECTION, SUSPENSION",SUBCUTANEOUS,20070906,,NDA,NDA021017,Eli Lilly and Company,INSULIN LISPRO,100,[iU]/mL,"Insulin [Chemical/Ingredient],Insulin Analog [EPC]",
0002-8798_cecf254f-646c-49ae-bc7e-80cff483c2c5,0002-8798,HUMAN PRESCRIPTION DRUG,Humalog,Mix50/50 KwikPen,Insulin lispro,"INJECTION, SUSPENSION",SUBCUTANEOUS,20070906,,NDA,NDA021018,Eli Lilly and Company,INSULIN LISPRO,100,[iU]/mL,"Insulin [Chemical/Ingredient],Insulin Analog [EPC]",
0002-8799_5b040825-3777-4cc2-a30a-34aa47a7b7d5,0002-8799,HUMAN PRESCRIPTION DRUG,Humalog,KwikPen,Insulin lispro,"INJECTION, SOLUTION",INTRAVENOUS; SUBCUTANEOUS,20070906,,NDA,NDA020563,Eli Lilly and Company,INSULIN LISPRO,100,[iU]/mL,"Insulin [Chemical/Ingredient],Insulin Analog [EPC]",
0002-8803_adccb1d5-7fb9-48d1-8dd9-e2a0a6a8a735,0002-8803,HUMAN OTC DRUG,Humulin,70/30,Insulin human,"INJECTION, SUSPENSION",SUBCUTANEOUS,20131107,,NDA,NDA019717,Eli Lilly and Company,INSULIN HUMAN,100,[iU]/mL,,
0002-8805_96565fb7-dbd9-4048-96a7-73e9c3626f6e,0002-8805,HUMAN OTC DRUG,Humulin,N,Insulin human,"INJECTION, SUSPENSION",SUBCUTANEOUS,20131107,,NDA,NDA018781,Eli Lilly and Company,INSULIN HUMAN,100,[iU]/mL,,
0002-8824_78d3163c-1688-4a57-9d91-61b0a5f1a7f4,0002-8824,HUMAN PRESCRIPTION DRUG,Humulin,R U-500 KwikPen,Insulin human,"INJECTION, SOLUTION",SUBCUTANEOUS,20151229,,NDA,NDA018780,Eli Lilly and Company,INSULIN HUMAN,500,[iU]/mL,"Insulin [Chemical/Ingredient],Insulin [EPC]",
0002-8926_1742bd54-1adb-4528-9617-5a39f07dd957,0002-8926,HUMAN PRESCRIPTION DRUG,LARTRUVO,,olaratumab,"INJECTION, SOLUTION",INTRAVENOUS,20161019,,BLA,BLA761038,Eli Lilly and Company,OLARATUMAB,10,mg/mL,,
0003-0011_37ce5129-6591-4b3f-b8dc-aad593664c37,0003-0011,HUMAN PRESCRIPTION DRUG,DAKLINZA,,daclatasvir,TABLET,ORAL,20160518,,NDA,NDA206843,"E.R. Squibb & Sons, L.L.C.",DACLATASVIR DIHYDROCHLORIDE,90,mg/1,"Hepatitis C Virus NS5A Inhibitor [EPC],P-Glycoprotein Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA]",
0003-0213_37ce5129-6591-4b3f-b8dc-aad593664c37,0003-0213,HUMAN PRESCRIPTION DRUG,DAKLINZA,,daclatasvir,TABLET,ORAL,20150727,,NDA,NDA206843,"E.R. Squibb & Sons, L.L.C.",DACLATASVIR DIHYDROCHLORIDE,30,mg/1,"Hepatitis C Virus NS5A Inhibitor [EPC],P-Glycoprotein Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA]",
0003-0215_37ce5129-6591-4b3f-b8dc-aad593664c37,0003-0215,HUMAN PRESCRIPTION DRUG,DAKLINZA,,daclatasvir,TABLET,ORAL,20150727,,NDA,NDA206843,"E.R. Squibb & Sons, L.L.C.",DACLATASVIR DIHYDROCHLORIDE,60,mg/1,"Hepatitis C Virus NS5A Inhibitor [EPC],P-Glycoprotein Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA]",
0003-0249_7d355981-e4d6-4d06-a2b3-eb83edce221b,0003-0249,HUMAN PRESCRIPTION DRUG,HALOG,,Halcinonide,SOLUTION,TOPICAL,20090101,,NDA,NDA017823,"E.R. Squibb & Sons, L.L.C.",HALCINONIDE,1,mg/mL,"Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]",
0003-0293_6fdf8a2a-446a-4fcd-9cff-811352938e2f,0003-0293,HUMAN PRESCRIPTION DRUG,KENALOG-40,,TRIAMCINOLONE ACETONIDE,"INJECTION, SUSPENSION",INTRA-ARTICULAR; INTRAMUSCULAR,20090601,,NDA,NDA014901,"E.R. Squibb & Sons, L.L.C.",TRIAMCINOLONE ACETONIDE,40,mg/mL,,
0003-0371_8cd30e49-c7bb-4f44-8de9-b0a267d6a3cb,0003-0371,HUMAN PRESCRIPTION DRUG,NULOJIX,,BELATACEPT,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20110615,,BLA,BLA125288,"E.R. Squibb & Sons, L.L.C.",BELATACEPT,250,mg/1,"T Lymphocyte Costimulation Activity Blockade [PE],Selective T Cell Costimulation Blocker [EPC],CD80-directed Antibody Interactions [MoA],CD86-directed Antibody Interactions [MoA]",
0003-0494_bf560cd2-1348-49d2-a82b-fa2eb7870f07,0003-0494,HUMAN PRESCRIPTION DRUG,KENALOG-10,,TRIAMCINOLONE ACETONIDE,"INJECTION, SUSPENSION",INTRA-ARTICULAR; INTRALESIONAL,20090601,,NDA,NDA012041,"E.R. Squibb & Sons, L.L.C.",TRIAMCINOLONE ACETONIDE,10,mg/mL,,
0003-0524_f0719d03-ac55-413a-aea2-677a5cde1ff3,0003-0524,HUMAN PRESCRIPTION DRUG,SPRYCEL,,dasatinib,TABLET,ORAL,20060627,,NDA,NDA021986,"E.R. Squibb & Sons, L.L.C.",DASATINIB,70,mg/1,"Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA]",
0003-0527_f0719d03-ac55-413a-aea2-677a5cde1ff3,0003-0527,HUMAN PRESCRIPTION DRUG,SPRYCEL,,dasatinib,TABLET,ORAL,20060627,,NDA,NDA021986,"E.R. Squibb & Sons, L.L.C.",DASATINIB,20,mg/1,"Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA]",
0003-0528_f0719d03-ac55-413a-aea2-677a5cde1ff3,0003-0528,HUMAN PRESCRIPTION DRUG,SPRYCEL,,dasatinib,TABLET,ORAL,20060627,,NDA,NDA021986,"E.R. Squibb & Sons, L.L.C.",DASATINIB,50,mg/1,"Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA]",
0003-0830_5f9834d9-c6d3-4f3d-aab6-c86752c696e2,0003-0830,HUMAN PRESCRIPTION DRUG,HYDREA,,HYDROXYUREA,CAPSULE,ORAL,20090601,,NDA,NDA016295,"E.R. Squibb & Sons, L.L.C.",HYDROXYUREA,500,mg/1,"Antimetabolite [EPC],Urea [Chemical/Ingredient]",
0003-0852_f0719d03-ac55-413a-aea2-677a5cde1ff3,0003-0852,HUMAN PRESCRIPTION DRUG,SPRYCEL,,dasatinib,TABLET,ORAL,20080530,,NDA,NDA021986,"E.R. Squibb & Sons, L.L.C.",DASATINIB,100,mg/1,"Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA]",
0003-0855_f0719d03-ac55-413a-aea2-677a5cde1ff3,0003-0855,HUMAN PRESCRIPTION DRUG,SPRYCEL,,dasatinib,TABLET,ORAL,20101028,,NDA,NDA021986,"E.R. Squibb & Sons, L.L.C.",DASATINIB,80,mg/1,"Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA]",
0003-0857_f0719d03-ac55-413a-aea2-677a5cde1ff3,0003-0857,HUMAN PRESCRIPTION DRUG,SPRYCEL,,dasatinib,TABLET,ORAL,20101028,,NDA,NDA021986,"E.R. Squibb & Sons, L.L.C.",DASATINIB,140,mg/1,"Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA]",
0003-0893_85dab2fd-ac9a-4279-92e2-c1c9cf83ffb2,0003-0893,HUMAN PRESCRIPTION DRUG,ELIQUIS,,apixaban,"TABLET, FILM COATED",ORAL,20121228,,NDA,NDA202155,"E.R. Squibb & Sons, L.L.C.",APIXABAN,2.5,mg/1,"Factor Xa Inhibitor [EPC],Factor Xa Inhibitors [MoA]",
0003-0894_85dab2fd-ac9a-4279-92e2-c1c9cf83ffb2,0003-0894,HUMAN PRESCRIPTION DRUG,ELIQUIS,,apixaban,"TABLET, FILM COATED",ORAL,20121228,,NDA,NDA202155,"E.R. Squibb & Sons, L.L.C.",APIXABAN,5,mg/1,"Factor Xa Inhibitor [EPC],Factor Xa Inhibitors [MoA]",
0003-1611_cecc647b-3bcf-454f-913e-6c629b3289b1,0003-1611,HUMAN PRESCRIPTION DRUG,BARACLUDE,,entecavir,"TABLET, FILM COATED",ORAL,20050329,,NDA,NDA021797,"E.R. Squibb & Sons, L.L.C.",ENTECAVIR,0.5,mg/1,"Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA]",
0003-1612_cecc647b-3bcf-454f-913e-6c629b3289b1,0003-1612,HUMAN PRESCRIPTION DRUG,BARACLUDE,,entecavir,"TABLET, FILM COATED",ORAL,20050329,,NDA,NDA021797,"E.R. Squibb & Sons, L.L.C.",ENTECAVIR,1,mg/1,"Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA]",
0003-1614_cecc647b-3bcf-454f-913e-6c629b3289b1,0003-1614,HUMAN PRESCRIPTION DRUG,BARACLUDE,,entecavir,SOLUTION,ORAL,20050329,,NDA,NDA021798,"E.R. Squibb & Sons, L.L.C.",ENTECAVIR,0.05,mg/mL,"Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA]",
0003-1964_c6c7d0ff-a3cb-4a61-8acd-aceaf2b979fd,0003-1964,HUMAN PRESCRIPTION DRUG,ZERIT,,Stavudine,"CAPSULE, GELATIN COATED",ORAL,19940624,,NDA,NDA020412,"E.R. Squibb & Sons, L.L.C.",STAVUDINE,15,mg/1,"Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA]",
0003-1965_c6c7d0ff-a3cb-4a61-8acd-aceaf2b979fd,0003-1965,HUMAN PRESCRIPTION DRUG,ZERIT,,stavudine,"CAPSULE, GELATIN COATED",ORAL,19940624,,NDA,NDA020412,"E.R. Squibb & Sons, L.L.C.",STAVUDINE,20,mg/1,"Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA]",
0003-1966_c6c7d0ff-a3cb-4a61-8acd-aceaf2b979fd,0003-1966,HUMAN PRESCRIPTION DRUG,ZERIT,,stavudine,"CAPSULE, GELATIN COATED",ORAL,19940624,,NDA,NDA020412,"E.R. Squibb & Sons, L.L.C.",STAVUDINE,30,mg/1,"Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA]",
0003-1967_c6c7d0ff-a3cb-4a61-8acd-aceaf2b979fd,0003-1967,HUMAN PRESCRIPTION DRUG,ZERIT,,stavudine,"CAPSULE, GELATIN COATED",ORAL,19940624,,NDA,NDA020412,"E.R. Squibb & Sons, L.L.C.",STAVUDINE,40,mg/1,"Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA]",
0003-1968_c6c7d0ff-a3cb-4a61-8acd-aceaf2b979fd,0003-1968,HUMAN PRESCRIPTION DRUG,ZERIT,,stavudine,"POWDER, FOR SOLUTION",ORAL,19960906,,NDA,NDA020413,"E.R. Squibb & Sons, L.L.C.",STAVUDINE,1,mg/mL,"Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA]",
0003-2187_5ada8930-df4f-4371-9229-c66142f2c249,0003-2187,HUMAN PRESCRIPTION DRUG,ORENCIA,,abatacept,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20090101,,BLA,BLA125118,"E.R. Squibb & Sons, L.L.C.",ABATACEPT,250,mg/15mL,"Decreased Cytokine Activity [PE],Selective T Cell Costimulation Modulator [EPC],Recombinant Fusion Proteins [Chemical/Ingredient]",
0003-2188_5ada8930-df4f-4371-9229-c66142f2c249,0003-2188,HUMAN PRESCRIPTION DRUG,ORENCIA,,abatacept,"INJECTION, SOLUTION",SUBCUTANEOUS,20110729,,BLA,BLA125118,"E.R. Squibb & Sons, L.L.C.",ABATACEPT,125,mg/mL,"Decreased Cytokine Activity [PE],Selective T Cell Costimulation Modulator [EPC],Recombinant Fusion Proteins [Chemical/Ingredient]",
0003-2230_66c3b04a-c7ec-4784-a515-2f5601c648ba,0003-2230,HUMAN PRESCRIPTION DRUG,AZACTAM,,AZTREONAM,"INJECTION, SOLUTION",INTRAVENOUS,20100401,,NDA,NDA050632,"E.R. Squibb & Sons, L.L.C.",AZTREONAM,1,g/50mL,"Monobactam Antibacterial [EPC],Monobactams [Chemical/Ingredient]",
0003-2240_66c3b04a-c7ec-4784-a515-2f5601c648ba,0003-2240,HUMAN PRESCRIPTION DRUG,AZACTAM,,AZTREONAM,"INJECTION, SOLUTION",INTRAVENOUS,20100401,,NDA,NDA050632,"E.R. Squibb & Sons, L.L.C.",AZTREONAM,2,g/50mL,"Monobactam Antibacterial [EPC],Monobactams [Chemical/Ingredient]",
0003-2291_be84256f-8250-44f9-aef0-196432bab8f9,0003-2291,HUMAN PRESCRIPTION DRUG,EMPLICITI,,elotuzumab,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20151130,,BLA,BLA761035,"E.R. Squibb & Sons, L.L.C.",ELOTUZUMAB,300,mg/1,"SLAMF7-directed Immunostimulatory Antibody [EPC],SLAMF7-directed Antibody Interactions [MoA],Antibodies, Monoclonal [Chemical/Ingredient]",
0003-2327_073f3e6a-633a-4a0a-812d-8458c1c6d02d,0003-2327,HUMAN PRESCRIPTION DRUG,YERVOY,,ipilimumab,INJECTION,INTRAVENOUS,20110325,,BLA,BLA125377,"E.R. Squibb & Sons, L.L.C.",IPILIMUMAB,5,mg/mL,"CTLA-4-directed Blocking Antibody [EPC],CTLA-4-directed Antibody Interactions [MoA],Increased T Lymphocyte Activation [PE]",
0003-2328_073f3e6a-633a-4a0a-812d-8458c1c6d02d,0003-2328,HUMAN PRESCRIPTION DRUG,YERVOY,,ipilimumab,INJECTION,INTRAVENOUS,20110325,,BLA,BLA125377,"E.R. Squibb & Sons, L.L.C.",IPILIMUMAB,5,mg/mL,"CTLA-4-directed Blocking Antibody [EPC],CTLA-4-directed Antibody Interactions [MoA],Increased T Lymphocyte Activation [PE]",
0003-2560_a61e1b87-53c7-40d6-b30c-7b00f851e17c,0003-2560,HUMAN PRESCRIPTION DRUG,AZACTAM,,AZTREONAM,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,20100401,,NDA,NDA050580,"E.R. Squibb & Sons, L.L.C.",AZTREONAM,1,g/1,"Monobactam Antibacterial [EPC],Monobactams [Chemical/Ingredient]",
0003-2570_a61e1b87-53c7-40d6-b30c-7b00f851e17c,0003-2570,HUMAN PRESCRIPTION DRUG,AZACTAM,,AZTREONAM,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,20100401,,NDA,NDA050580,"E.R. Squibb & Sons, L.L.C.",AZTREONAM,2,g/1,"Monobactam Antibacterial [EPC],Monobactams [Chemical/Ingredient]",
0003-2814_5ada8930-df4f-4371-9229-c66142f2c249,0003-2814,HUMAN PRESCRIPTION DRUG,ORENCIA,,abatacept,"INJECTION, SOLUTION",SUBCUTANEOUS,20110729,,BLA,BLA125118,"E.R. Squibb & Sons, L.L.C.",ABATACEPT,50,mg/.4mL,"Decreased Cytokine Activity [PE],Selective T Cell Costimulation Modulator [EPC],Recombinant Fusion Proteins [Chemical/Ingredient]",
0003-2818_5ada8930-df4f-4371-9229-c66142f2c249,0003-2818,HUMAN PRESCRIPTION DRUG,ORENCIA,,abatacept,"INJECTION, SOLUTION",SUBCUTANEOUS,20110729,,BLA,BLA125118,"E.R. Squibb & Sons, L.L.C.",ABATACEPT,87.5,mg/.7mL,"Decreased Cytokine Activity [PE],Selective T Cell Costimulation Modulator [EPC],Recombinant Fusion Proteins [Chemical/Ingredient]",
0003-3622_19b70559-4f35-43b8-9fb9-104d134828e4,0003-3622,HUMAN PRESCRIPTION DRUG,REYATAZ,,ATAZANAVIR,"CAPSULE, GELATIN COATED",ORAL,20030624,,NDA,NDA021567,"E.R. Squibb & Sons, L.L.C.",ATAZANAVIR SULFATE,300,mg/1,"HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],UGT1A1 Inhibitors [MoA],UDP Glucuronosyltransferases Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA]",
0003-3624_19b70559-4f35-43b8-9fb9-104d134828e4,0003-3624,HUMAN PRESCRIPTION DRUG,REYATAZ,,ATAZANAVIR,"CAPSULE, GELATIN COATED",ORAL,20030624,,NDA,NDA021567,"E.R. Squibb & Sons, L.L.C.",ATAZANAVIR SULFATE,150,mg/1,"HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],UGT1A1 Inhibitors [MoA],UDP Glucuronosyltransferases Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA]",
0003-3631_19b70559-4f35-43b8-9fb9-104d134828e4,0003-3631,HUMAN PRESCRIPTION DRUG,REYATAZ,,ATAZANAVIR,"CAPSULE, GELATIN COATED",ORAL,20030624,,NDA,NDA021567,"E.R. Squibb & Sons, L.L.C.",ATAZANAVIR SULFATE,200,mg/1,"HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],UGT1A1 Inhibitors [MoA],UDP Glucuronosyltransferases Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA]",
0003-3638_19b70559-4f35-43b8-9fb9-104d134828e4,0003-3638,HUMAN PRESCRIPTION DRUG,REYATAZ,,ATAZANAVIR,POWDER,ORAL,20141219,,NDA,NDA206352,"E.R. Squibb & Sons, L.L.C.",ATAZANAVIR SULFATE,50,mg/1,"HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],UGT1A1 Inhibitors [MoA],UDP Glucuronosyltransferases Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA]",
0003-3641_a85ac210-0d90-457c-827b-7b7bc64681e2,0003-3641,HUMAN PRESCRIPTION DRUG,EVOTAZ,,atazanavir and cobicistat,TABLET,ORAL,20150129,,NDA,NDA206353,"E.R. Squibb & Sons, L.L.C.",ATAZANAVIR SULFATE; COBICISTAT,300; 150,mg/1; mg/1,"HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],UGT1A1 Inhibitors [MoA],UDP Glucuronosyltransferases Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 3A Inhibitor [EPC],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA]",
0003-3772_0d2608e9-4cf2-4730-91ba-32175d2b50a7,0003-3772,HUMAN PRESCRIPTION DRUG,OPDIVO,,nivolumab,INJECTION,INTRAVENOUS,20141222,,BLA,BLA125554,"E.R. Squibb & Sons, L.L.C.",NIVOLUMAB,10,mg/mL,"Programmed Death Receptor-1 Blocking Antibody [EPC],Programmed Death Receptor-1-directed Antibody Interactions [MoA]",
0003-3774_0d2608e9-4cf2-4730-91ba-32175d2b50a7,0003-3774,HUMAN PRESCRIPTION DRUG,OPDIVO,,nivolumab,INJECTION,INTRAVENOUS,20141222,,BLA,BLA125554,"E.R. Squibb & Sons, L.L.C.",NIVOLUMAB,10,mg/mL,"Programmed Death Receptor-1 Blocking Antibody [EPC],Programmed Death Receptor-1-directed Antibody Interactions [MoA]",
0003-4522_be84256f-8250-44f9-aef0-196432bab8f9,0003-4522,HUMAN PRESCRIPTION DRUG,EMPLICITI,,elotuzumab,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20151130,,BLA,BLA761035,"E.R. Squibb & Sons, L.L.C.",ELOTUZUMAB,400,mg/1,"SLAMF7-directed Immunostimulatory Antibody [EPC],SLAMF7-directed Antibody Interactions [MoA],Antibodies, Monoclonal [Chemical/Ingredient]",
0003-5178_2f2e9096-5021-4425-8195-1cbd5d921dfc,0003-5178,HUMAN PRESCRIPTION DRUG,PRAVACHOL,,PRAVASTATIN SODIUM,TABLET,ORAL,20090601,,NDA,NDA019898,"E.R. Squibb & Sons, L.L.C.",PRAVASTATIN SODIUM,20,mg/1,"HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]",
0003-5194_2f2e9096-5021-4425-8195-1cbd5d921dfc,0003-5194,HUMAN PRESCRIPTION DRUG,PRAVACHOL,,PRAVASTATIN SODIUM,TABLET,ORAL,20090601,,NDA,NDA019898,"E.R. Squibb & Sons, L.L.C.",PRAVASTATIN SODIUM,40,mg/1,"HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]",
0003-5195_2f2e9096-5021-4425-8195-1cbd5d921dfc,0003-5195,HUMAN PRESCRIPTION DRUG,PRAVACHOL,,PRAVASTATIN SODIUM,TABLET,ORAL,20090601,,NDA,NDA019898,"E.R. Squibb & Sons, L.L.C.",PRAVASTATIN SODIUM,80,mg/1,"HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]",
0003-6335_a8bc29c3-232a-445e-831d-f167031da663,0003-6335,HUMAN PRESCRIPTION DRUG,DROXIA,,HYDROXYUREA,CAPSULE,ORAL,20090601,,NDA,NDA016295,"E.R. Squibb & Sons, L.L.C.",HYDROXYUREA,200,mg/1,"Antimetabolite [EPC],Urea [Chemical/Ingredient]",
0003-6336_a8bc29c3-232a-445e-831d-f167031da663,0003-6336,HUMAN PRESCRIPTION DRUG,DROXIA,,HYDROXYUREA,CAPSULE,ORAL,20090601,,NDA,NDA016295,"E.R. Squibb & Sons, L.L.C.",HYDROXYUREA,300,mg/1,"Antimetabolite [EPC],Urea [Chemical/Ingredient]",
0003-6337_a8bc29c3-232a-445e-831d-f167031da663,0003-6337,HUMAN PRESCRIPTION DRUG,DROXIA,,HYDROXYUREA,CAPSULE,ORAL,20090601,,NDA,NDA016295,"E.R. Squibb & Sons, L.L.C.",HYDROXYUREA,400,mg/1,"Antimetabolite [EPC],Urea [Chemical/Ingredient]",
0004-0038_56501016-bcc9-49f9-a249-43071c390211,0004-0038,HUMAN PRESCRIPTION DRUG,Valcyte,,valganciclovir hydrochloride,"TABLET, FILM COATED",ORAL,20010329,,NDA,NDA021304,"Genentech, Inc.",VALGANCICLOVIR HYDROCHLORIDE,450,mg/1,"Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC]",
0004-0039_56501016-bcc9-49f9-a249-43071c390211,0004-0039,HUMAN PRESCRIPTION DRUG,Valcyte,,valganciclovir hydrochloride,"POWDER, FOR SOLUTION",ORAL,20090828,,NDA,NDA022257,"Genentech, Inc.",VALGANCICLOVIR HYDROCHLORIDE,50,mg/mL,"Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC]",
0004-0058_9b22f7ab-41df-4094-b72b-2721344fd976,0004-0058,HUMAN PRESCRIPTION DRUG,Klonopin,,Clonazepam,TABLET,ORAL,19750602,,NDA,NDA017533,"Genentech, Inc.",CLONAZEPAM,1,mg/1,"Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient]",CIV
0004-0068_9b22f7ab-41df-4094-b72b-2721344fd976,0004-0068,HUMAN PRESCRIPTION DRUG,Klonopin,,Clonazepam,TABLET,ORAL,19750602,,NDA,NDA017533,"Genentech, Inc.",CLONAZEPAM,0.5,mg/1,"Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient]",CIV
0004-0086_b6c64bc6-3918-427c-8ef2-bd7ab7ce01c8,0004-0086,HUMAN PRESCRIPTION DRUG,Copegus,,Ribavirin,"TABLET, FILM COATED",ORAL,20021203,,NDA,NDA021511,"Genentech, Inc.",RIBAVIRIN,200,mg/1,"Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC]",
0004-0098_9b22f7ab-41df-4094-b72b-2721344fd976,0004-0098,HUMAN PRESCRIPTION DRUG,Klonopin,,Clonazepam,TABLET,ORAL,19750602,,NDA,NDA017533,"Genentech, Inc.",CLONAZEPAM,2,mg/1,"Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient]",CIV
0004-0186_4c65ed19-ef93-443d-ad40-0a1838fb0b2a,0004-0186,HUMAN PRESCRIPTION DRUG,Boniva,,ibandronate sodium,"TABLET, FILM COATED",ORAL,20020715,,NDA,NDA021455,"Genentech, Inc.",IBANDRONATE SODIUM,150,mg/1,"Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient]",
0004-0191_2fbd353f-ae14-484d-a84b-d5b0e34173f3,0004-0191,HUMAN PRESCRIPTION DRUG,Boniva,,ibandronate sodium,"INJECTION, SOLUTION",INTRAVENOUS,20110601,,NDA,NDA021858,"Genentech, Inc.",IBANDRONATE SODIUM,3,mg/3mL,"Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient]",
0004-0244_6d9b8bd6-0351-4c02-a0e4-ee880b9a26e5,0004-0244,HUMAN PRESCRIPTION DRUG,Invirase,,saquinavir mesylate,"TABLET, FILM COATED",ORAL,20041217,,NDA,NDA021785,"Genentech, Inc.",SAQUINAVIR MESYLATE,500,mg/1,"HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA]",
0004-0245_6d9b8bd6-0351-4c02-a0e4-ee880b9a26e5,0004-0245,HUMAN PRESCRIPTION DRUG,Invirase,,saquinavir mesylate,CAPSULE,ORAL,19951206,,NDA,NDA020628,"Genentech, Inc.",SAQUINAVIR MESYLATE,200,mg/1,"HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA]",
0004-0257_c34001f0-9f46-4b8b-a4b4-3e78e0f2aac5,0004-0257,HUMAN PRESCRIPTION DRUG,Xenical,,orlistat,CAPSULE,ORAL,20101217,,NDA,NDA020766,"Genentech, Inc.",ORLISTAT,120,mg/1,"Intestinal Lipase Inhibitor [EPC],Lipase Inhibitors [MoA]",
0004-0259_d5f5de2c-01e5-446e-82be-a1e0e6a3e953,0004-0259,HUMAN PRESCRIPTION DRUG,CellCept,,Mycophenolate Mofetil,CAPSULE,ORAL,19950503,,NDA,NDA050722,"Genentech, Inc.",MYCOPHENOLATE MOFETIL,250,mg/1,Antimetabolite Immunosuppressant [EPC],
0004-0260_d5f5de2c-01e5-446e-82be-a1e0e6a3e953,0004-0260,HUMAN PRESCRIPTION DRUG,CellCept,,Mycophenolate Mofetil,"TABLET, FILM COATED",ORAL,19970619,,NDA,NDA050723,"Genentech, Inc.",MYCOPHENOLATE MOFETIL,500,mg/1,Antimetabolite Immunosuppressant [EPC],
0004-0261_d5f5de2c-01e5-446e-82be-a1e0e6a3e953,0004-0261,HUMAN PRESCRIPTION DRUG,CellCept,,Mycophenolate Mofetil,"POWDER, FOR SUSPENSION",ORAL,19981001,,NDA,NDA050759,"Genentech, Inc.",MYCOPHENOLATE MOFETIL,200,mg/mL,Antimetabolite Immunosuppressant [EPC],
0004-0298_d5f5de2c-01e5-446e-82be-a1e0e6a3e953,0004-0298,HUMAN PRESCRIPTION DRUG,CellCept,,Mycophenolate Mofetil hydrochloride,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,19980812,,NDA,NDA050758,"Genentech, Inc.",MYCOPHENOLATE MOFETIL HYDROCHLORIDE,500,mg/20mL,Antimetabolite Immunosuppressant [EPC],
0004-0350_95a6b02c-0779-4ee8-966e-f31625cd7ab7,0004-0350,HUMAN PRESCRIPTION DRUG,Pegasys,,peginterferon alfa-2a,"INJECTION, SOLUTION",SUBCUTANEOUS,20021016,,BLA,BLA103964,"Genentech, Inc.",PEGINTERFERON ALFA-2A,180,ug/mL,"Interferon alpha [EPC],peginterferon alfa-2a [Chemical/Ingredient]",
0004-0357_95a6b02c-0779-4ee8-966e-f31625cd7ab7,0004-0357,HUMAN PRESCRIPTION DRUG,Pegasys,,peginterferon alfa-2a,"INJECTION, SOLUTION",SUBCUTANEOUS,20110329,,BLA,BLA103964,"Genentech, Inc.",PEGINTERFERON ALFA-2A,180,ug/.5mL,"Interferon alpha [EPC],peginterferon alfa-2a [Chemical/Ingredient]",
0004-0360_95a6b02c-0779-4ee8-966e-f31625cd7ab7,0004-0360,HUMAN PRESCRIPTION DRUG,Pegasys,,peginterferon alfa-2a,"INJECTION, SOLUTION",SUBCUTANEOUS,20111101,,BLA,BLA103964,"Genentech, Inc.",PEGINTERFERON ALFA-2A,135,ug/.5mL,"Interferon alpha [EPC],peginterferon alfa-2a [Chemical/Ingredient]",
0004-0365_95a6b02c-0779-4ee8-966e-f31625cd7ab7,0004-0365,HUMAN PRESCRIPTION DRUG,Pegasys,,peginterferon alfa-2a,"INJECTION, SOLUTION",SUBCUTANEOUS,20111101,,BLA,BLA103964,"Genentech, Inc.",PEGINTERFERON ALFA-2A,180,ug/.5mL,"Interferon alpha [EPC],peginterferon alfa-2a [Chemical/Ingredient]",
0004-0381_c1809e73-7445-4d22-87ff-8ce46cac78ce,0004-0381,HUMAN PRESCRIPTION DRUG,FUZEON,,Enfuvirtide,KIT,,20120410,,NDA,NDA021481,"Genentech, Inc.",,,,,
0004-0401_b6ab110d-70a9-4fdb-9808-79db877596d0,0004-0401,HUMAN PRESCRIPTION DRUG,Mircera,,Methoxy polyethylene glycol-epoetin beta,"INJECTION, SOLUTION",INTRAVENOUS,20141024,20190531,BLA,BLA125164,"Genentech, Inc.",METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA,50,ug/.3mL,"Erythropoiesis-stimulating Agent [EPC],Erythropoietin [Chemical/Ingredient],Increased Erythroid Cell Production [PE]",
0004-0402_b6ab110d-70a9-4fdb-9808-79db877596d0,0004-0402,HUMAN PRESCRIPTION DRUG,Mircera,,Methoxy polyethylene glycol-epoetin beta,"INJECTION, SOLUTION",INTRAVENOUS,20141024,20190731,BLA,BLA125164,"Genentech, Inc.",METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA,75,ug/.3mL,"Erythropoiesis-stimulating Agent [EPC],Erythropoietin [Chemical/Ingredient],Increased Erythroid Cell Production [PE]",
0004-0403_b6ab110d-70a9-4fdb-9808-79db877596d0,0004-0403,HUMAN PRESCRIPTION DRUG,Mircera,,Methoxy polyethylene glycol-epoetin beta,"INJECTION, SOLUTION",INTRAVENOUS,20141024,20190731,BLA,BLA125164,"Genentech, Inc.",METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA,100,ug/.3mL,"Erythropoiesis-stimulating Agent [EPC],Erythropoietin [Chemical/Ingredient],Increased Erythroid Cell Production [PE]",
0004-0404_b6ab110d-70a9-4fdb-9808-79db877596d0,0004-0404,HUMAN PRESCRIPTION DRUG,Mircera,,Methoxy polyethylene glycol-epoetin beta,"INJECTION, SOLUTION",INTRAVENOUS,20141024,20190731,BLA,BLA125164,"Genentech, Inc.",METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA,150,ug/.3mL,"Erythropoiesis-stimulating Agent [EPC],Erythropoietin [Chemical/Ingredient],Increased Erythroid Cell Production [PE]",
0004-0405_b6ab110d-70a9-4fdb-9808-79db877596d0,0004-0405,HUMAN PRESCRIPTION DRUG,Mircera,,Methoxy polyethylene glycol-epoetin beta,"INJECTION, SOLUTION",INTRAVENOUS,20141024,20180630,BLA,BLA125164,"Genentech, Inc.",METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA,200,ug/.3mL,"Erythropoiesis-stimulating Agent [EPC],Erythropoietin [Chemical/Ingredient],Increased Erythroid Cell Production [PE]",
0004-0406_b6ab110d-70a9-4fdb-9808-79db877596d0,0004-0406,HUMAN PRESCRIPTION DRUG,Mircera,,Methoxy polyethylene glycol-epoetin beta,"INJECTION, SOLUTION",INTRAVENOUS,20141024,20190731,BLA,BLA125164,"Genentech, Inc.",METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA,250,ug/.3mL,"Erythropoiesis-stimulating Agent [EPC],Erythropoietin [Chemical/Ingredient],Increased Erythroid Cell Production [PE]",
0004-0800_60278de2-6767-4f6e-9935-47bd8d365464,0004-0800,HUMAN PRESCRIPTION DRUG,Tamiflu,,oseltamivir phosphate,CAPSULE,ORAL,19991027,,NDA,NDA021087,"Genentech, Inc.",OSELTAMIVIR PHOSPHATE,75,mg/1,,
0004-0801_60278de2-6767-4f6e-9935-47bd8d365464,0004-0801,HUMAN PRESCRIPTION DRUG,Tamiflu,,oseltamivir phosphate,CAPSULE,ORAL,19991027,,NDA,NDA021087,"Genentech, Inc.",OSELTAMIVIR PHOSPHATE,45,mg/1,,
0004-0802_60278de2-6767-4f6e-9935-47bd8d365464,0004-0802,HUMAN PRESCRIPTION DRUG,Tamiflu,,oseltamivir phosphate,CAPSULE,ORAL,19991027,,NDA,NDA021087,"Genentech, Inc.",OSELTAMIVIR PHOSPHATE,30,mg/1,,
0004-0822_60278de2-6767-4f6e-9935-47bd8d365464,0004-0822,HUMAN PRESCRIPTION DRUG,Tamiflu,,Oseltamivir Phosphate,"POWDER, FOR SUSPENSION",ORAL,20130801,,NDA,NDA021246,"Genentech, Inc.",OSELTAMIVIR PHOSPHATE,6,mg/mL,,
0004-1100_821a3c98-6fe7-43d3-a1b0-418b94d184da,0004-1100,HUMAN PRESCRIPTION DRUG,Xeloda,,capecitabine,"TABLET, FILM COATED",ORAL,19980430,,NDA,NDA020896,"Genentech, Inc.",CAPECITABINE,150,mg/1,"Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]",
0004-1101_821a3c98-6fe7-43d3-a1b0-418b94d184da,0004-1101,HUMAN PRESCRIPTION DRUG,Xeloda,,capecitabine,"TABLET, FILM COATED",ORAL,19980430,,NDA,NDA020896,"Genentech, Inc.",CAPECITABINE,500,mg/1,"Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]",
0004-6203_4f829771-dcf6-4b35-90d9-b5a5c31bcb8d,0004-6203,HUMAN PRESCRIPTION DRUG,Anaprox DS,,naproxen sodium,TABLET,ORAL,19800904,20180731,NDA,NDA018164,"Genentech, Inc.",NAPROXEN SODIUM,550,mg/1,"Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC]",
0004-6316_4f829771-dcf6-4b35-90d9-b5a5c31bcb8d,0004-6316,HUMAN PRESCRIPTION DRUG,Naprosyn,,naproxen,TABLET,ORAL,19760311,20181031,NDA,NDA017581,"Genentech, Inc.",NAPROXEN,500,mg/1,"Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC]",
0004-6415_4f829771-dcf6-4b35-90d9-b5a5c31bcb8d,0004-6415,HUMAN PRESCRIPTION DRUG,EC-Naprosyn,,naproxen,"TABLET, DELAYED RELEASE",ORAL,19941014,20190531,NDA,NDA020067,"Genentech, Inc.",NAPROXEN,375,mg/1,"Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC]",
0004-6416_4f829771-dcf6-4b35-90d9-b5a5c31bcb8d,0004-6416,HUMAN PRESCRIPTION DRUG,EC-Naprosyn,,naproxen,"TABLET, DELAYED RELEASE",ORAL,19941014,20180731,NDA,NDA020067,"Genentech, Inc.",NAPROXEN,500,mg/1,"Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC]",
0004-6940_fa6df59c-ef10-4f40-9f14-5c8dceaaa4a0,0004-6940,HUMAN PRESCRIPTION DRUG,Cytovene,IV,ganciclovir sodium,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,19890623,,NDA,NDA019661,"Genentech, Inc.",GANCICLOVIR SODIUM,500,mg/10mL,"Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC]",
0005-0100_1702490a-0af8-427e-a499-8bd111dde172,0005-0100,VACCINE,Trumenba,,meningococcal group B vaccine,"INJECTION, SUSPENSION",INTRAMUSCULAR,20141105,,BLA,BLA125549,"Wyeth Pharmaceutical Division of Wyeth Holdings LLC, a subsidiary of Pfizer Inc.",NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT LP2086 A05 PROTEIN VARIANT ANTIGEN; NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT LP2086 B01 PROTEIN VARIANT ANTIGEN,60; 60,ug/.5mL; ug/.5mL,,
0005-1971_5515fa1d-4829-4390-970a-642304d9d936,0005-1971,VACCINE,PREVNAR 13,,pneumococcal 13-valent conjugate vaccine,"INJECTION, SUSPENSION",INTRAMUSCULAR,20100312,,BLA,BLA125324,"Wyeth Pharmaceutical Division of Wyeth Holdings LLC, a subsidiary of Pfizer Inc.",STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 3 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 4 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 5 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 6A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 6B CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 7F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 9V CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 14 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 18C CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 23F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 19F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN,2.2; 2.2; 2.2; 2.2; 2.2; 4.4; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2,ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL,"Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [Chemical/Ingredient],Pneumococcal Vaccines [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [Chemical/Ingredient],Pneumococcal Vaccines [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [Chemical/Ingredient],Pneumococcal Vaccines [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [Chemical/Ingredient],Pneumococcal Vaccines [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [Chemical/Ingredient],Pneumococcal Vaccines [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [Chemical/Ingredient],Pneumococcal Vaccines [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [Chemical/Ingredient],Pneumococcal Vaccines [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [Chemical/Ingredient],Pneumococcal Vaccines [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [Chemical/Ingredient],Pneumococcal Vaccines [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [Chemical/Ingredient],Pneumococcal Vaccines [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [Chemical/Ingredient],Pneumococcal Vaccines [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [Chemical/Ingredient],Pneumococcal Vaccines [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Conjugate [Chemical/Ingredient]",
0005-2500_ffb6c98d-e53e-474b-a4c6-1bc7f02b90bb,0005-2500,HUMAN OTC DRUG,FIBERCON,,CALCIUM POLYCARBOPHIL,TABLET,ORAL,20040105,,OTC MONOGRAPH NOT FINAL,part334,"Wyeth Pharmaceutical Division of Wyeth Holdings Corporation, a subsidiary of Pfizer Inc.",CALCIUM POLYCARBOPHIL,625,mg/1,,
0006-0005_d00b54da-7063-47e2-bb66-1c5723561200,0006-0005,HUMAN PRESCRIPTION DRUG,BELSOMRA,,suvorexant,"TABLET, FILM COATED",ORAL,20140829,,NDA,NDA204569,Merck Sharp & Dohme Corp.,SUVOREXANT,5,mg/1,"Orexin Receptor Antagonist [EPC],Orexin Receptor Antagonists [MoA],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA]",CIV
0006-0019_f43abf9e-69d1-4a66-9125-195187fcb978,0006-0019,HUMAN PRESCRIPTION DRUG,PRINIVIL,,lisinopril,TABLET,ORAL,19871229,,NDA,NDA019558,Merck Sharp & Dohme Corp.,LISINOPRIL,5,mg/1,"Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA]",
0006-0031_d6630870-e0ee-4e4a-91bb-d2e578d097c2,0006-0031,HUMAN PRESCRIPTION DRUG,FOSAMAX,,alendronate sodium,TABLET,ORAL,19950929,,NDA,NDA020560,Merck Sharp & Dohme Corp.,ALENDRONATE SODIUM,70,mg/1,"Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient]",
0006-0032_1bd71a49-88a0-4a58-8d78-13bd07871f6c,0006-0032,HUMAN PRESCRIPTION DRUG,STROMECTOL,,ivermectin,TABLET,ORAL,19961122,,NDA,NDA050742,Merck Sharp & Dohme Corp.,IVERMECTIN,3,mg/1,"Antiparasitic [EPC],Pediculicide [EPC]",
0006-0033_d00b54da-7063-47e2-bb66-1c5723561200,0006-0033,HUMAN PRESCRIPTION DRUG,BELSOMRA,,suvorexant,"TABLET, FILM COATED",ORAL,20140829,,NDA,NDA204569,Merck Sharp & Dohme Corp.,SUVOREXANT,10,mg/1,"Orexin Receptor Antagonist [EPC],Orexin Receptor Antagonists [MoA],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA]",CIV
0006-0071_f97459d2-f336-4904-b4fc-c24dcc27888a,0006-0071,HUMAN PRESCRIPTION DRUG,PROPECIA,,finasteride,"TABLET, FILM COATED",ORAL,19971219,,NDA,NDA020788,Merck Sharp & Dohme Corp.,FINASTERIDE,1,mg/1,"5-alpha Reductase Inhibitor [EPC],5-alpha Reductase Inhibitors [MoA]",
0006-0072_534ba8df-c573-489b-9b3f-f87a54cd994f,0006-0072,HUMAN PRESCRIPTION DRUG,PROSCAR,,FINASTERIDE,"TABLET, FILM COATED",ORAL,19920619,,NDA,NDA020180,Merck Sharp & Dohme Corp.,FINASTERIDE,5,mg/1,"5-alpha Reductase Inhibitor [EPC],5-alpha Reductase Inhibitors [MoA]",
0006-0078_ab9e9dd2-57db-4bfa-bd0d-ffc04a704d87,0006-0078,HUMAN PRESCRIPTION DRUG,JANUMET,XR,sitagliptin and metformin hydrochloride,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,20120202,,NDA,NDA202270,Merck Sharp & Dohme Corp.,SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE,50; 500,mg/1; mg/1,"Dipeptidyl Peptidase 4 Inhibitor [EPC],Dipeptidyl Peptidase 4 Inhibitors [MoA],Biguanide [EPC],Biguanides [Chemical/Ingredient]",
0006-0080_ab9e9dd2-57db-4bfa-bd0d-ffc04a704d87,0006-0080,HUMAN PRESCRIPTION DRUG,JANUMET,XR,sitagliptin and metformin hydrochloride,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,20120202,,NDA,NDA202270,Merck Sharp & Dohme Corp.,SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE,50; 1000,mg/1; mg/1,"Dipeptidyl Peptidase 4 Inhibitor [EPC],Dipeptidyl Peptidase 4 Inhibitors [MoA],Biguanide [EPC],Biguanides [Chemical/Ingredient]",
0006-0081_ab9e9dd2-57db-4bfa-bd0d-ffc04a704d87,0006-0081,HUMAN PRESCRIPTION DRUG,JANUMET,XR,sitagliptin and metformin hydrochloride,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,20120202,,NDA,NDA202270,Merck Sharp & Dohme Corp.,SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE,100; 1000,mg/1; mg/1,"Dipeptidyl Peptidase 4 Inhibitor [EPC],Dipeptidyl Peptidase 4 Inhibitors [MoA],Biguanide [EPC],Biguanides [Chemical/Ingredient]",
0006-0106_f43abf9e-69d1-4a66-9125-195187fcb978,0006-0106,HUMAN PRESCRIPTION DRUG,PRINIVIL,,lisinopril,TABLET,ORAL,19871229,,NDA,NDA019558,Merck Sharp & Dohme Corp.,LISINOPRIL,10,mg/1,"Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA]",
0006-0112_f9f3a9af-477e-4325-a8d6-ce8d675c9e9b,0006-0112,HUMAN PRESCRIPTION DRUG,JANUVIA,,sitagliptin,"TABLET, FILM COATED",ORAL,20061016,,NDA,NDA021995,Merck Sharp & Dohme Corp.,SITAGLIPTIN PHOSPHATE,50,mg/1,"Dipeptidyl Peptidase 4 Inhibitor [EPC],Dipeptidyl Peptidase 4 Inhibitors [MoA]",
0006-0207_f43abf9e-69d1-4a66-9125-195187fcb978,0006-0207,HUMAN PRESCRIPTION DRUG,PRINIVIL,,lisinopril,TABLET,ORAL,19871229,,NDA,NDA019558,Merck Sharp & Dohme Corp.,LISINOPRIL,20,mg/1,"Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA]",
0006-0221_f9f3a9af-477e-4325-a8d6-ce8d675c9e9b,0006-0221,HUMAN PRESCRIPTION DRUG,JANUVIA,,sitagliptin,"TABLET, FILM COATED",ORAL,20061016,,NDA,NDA021995,Merck Sharp & Dohme Corp.,SITAGLIPTIN PHOSPHATE,25,mg/1,"Dipeptidyl Peptidase 4 Inhibitor [EPC],Dipeptidyl Peptidase 4 Inhibitors [MoA]",
0006-0227_dea5d8a6-af2b-46c0-ba65-3a3f7b2fd1ec,0006-0227,HUMAN PRESCRIPTION DRUG,ISENTRESS,,RALTEGRAVIR,"TABLET, FILM COATED",ORAL,20071012,,NDA,NDA022145,Merck Sharp & Dohme Corp.,RALTEGRAVIR POTASSIUM,400,mg/1,"HIV Integrase Inhibitors [MoA],Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]",
0006-0266_ba3f7068-96be-4e75-be96-c75ea78f09d4,0006-0266,HUMAN PRESCRIPTION DRUG,MAXALT,,rizatriptan benzoate,TABLET,ORAL,19980629,,NDA,NDA020864,Merck Sharp & Dohme Corp.,RIZATRIPTAN BENZOATE,5,mg/1,"Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]",
0006-0267_ba3f7068-96be-4e75-be96-c75ea78f09d4,0006-0267,HUMAN PRESCRIPTION DRUG,MAXALT,,rizatriptan benzoate,TABLET,ORAL,19980629,,NDA,NDA020864,Merck Sharp & Dohme Corp.,RIZATRIPTAN BENZOATE,10,mg/1,"Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]",
0006-0270_0184c6bc-b2db-4e60-94ec-0f4586c3b2f6,0006-0270,HUMAN PRESCRIPTION DRUG,FOSAMAX PLUS D,,ALENDRONATE SODIUM and CHOLECALCIFEROL,TABLET,ORAL,20050407,,NDA,NDA021762,Merck Sharp & Dohme Corp.,ALENDRONATE SODIUM; CHOLECALCIFEROL,70; 5600,mg/1; [iU]/1,"Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient],Vitamin D [Chemical/Ingredient],Vitamin D [EPC]",
0006-0277_f9f3a9af-477e-4325-a8d6-ce8d675c9e9b,0006-0277,HUMAN PRESCRIPTION DRUG,JANUVIA,,sitagliptin,"TABLET, FILM COATED",ORAL,20061016,,NDA,NDA021995,Merck Sharp & Dohme Corp.,SITAGLIPTIN PHOSPHATE,100,mg/1,"Dipeptidyl Peptidase 4 Inhibitor [EPC],Dipeptidyl Peptidase 4 Inhibitors [MoA]",
0006-0325_d00b54da-7063-47e2-bb66-1c5723561200,0006-0325,HUMAN PRESCRIPTION DRUG,BELSOMRA,,suvorexant,"TABLET, FILM COATED",ORAL,20140829,,NDA,NDA204569,Merck Sharp & Dohme Corp.,SUVOREXANT,15,mg/1,"Orexin Receptor Antagonist [EPC],Orexin Receptor Antagonists [MoA],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA]",CIV
0006-0335_d00b54da-7063-47e2-bb66-1c5723561200,0006-0335,HUMAN PRESCRIPTION DRUG,BELSOMRA,,suvorexant,"TABLET, FILM COATED",ORAL,20140829,,NDA,NDA204569,Merck Sharp & Dohme Corp.,SUVOREXANT,20,mg/1,"Orexin Receptor Antagonist [EPC],Orexin Receptor Antagonists [MoA],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA]",CIV
0006-0351_ae634203-7414-4955-95ff-fa16cf025ab2,0006-0351,HUMAN PRESCRIPTION DRUG,ZONTIVITY,,vorapaxar,"TABLET, FILM COATED",ORAL,20140508,,NDA,NDA204886,Merck Sharp & Dohme Corp.,VORAPAXAR SULFATE,2.08,mg/1,"Protease-activated Receptor-1 Antagonist [EPC],Protease-activated Receptor-1 Antagonists [MoA]",
0006-0461_9d4c63df-4a74-4ee4-8df0-78b6283591cb,0006-0461,HUMAN PRESCRIPTION DRUG,EMEND,,aprepitant,CAPSULE,ORAL,20030326,,NDA,NDA021549,Merck Sharp & Dohme Corp.,APREPITANT,80,mg/1,"Neurokinin 1 Antagonists [MoA],Substance P/Neurokinin-1 Receptor Antagonist [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 3A4 Inducers [MoA]",
0006-0462_9d4c63df-4a74-4ee4-8df0-78b6283591cb,0006-0462,HUMAN PRESCRIPTION DRUG,EMEND,,aprepitant,CAPSULE,ORAL,20030326,,NDA,NDA021549,Merck Sharp & Dohme Corp.,APREPITANT,125,mg/1,"Neurokinin 1 Antagonists [MoA],Substance P/Neurokinin-1 Receptor Antagonist [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 3A4 Inducers [MoA]",
0006-0464_9d4c63df-4a74-4ee4-8df0-78b6283591cb,0006-0464,HUMAN PRESCRIPTION DRUG,EMEND,,aprepitant,CAPSULE,ORAL,20030326,,NDA,NDA021549,Merck Sharp & Dohme Corp.,APREPITANT,40,mg/1,"Neurokinin 1 Antagonists [MoA],Substance P/Neurokinin-1 Receptor Antagonist [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 3A4 Inducers [MoA]",
0006-0473_dea5d8a6-af2b-46c0-ba65-3a3f7b2fd1ec,0006-0473,HUMAN PRESCRIPTION DRUG,ISENTRESS,,RALTEGRAVIR,"TABLET, CHEWABLE",ORAL,20111221,,NDA,NDA203045,Merck Sharp & Dohme Corp.,RALTEGRAVIR POTASSIUM,25,mg/1,"HIV Integrase Inhibitors [MoA],Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]",
0006-0477_dea5d8a6-af2b-46c0-ba65-3a3f7b2fd1ec,0006-0477,HUMAN PRESCRIPTION DRUG,ISENTRESS,,RALTEGRAVIR,"TABLET, CHEWABLE",ORAL,20111221,,NDA,NDA203045,Merck Sharp & Dohme Corp.,RALTEGRAVIR POTASSIUM,100,mg/1,"HIV Integrase Inhibitors [MoA],Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]",
0006-0543_f57237f9-1282-4beb-afe6-6fc13b474e2c,0006-0543,HUMAN PRESCRIPTION DRUG,ZOCOR,,SIMVASTATIN,"TABLET, FILM COATED",ORAL,19911223,,NDA,NDA019766,Merck Sharp & Dohme Corp.,SIMVASTATIN,80,mg/1,"HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]",
0006-0568_87947de5-7d26-41bf-be8b-10cf3a6f28c3,0006-0568,HUMAN PRESCRIPTION DRUG,ZOLINZA,,vorinostat,CAPSULE,ORAL,20061006,,NDA,NDA021991,Merck Sharp & Dohme Corp.,VORINOSTAT,100,mg/1,"Histone Deacetylase Inhibitor [EPC],Histone Deacetylase Inhibitors [MoA]",
0006-0571_c257f3d4-d499-41fa-9161-1ec22456ab16,0006-0571,HUMAN PRESCRIPTION DRUG,CRIXIVAN,,indinavir sulfate,CAPSULE,ORAL,19960313,,NDA,NDA020685,Merck Sharp & Dohme Corp.,INDINAVIR SULFATE,200,mg/1,"HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],Cytochrome P450 3A4 Inhibitors [MoA]",
0006-0573_c257f3d4-d499-41fa-9161-1ec22456ab16,0006-0573,HUMAN PRESCRIPTION DRUG,CRIXIVAN,,indinavir sulfate,CAPSULE,ORAL,19960313,,NDA,NDA020685,Merck Sharp & Dohme Corp.,INDINAVIR SULFATE,400,mg/1,"HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],Cytochrome P450 3A4 Inhibitors [MoA]",
0006-0575_1702daca-0ba2-476b-a9a3-0b977320b868,0006-0575,HUMAN PRESCRIPTION DRUG,JANUMET,,SITAGLIPTIN and METFORMIN HYDROCHLORIDE,"TABLET, FILM COATED",ORAL,20070330,,NDA,NDA022044,Merck Sharp & Dohme Corp.,SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE,50; 500,mg/1; mg/1,"Dipeptidyl Peptidase 4 Inhibitor [EPC],Dipeptidyl Peptidase 4 Inhibitors [MoA],Biguanide [EPC],Biguanides [Chemical/Ingredient]",
0006-0577_1702daca-0ba2-476b-a9a3-0b977320b868,0006-0577,HUMAN PRESCRIPTION DRUG,JANUMET,,SITAGLIPTIN and METFORMIN HYDROCHLORIDE,"TABLET, FILM COATED",ORAL,20070330,,NDA,NDA022044,Merck Sharp & Dohme Corp.,SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE,50; 1000,mg/1; mg/1,"Dipeptidyl Peptidase 4 Inhibitor [EPC],Dipeptidyl Peptidase 4 Inhibitors [MoA],Biguanide [EPC],Biguanides [Chemical/Ingredient]",
0006-0710_0184c6bc-b2db-4e60-94ec-0f4586c3b2f6,0006-0710,HUMAN PRESCRIPTION DRUG,FOSAMAX PLUS D,,ALENDRONATE SODIUM and CHOLECALCIFEROL,TABLET,ORAL,20050407,,NDA,NDA021762,Merck Sharp & Dohme Corp.,ALENDRONATE SODIUM; CHOLECALCIFEROL,70; 2800,mg/1; [iU]/1,"Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient],Vitamin D [Chemical/Ingredient],Vitamin D [EPC]",
0006-0717_380f864a-e812-4c80-b2b0-41d3347d2ecc,0006-0717,HUMAN PRESCRIPTION DRUG,HYZAAR,,losartan potassium and hydrochlorothiazide,"TABLET, FILM COATED",ORAL,19950428,,NDA,NDA020387,Merck Sharp & Dohme Corp.,LOSARTAN POTASSIUM; HYDROCHLOROTHIAZIDE,50; 12.5,mg/1; mg/1,"Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient]",
0006-0726_f57237f9-1282-4beb-afe6-6fc13b474e2c,0006-0726,HUMAN PRESCRIPTION DRUG,ZOCOR,,SIMVASTATIN,"TABLET, FILM COATED",ORAL,19911223,,NDA,NDA019766,Merck Sharp & Dohme Corp.,SIMVASTATIN,5,mg/1,"HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]",
0006-0735_f57237f9-1282-4beb-afe6-6fc13b474e2c,0006-0735,HUMAN PRESCRIPTION DRUG,ZOCOR,,SIMVASTATIN,"TABLET, FILM COATED",ORAL,19911223,,NDA,NDA019766,Merck Sharp & Dohme Corp.,SIMVASTATIN,10,mg/1,"HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]",
0006-0740_f57237f9-1282-4beb-afe6-6fc13b474e2c,0006-0740,HUMAN PRESCRIPTION DRUG,ZOCOR,,SIMVASTATIN,"TABLET, FILM COATED",ORAL,19911223,,NDA,NDA019766,Merck Sharp & Dohme Corp.,SIMVASTATIN,20,mg/1,"HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]",
0006-0745_380f864a-e812-4c80-b2b0-41d3347d2ecc,0006-0745,HUMAN PRESCRIPTION DRUG,HYZAAR,,losartan potassium and hydrochlorothiazide,"TABLET, FILM COATED",ORAL,19950428,,NDA,NDA020387,Merck Sharp & Dohme Corp.,LOSARTAN POTASSIUM; HYDROCHLOROTHIAZIDE,100; 12.5,mg/1; mg/1,"Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient]",
0006-0747_380f864a-e812-4c80-b2b0-41d3347d2ecc,0006-0747,HUMAN PRESCRIPTION DRUG,HYZAAR,,losartan potassium and hydrochlorothiazide,"TABLET, FILM COATED",ORAL,19950428,,NDA,NDA020387,Merck Sharp & Dohme Corp.,LOSARTAN POTASSIUM; HYDROCHLOROTHIAZIDE,100; 25,mg/1; mg/1,"Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient]",
0006-0749_f57237f9-1282-4beb-afe6-6fc13b474e2c,0006-0749,HUMAN PRESCRIPTION DRUG,ZOCOR,,SIMVASTATIN,"TABLET, FILM COATED",ORAL,19911223,,NDA,NDA019766,Merck Sharp & Dohme Corp.,SIMVASTATIN,40,mg/1,"HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]",
0006-0951_44a1f564-b09f-48d3-b3a8-8b1cb5f6a7cf,0006-0951,HUMAN PRESCRIPTION DRUG,COZAAR,,losartan potassium,"TABLET, FILM COATED",ORAL,19950414,,NDA,NDA020386,Merck Sharp & Dohme Corp.,LOSARTAN POTASSIUM,25,mg/1,"Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC]",
0006-0952_44a1f564-b09f-48d3-b3a8-8b1cb5f6a7cf,0006-0952,HUMAN PRESCRIPTION DRUG,COZAAR,,losartan potassium,"TABLET, FILM COATED",ORAL,19950414,,NDA,NDA020386,Merck Sharp & Dohme Corp.,LOSARTAN POTASSIUM,50,mg/1,"Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC]",
0006-0960_44a1f564-b09f-48d3-b3a8-8b1cb5f6a7cf,0006-0960,HUMAN PRESCRIPTION DRUG,COZAAR,,losartan potassium,"TABLET, FILM COATED",ORAL,19950414,,NDA,NDA020386,Merck Sharp & Dohme Corp.,LOSARTAN POTASSIUM,100,mg/1,"Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC]",
0006-1711_cf56f56a-26fc-4add-9dcd-b7ef4842f3d8,0006-1711,HUMAN PRESCRIPTION DRUG,SINGULAIR,,montelukast sodium,"TABLET, CHEWABLE",ORAL,19980220,,NDA,NDA020830,Merck Sharp & Dohme Corp.,MONTELUKAST SODIUM,4,mg/1,"Leukotriene Receptor Antagonist [EPC],Leukotriene Receptor Antagonists [MoA]",
0006-3025_d6c5254f-8153-4861-b4ad-6f439fed4b63,0006-3025,HUMAN PRESCRIPTION DRUG,ZINPLAVA,,bezlotoxumab,"INJECTION, SOLUTION",INTRAVENOUS,20161021,,BLA,BLA761046,Merck Sharp & Dohme Corp.,BEZLOTOXUMAB,25,mg/mL,,
0006-3026_8435cc61-92b4-4718-ab09-e42585e92d19,0006-3026,HUMAN PRESCRIPTION DRUG,KEYTRUDA,,pembrolizumab,"INJECTION, SOLUTION",INTRAVENOUS,20150115,,BLA,BLA125514,Merck Sharp & Dohme Corp.,PEMBROLIZUMAB,25,mg/mL,"Programmed Death Receptor-1 Blocking Antibody [EPC],Programmed Death Receptor-1-directed Antibody Interactions [MoA]",
0006-3029_8435cc61-92b4-4718-ab09-e42585e92d19,0006-3029,HUMAN PRESCRIPTION DRUG,KEYTRUDA,,pembrolizumab,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20140904,,BLA,BLA125514,Merck Sharp & Dohme Corp.,PEMBROLIZUMAB,50,mg/2mL,"Programmed Death Receptor-1 Blocking Antibody [EPC],Programmed Death Receptor-1-directed Antibody Interactions [MoA]",
0006-3061_8ae181cc-f15d-436d-80aa-e880e217ddeb,0006-3061,HUMAN PRESCRIPTION DRUG,EMEND,,FOSAPREPITANT DIMEGLUMINE,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20170203,,NDA,NDA022023,Merck Sharp & Dohme Corp.,FOSAPREPITANT DIMEGLUMINE,150,mg/5mL,"Neurokinin 1 Antagonists [MoA],Substance P/Neurokinin-1 Receptor Antagonist [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 3A4 Inducers [MoA]",
0006-3066_9d4c63df-4a74-4ee4-8df0-78b6283591cb,0006-3066,HUMAN PRESCRIPTION DRUG,EMEND,,aprepitant,"POWDER, FOR SUSPENSION",ORAL,20151217,,NDA,NDA207865,Merck Sharp & Dohme Corp.,APREPITANT,125,mg/1,"Neurokinin 1 Antagonists [MoA],Substance P/Neurokinin-1 Receptor Antagonist [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 3A4 Inducers [MoA]",
0006-3074_c26a08e8-ff71-4867-b547-3a3f384c6b90,0006-3074,HUMAN PRESCRIPTION DRUG,ZEPATIER,,elbasvir and grazoprevir,"TABLET, FILM COATED",ORAL,20160128,,NDA,NDA208261,Merck Sharp & Dohme Corp.,ELBASVIR; GRAZOPREVIR ANHYDROUS,50; 100,mg/1; mg/1,"Hepatitis C Virus NS5A Inhibitor [EPC],Breast Cancer Resistance Protein Inhibitors [MoA],HCV NS3/4A Protease Inhibitors [MoA],Hepatitis C Virus NS3/4A Protease Inhibitor [EPC],Breast Cancer Resistance Protein Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA]",
0006-3080_dea5d8a6-af2b-46c0-ba65-3a3f7b2fd1ec,0006-3080,HUMAN PRESCRIPTION DRUG,ISENTRESS,,RALTEGRAVIR,"TABLET, FILM COATED",ORAL,20170526,,NDA,NDA022145,Merck Sharp & Dohme Corp.,RALTEGRAVIR POTASSIUM,600,mg/1,"HIV Integrase Inhibitors [MoA],Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]",
0006-3514_eedd8a01-302b-4c42-8d78-5fac2a2d2830,0006-3514,HUMAN PRESCRIPTION DRUG,PRIMAXIN,IV,imipenem and cilastatin sodium,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS,19851126,,NDA,NDA050587,Merck Sharp & Dohme Corp.,IMIPENEM; CILASTATIN SODIUM,250; 250,mg/100mL; mg/100mL,"Dipeptidase Inhibitors [MoA],Renal Dehydropeptidase Inhibitor [EPC],Carbapenems [Chemical/Ingredient],Penem Antibacterial [EPC]",
0006-3516_eedd8a01-302b-4c42-8d78-5fac2a2d2830,0006-3516,HUMAN PRESCRIPTION DRUG,PRIMAXIN,IV,imipenem and cilastatin sodium,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS,19851126,,NDA,NDA050587,Merck Sharp & Dohme Corp.,IMIPENEM; CILASTATIN SODIUM,500; 500,mg/100mL; mg/100mL,"Carbapenems [Chemical/Ingredient],Penem Antibacterial [EPC],Dipeptidase Inhibitors [MoA],Renal Dehydropeptidase Inhibitor [EPC]",
0006-3519_0ab2a390-2925-4b2c-98d3-24f338eee2c2,0006-3519,HUMAN PRESCRIPTION DRUG,TRUSOPT,,dorzolamide hydrochloride,SOLUTION,OPHTHALMIC,19941209,,NDA,NDA020408,Merck Sharp & Dohme Corp.,DORZOLAMIDE HYDROCHLORIDE,20,mg/mL,"Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA]",
0006-3551_eedd8a01-302b-4c42-8d78-5fac2a2d2830,0006-3551,HUMAN PRESCRIPTION DRUG,PRIMAXIN,IV,imipenem and cilastatin sodium,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS,19870108,,ANDA,ANDA062756,Merck Sharp & Dohme Corp.,IMIPENEM; CILASTATIN SODIUM,250; 250,mg/100mL; mg/100mL,"Carbapenems [Chemical/Ingredient],Penem Antibacterial [EPC],Dipeptidase Inhibitors [MoA],Renal Dehydropeptidase Inhibitor [EPC]",
0006-3552_eedd8a01-302b-4c42-8d78-5fac2a2d2830,0006-3552,HUMAN PRESCRIPTION DRUG,PRIMAXIN,IV,imipenem and cilastatin sodium,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS,19870108,,ANDA,ANDA062756,Merck Sharp & Dohme Corp.,IMIPENEM; CILASTATIN SODIUM,500; 500,mg/100mL; mg/100mL,"Carbapenems [Chemical/Ingredient],Penem Antibacterial [EPC],Dipeptidase Inhibitors [MoA],Renal Dehydropeptidase Inhibitor [EPC]",
0006-3603_dea5d8a6-af2b-46c0-ba65-3a3f7b2fd1ec,0006-3603,HUMAN PRESCRIPTION DRUG,ISENTRESS,,RALTEGRAVIR,"GRANULE, FOR SUSPENSION",ORAL,20131220,,NDA,NDA205786,Merck Sharp & Dohme Corp.,RALTEGRAVIR POTASSIUM,100,mg/1,"HIV Integrase Inhibitors [MoA],Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]",
0006-3800_ba3f7068-96be-4e75-be96-c75ea78f09d4,0006-3800,HUMAN PRESCRIPTION DRUG,MAXALT-MLT,,rizatriptan benzoate,"TABLET, ORALLY DISINTEGRATING",ORAL,19980629,,NDA,NDA020865,Merck Sharp & Dohme Corp.,RIZATRIPTAN BENZOATE,5,mg/1,"Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]",
0006-3801_ba3f7068-96be-4e75-be96-c75ea78f09d4,0006-3801,HUMAN PRESCRIPTION DRUG,MAXALT-MLT,,rizatriptan benzoate,"TABLET, ORALLY DISINTEGRATING",ORAL,19980629,,NDA,NDA020865,Merck Sharp & Dohme Corp.,RIZATRIPTAN BENZOATE,10,mg/1,"Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]",
0006-3822_df4a2f99-0b41-4727-86ce-e50c18078089,0006-3822,HUMAN PRESCRIPTION DRUG,CANCIDAS,,CASPOFUNGIN ACETATE,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20010126,,NDA,NDA021227,Merck Sharp & Dohme Corp.,CASPOFUNGIN ACETATE,5,mg/mL,"Echinocandin Antifungal [EPC],Lipopeptides [Chemical/Ingredient]",
0006-3823_df4a2f99-0b41-4727-86ce-e50c18078089,0006-3823,HUMAN PRESCRIPTION DRUG,CANCIDAS,,CASPOFUNGIN ACETATE,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20010126,,NDA,NDA021227,Merck Sharp & Dohme Corp.,CASPOFUNGIN ACETATE,7,mg/mL,"Echinocandin Antifungal [EPC],Lipopeptides [Chemical/Ingredient]",
0006-3841_cf56f56a-26fc-4add-9dcd-b7ef4842f3d8,0006-3841,HUMAN PRESCRIPTION DRUG,SINGULAIR,,montelukast sodium,GRANULE,ORAL,20020726,,NDA,NDA021409,Merck Sharp & Dohme Corp.,MONTELUKAST SODIUM,4,mg/1,"Leukotriene Receptor Antagonist [EPC],Leukotriene Receptor Antagonists [MoA]",
0006-3843_424b0d88-6662-498a-9aff-68b7bba48d14,0006-3843,HUMAN PRESCRIPTION DRUG,INVANZ,,ertapenem sodium,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,20011121,,NDA,NDA021337,Merck Sharp & Dohme Corp.,ERTAPENEM SODIUM,1,g/1,"Carbapenems [Chemical/Ingredient],Penem Antibacterial [EPC]",
0006-3845_424b0d88-6662-498a-9aff-68b7bba48d14,0006-3845,HUMAN PRESCRIPTION DRUG,INVANZ,,ertapenem sodium,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20011121,,NDA,NDA021337,Merck Sharp & Dohme Corp.,ERTAPENEM SODIUM,1,g/1,"Carbapenems [Chemical/Ingredient],Penem Antibacterial [EPC]",
0006-3862_9d4c63df-4a74-4ee4-8df0-78b6283591cb,0006-3862,HUMAN PRESCRIPTION DRUG,EMEND,,aprepitant,KIT,,20030326,,NDA,NDA021549,Merck Sharp & Dohme Corp.,,,,,
0006-3915_6145f3e9-40af-4662-896e-5953bff18453,0006-3915,HUMAN PRESCRIPTION DRUG,SINEMET,,carbidopa and levodopa,TABLET,ORAL,19750502,,NDA,NDA017555,Merck Sharp & Dohme Corp.,CARBIDOPA; LEVODOPA,10; 100,mg/1; mg/1,"Aromatic Amino Acid [EPC],Amino Acids, Aromatic [Chemical/Ingredient]",
0006-3916_6145f3e9-40af-4662-896e-5953bff18453,0006-3916,HUMAN PRESCRIPTION DRUG,SINEMET,,carbidopa and levodopa,TABLET,ORAL,19750502,,NDA,NDA017555,Merck Sharp & Dohme Corp.,CARBIDOPA; LEVODOPA,25; 100,mg/1; mg/1,"Aromatic Amino Acid [EPC],Amino Acids, Aromatic [Chemical/Ingredient]",
0006-3917_6145f3e9-40af-4662-896e-5953bff18453,0006-3917,HUMAN PRESCRIPTION DRUG,SINEMET,,carbidopa and levodopa,TABLET,ORAL,19750502,,NDA,NDA017555,Merck Sharp & Dohme Corp.,CARBIDOPA; LEVODOPA,25; 250,mg/1; mg/1,"Aromatic Amino Acid [EPC],Amino Acids, Aromatic [Chemical/Ingredient]",
0006-3918_6f98927f-48cd-4c54-a67d-f318eac3e5fe,0006-3918,HUMAN PRESCRIPTION DRUG,SINEMET,CR,carbidopa and levodopa,"TABLET, EXTENDED RELEASE",ORAL,19910530,,NDA,NDA019856,Merck Sharp & Dohme Corp.,CARBIDOPA; LEVODOPA,25; 100,mg/1; mg/1,"Aromatic Amino Acid [EPC],Amino Acids, Aromatic [Chemical/Ingredient]",
0006-3919_6f98927f-48cd-4c54-a67d-f318eac3e5fe,0006-3919,HUMAN PRESCRIPTION DRUG,SINEMET,CR,carbidopa and levodopa,"TABLET, EXTENDED RELEASE",ORAL,19910530,,NDA,NDA019856,Merck Sharp & Dohme Corp.,CARBIDOPA; LEVODOPA,50; 200,mg/1; mg/1,"Aromatic Amino Acid [EPC],Amino Acids, Aromatic [Chemical/Ingredient]",
0006-3941_8cd0485e-e39f-4502-8dad-31a578310940,0006-3941,HUMAN PRESCRIPTION DRUG,EMEND,,FOSAPREPITANT DIMEGLUMINE,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20101112,,NDA,NDA022023,Merck Sharp & Dohme Corp.,FOSAPREPITANT DIMEGLUMINE,150,mg/5mL,"Neurokinin 1 Antagonists [MoA],Substance P/Neurokinin-1 Receptor Antagonist [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 3A4 Inducers [MoA]",
0006-4045_eb224f0a-88db-4a63-9020-0bb55682833e,0006-4045,VACCINE,GARDASIL,,"Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant","INJECTION, SUSPENSION",INTRAMUSCULAR,20060608,,BLA,BLA125126,Merck Sharp & Dohme Corp.,HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN,20; 40; 40; 20,ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL,"Inactivated Human Papillomavirus Vaccine [EPC],Actively Acquired Immunity [PE],Papillomavirus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Human Papillomavirus Vaccine [EPC],Actively Acquired Immunity [PE],Papillomavirus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Human Papillomavirus Vaccine [EPC],Actively Acquired Immunity [PE],Papillomavirus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Human Papillomavirus Vaccine [EPC],Actively Acquired Immunity [PE],Papillomavirus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient]",
0006-4047_f4fa79ca-b0fe-49bc-9c58-8b85032b9f7f,0006-4047,VACCINE,RotaTeq,,"Rotavirus Vaccine, Live, Oral, Pentavalent",SOLUTION,ORAL,20060203,,BLA,BLA125122,Merck Sharp & Dohme Corp.,HUMAN ROTAVIRUS A TYPE G1P7(5) STRAIN WI79 LIVE ANTIGEN; HUMAN ROTAVIRUS A TYPE G2P7(5) STRAIN SC2 LIVE ANTIGEN; HUMAN ROTAVIRUS A TYPE G3P7(5) STRAIN WI78 LIVE ANTIGEN; HUMAN ROTAVIRUS A TYPE G4P7(5) STRAIN BRB LIVE ANTIGEN; HUMAN ROTAVIRUS A TYPE G6P1A(8) STRAIN WI79 LIVE ANTIGEN,2200000; 2800000; 2200000; 2000000; 2300000,[iU]/2mL; [iU]/2mL; [iU]/2mL; [iU]/2mL; [iU]/2mL,"Live Rotavirus Vaccine [EPC],Actively Acquired Immunity [PE],Rotavirus Vaccines [Chemical/Ingredient],Vaccines, Live, Unattenuated [Chemical/Ingredient],Live Rotavirus Vaccine [EPC],Actively Acquired Immunity [PE],Rotavirus Vaccines [Chemical/Ingredient],Vaccines, Live, Unattenuated [Chemical/Ingredient],Live Rotavirus Vaccine [EPC],Actively Acquired Immunity [PE],Rotavirus Vaccines [Chemical/Ingredient],Vaccines, Live, Unattenuated [Chemical/Ingredient],Live Rotavirus Vaccine [EPC],Actively Acquired Immunity [PE],Rotavirus Vaccines [Chemical/Ingredient],Vaccines, Live, Unattenuated [Chemical/Ingredient],Live Rotavirus Vaccine [EPC],Actively Acquired Immunity [PE],Rotavirus Vaccines [Chemical/Ingredient],Vaccines, Live, Unattenuated [Chemical/Ingredient]",
0006-4093_1644ba2a-c49d-4c92-afe5-3fd922dbc8ae,0006-4093,VACCINE,RECOMBIVAX HB,,Hepatitis B Vaccine (Recombinant),"INJECTION, SUSPENSION",INTRAMUSCULAR; SUBCUTANEOUS,19860723,,BLA,BLA101066,Merck Sharp & Dohme Corp.,HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN,5,ug/.5mL,"Inactivated Hepatitis B Virus Vaccine [EPC],Actively Acquired Immunity [PE],Hepatitis B Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient]",
0006-4094_1644ba2a-c49d-4c92-afe5-3fd922dbc8ae,0006-4094,VACCINE,RECOMBIVAX HB,,Hepatitis B Vaccine (Recombinant),"INJECTION, SUSPENSION",INTRAMUSCULAR; SUBCUTANEOUS,19860723,,BLA,BLA101066,Merck Sharp & Dohme Corp.,HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN,10,ug/mL,"Inactivated Hepatitis B Virus Vaccine [EPC],Actively Acquired Immunity [PE],Hepatitis B Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient]",
0006-4095_9ae11ba9-4ab4-476e-82ad-921333bbdb7d,0006-4095,VACCINE,VAQTA,,"hepatitis A vaccine, inactivated","INJECTION, SUSPENSION",INTRAMUSCULAR,19960329,,BLA,BLA103606,Merck Sharp & Dohme Corp.,HEPATITIS A VIRUS STRAIN CR 326F ANTIGEN (FORMALDEHYDE INACTIVATED),25,[iU]/.5mL,"Inactivated Hepatitis A Virus Vaccine [EPC],Actively Acquired Immunity [PE],Hepatitis A Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient]",
0006-4096_9ae11ba9-4ab4-476e-82ad-921333bbdb7d,0006-4096,VACCINE,VAQTA,,"hepatitis A vaccine, inactivated","INJECTION, SUSPENSION",INTRAMUSCULAR,19960329,,BLA,BLA103606,Merck Sharp & Dohme Corp.,HEPATITIS A VIRUS STRAIN CR 326F ANTIGEN (FORMALDEHYDE INACTIVATED),50,[iU]/mL,"Inactivated Hepatitis A Virus Vaccine [EPC],Actively Acquired Immunity [PE],Hepatitis A Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient]",
0006-4109_eb224f0a-88db-4a63-9020-0bb55682833e,0006-4109,VACCINE,GARDASIL,,"Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant","INJECTION, SUSPENSION",INTRAMUSCULAR,20060608,,BLA,BLA125126,Merck Sharp & Dohme Corp.,HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN,20; 40; 40; 20,ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL,"Inactivated Human Papillomavirus Vaccine [EPC],Actively Acquired Immunity [PE],Papillomavirus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Human Papillomavirus Vaccine [EPC],Actively Acquired Immunity [PE],Papillomavirus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Human Papillomavirus Vaccine [EPC],Actively Acquired Immunity [PE],Papillomavirus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Human Papillomavirus Vaccine [EPC],Actively Acquired Immunity [PE],Papillomavirus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient]",
0006-4119_f9b68e8e-3842-4a15-be21-b500db14b5dd,0006-4119,VACCINE,GARDASIL 9,,"Human Papillomavirus 9-valent Vaccine, Recombinant","INJECTION, SUSPENSION",INTRAMUSCULAR,20141210,,BLA,BLA125508,Merck Sharp & Dohme Corp.,HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 31 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 33 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 45 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 52 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 58 L1 CAPSID PROTEIN ANTIGEN,30; 40; 60; 40; 20; 20; 20; 20; 20,ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL,"Inactivated Human Papillomavirus Vaccine [EPC],Actively Acquired Immunity [PE],Papillomavirus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Human Papillomavirus Vaccine [EPC],Actively Acquired Immunity [PE],Papillomavirus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Human Papillomavirus Vaccine [EPC],Actively Acquired Immunity [PE],Papillomavirus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Human Papillomavirus Vaccine [EPC],Actively Acquired Immunity [PE],Papillomavirus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient]",
0006-4121_f9b68e8e-3842-4a15-be21-b500db14b5dd,0006-4121,VACCINE,GARDASIL 9,,"Human Papillomavirus 9-valent Vaccine, Recombinant","INJECTION, SUSPENSION",INTRAMUSCULAR,20141210,,BLA,BLA125508,Merck Sharp & Dohme Corp.,HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 31 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 33 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 45 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 52 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 58 L1 CAPSID PROTEIN ANTIGEN,30; 40; 60; 40; 20; 20; 20; 20; 20,ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL,"Inactivated Human Papillomavirus Vaccine [EPC],Actively Acquired Immunity [PE],Papillomavirus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Human Papillomavirus Vaccine [EPC],Actively Acquired Immunity [PE],Papillomavirus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Human Papillomavirus Vaccine [EPC],Actively Acquired Immunity [PE],Papillomavirus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Human Papillomavirus Vaccine [EPC],Actively Acquired Immunity [PE],Papillomavirus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient]",
0006-4171_cc108426-2c58-4ca0-948d-be5cd758bd70,0006-4171,VACCINE,ProQuad,,"Measles, Mumps, Rubella and Varicella Virus Vaccine Live","INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION",SUBCUTANEOUS,20150701,,BLA,BLA125108,Merck Sharp & Dohme Corp.,MEASLES VIRUS STRAIN ENDERS' ATTENUATED EDMONSTON LIVE ANTIGEN; MUMPS VIRUS STRAIN B LEVEL JERYL LYNN LIVE ANTIGEN; RUBELLA VIRUS STRAIN WISTAR RA 27/3 LIVE ANTIGEN; VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN,1000; 20000; 1000; 9772,[TCID_50]/.5mL; [TCID_50]/.5mL; [TCID_50]/.5mL; [PFU]/.5mL,"Live Attenuated Measles Virus Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Attenuated [Chemical/Ingredient],Measles Vaccine [Chemical/Ingredient],Live Attenuated Mumps Virus Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Attenuated [Chemical/Ingredient],Mumps Vaccine [Chemical/Ingredient],Live Attenuated Rubella Virus Vaccine [EPC],Actively Acquired Immunity [PE],Rubella Vaccine [Chemical/Ingredient],Vaccines, Attenuated [Chemical/Ingredient],Live Attenuated Varicella Zoster Virus Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Attenuated [Chemical/Ingredient],Chickenpox Vaccine [Chemical/Ingredient],Live Attenuated Herpes Zoster Virus Vaccine [EPC],Herpes Zoster Vaccine [Chemical/Ingredient]",
0006-4229_b7a32150-e15a-4109-93b8-a2368039e033,0006-4229,STANDARDIZED ALLERGENIC,GRASTEK,,Timothy Grass Pollen Allergen Extract,TABLET,SUBLINGUAL,20140411,,BLA,BLA125473,Merck Sharp & Dohme Corp.,PHLEUM PRATENSE POLLEN,2800,[BAU]/1,"Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient]",
0006-4305_80f9dcfe-a91b-405e-ae61-cc2895d43084,0006-4305,HUMAN PRESCRIPTION DRUG,Renflexis,,infliximab,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20170701,,BLA,BLA761054,Merck Sharp & Dohme Corp.,INFLIXIMAB,100,mg/1,"Tumor Necrosis Factor Blocker [EPC],Tumor Necrosis Factor Receptor Blocking Activity [MoA]",
0006-4309_531fec90-7b36-4a65-87a1-cfde58efbba6,0006-4309,VACCINE,STERILE DILUENT,,Sterile Water,INJECTION,SUBCUTANEOUS,20060525,,BLA,BLA125123,Merck Sharp & Dohme Corp.,,,,,
0006-4681_d773f47d-06b4-4ba9-bb39-4b25e03e0c13,0006-4681,VACCINE,M-M-R II,,"measles, mumps, and rubella virus vaccine live","INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION",SUBCUTANEOUS,19710421,,BLA,BLA101069,Merck Sharp & Dohme Corp.,MEASLES VIRUS STRAIN ENDERS' ATTENUATED EDMONSTON LIVE ANTIGEN; MUMPS VIRUS STRAIN B LEVEL JERYL LYNN LIVE ANTIGEN; RUBELLA VIRUS STRAIN WISTAR RA 27/3 LIVE ANTIGEN,1000; 12500; 1000,[TCID_50]/.5mL; [TCID_50]/.5mL; [TCID_50]/.5mL,"Live Attenuated Measles Virus Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Attenuated [Chemical/Ingredient],Measles Vaccine [Chemical/Ingredient],Live Attenuated Mumps Virus Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Attenuated [Chemical/Ingredient],Mumps Vaccine [Chemical/Ingredient],Live Attenuated Rubella Virus Vaccine [EPC],Actively Acquired Immunity [PE],Rubella Vaccine [Chemical/Ingredient],Vaccines, Attenuated [Chemical/Ingredient]",
0006-4739_071f8653-783b-4628-b0f6-7d26317b50ca,0006-4739,VACCINE,PNEUMOVAX 23,,pneumococcal vaccine polyvalent,"INJECTION, SOLUTION",INTRAMUSCULAR; SUBCUTANEOUS,19830707,,BLA,BLA101094,Merck Sharp & Dohme Corp.,STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 2 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 3 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 4 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 5 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 6B CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 7F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 8 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 9N CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 9V CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 10A CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 11A CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 12F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 14 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 15B CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 17F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 18C CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 19F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 20 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 22F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 23F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 33F CAPSULAR POLYSACCHARIDE ANTIGEN,25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25,ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL,"Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient]",
0006-4826_57f23194-526d-47d5-b2d0-d5cf06c7b544,0006-4826,VACCINE,VARIVAX,,Varicella Virus Vaccine Live,"INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION",SUBCUTANEOUS,19950317,,BLA,BLA103552,Merck Sharp & Dohme Corp.,VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN,1350,[PFU]/.5mL,"Live Attenuated Varicella Zoster Virus Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Attenuated [Chemical/Ingredient],Chickenpox Vaccine [Chemical/Ingredient],Live Attenuated Herpes Zoster Virus Vaccine [EPC],Herpes Zoster Vaccine [Chemical/Ingredient]",
0006-4827_57f23194-526d-47d5-b2d0-d5cf06c7b544,0006-4827,VACCINE,VARIVAX,,Varicella Virus Vaccine Live,"INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION",SUBCUTANEOUS,19950317,,BLA,BLA103552,Merck Sharp & Dohme Corp.,VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN,1350,[PFU]/.5mL,"Live Attenuated Varicella Zoster Virus Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Attenuated [Chemical/Ingredient],Chickenpox Vaccine [Chemical/Ingredient],Live Attenuated Herpes Zoster Virus Vaccine [EPC],Herpes Zoster Vaccine [Chemical/Ingredient]",
0006-4831_9ae11ba9-4ab4-476e-82ad-921333bbdb7d,0006-4831,VACCINE,VAQTA,,"hepatitis A vaccine, inactivated","INJECTION, SUSPENSION",INTRAMUSCULAR,19960329,,BLA,BLA103606,Merck Sharp & Dohme Corp.,HEPATITIS A VIRUS STRAIN CR 326F ANTIGEN (FORMALDEHYDE INACTIVATED),25,[iU]/.5mL,"Inactivated Hepatitis A Virus Vaccine [EPC],Actively Acquired Immunity [PE],Hepatitis A Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient]",
0006-4837_071f8653-783b-4628-b0f6-7d26317b50ca,0006-4837,VACCINE,PNEUMOVAX 23,,pneumococcal vaccine polyvalent,"INJECTION, SOLUTION",INTRAMUSCULAR; SUBCUTANEOUS,20140721,,BLA,BLA101094,Merck Sharp & Dohme Corp.,STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 2 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 3 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 4 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 5 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 6B CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 7F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 8 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 9N CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 9V CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 10A CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 11A CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 12F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 14 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 15B CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 17F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 18C CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 19F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 20 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 22F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 23F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 33F CAPSULAR POLYSACCHARIDE ANTIGEN,25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25,ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL,"Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient]",
0006-4841_9ae11ba9-4ab4-476e-82ad-921333bbdb7d,0006-4841,VACCINE,VAQTA,,"hepatitis A vaccine, inactivated","INJECTION, SUSPENSION",INTRAMUSCULAR,19960329,,BLA,BLA103606,Merck Sharp & Dohme Corp.,HEPATITIS A VIRUS STRAIN CR 326F ANTIGEN (FORMALDEHYDE INACTIVATED),50,[iU]/mL,"Inactivated Hepatitis A Virus Vaccine [EPC],Actively Acquired Immunity [PE],Hepatitis A Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient]",
0006-4897_96eff106-f303-4140-b50f-34ebb8ad0fb8,0006-4897,VACCINE,PedvaxHIB,,Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate),"INJECTION, SUSPENSION",INTRAMUSCULAR,19891220,,BLA,BLA103237,Merck Sharp & Dohme Corp.,HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE MENINGOCOCCAL OUTER MEMBRANE PROTEIN CONJUGATE ANTIGEN,7.5,ug/.5mL,"Inactivated Haemophilus Influenzae B Vaccine [EPC],Actively Acquired Immunity [PE],Haemophilus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient]",
0006-4943_071f8653-783b-4628-b0f6-7d26317b50ca,0006-4943,VACCINE,PNEUMOVAX 23,,pneumococcal vaccine polyvalent,"INJECTION, SOLUTION",INTRAMUSCULAR; SUBCUTANEOUS,19830707,,BLA,BLA101094,Merck Sharp & Dohme Corp.,STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 2 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 3 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 4 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 5 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 6B CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 7F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 8 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 9N CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 9V CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 10A CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 11A CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 12F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 14 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 15B CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 17F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 18C CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 19F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 20 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 22F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 23F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 33F CAPSULAR POLYSACCHARIDE ANTIGEN,25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25,ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL,"Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient]",
0006-4963_531fec90-7b36-4a65-87a1-cfde58efbba6,0006-4963,VACCINE,ZOSTAVAX,,Zoster Vaccine Live,"INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION",SUBCUTANEOUS,20060525,,BLA,BLA125123,Merck Sharp & Dohme Corp.,VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN,19400,[PFU]/.65mL,"Live Attenuated Varicella Zoster Virus Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Attenuated [Chemical/Ingredient],Chickenpox Vaccine [Chemical/Ingredient],Live Attenuated Herpes Zoster Virus Vaccine [EPC],Herpes Zoster Vaccine [Chemical/Ingredient]",
0006-4981_1644ba2a-c49d-4c92-afe5-3fd922dbc8ae,0006-4981,VACCINE,RECOMBIVAX HB,,Hepatitis B Vaccine (Recombinant),"INJECTION, SUSPENSION",INTRAMUSCULAR; SUBCUTANEOUS,19860723,,BLA,BLA101066,Merck Sharp & Dohme Corp.,HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN,5,ug/.5mL,"Inactivated Hepatitis B Virus Vaccine [EPC],Actively Acquired Immunity [PE],Hepatitis B Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient]",
0006-4992_1644ba2a-c49d-4c92-afe5-3fd922dbc8ae,0006-4992,VACCINE,RECOMBIVAX HB,,Hepatitis B Vaccine (Recombinant),"INJECTION, SUSPENSION",INTRAMUSCULAR; SUBCUTANEOUS,19860723,,BLA,BLA101066,Merck Sharp & Dohme Corp.,HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN,40,ug/mL,"Inactivated Hepatitis B Virus Vaccine [EPC],Actively Acquired Immunity [PE],Hepatitis B Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient]",
0006-4995_1644ba2a-c49d-4c92-afe5-3fd922dbc8ae,0006-4995,VACCINE,RECOMBIVAX HB,,Hepatitis B Vaccine (Recombinant),"INJECTION, SUSPENSION",INTRAMUSCULAR; SUBCUTANEOUS,19860723,,BLA,BLA101066,Merck Sharp & Dohme Corp.,HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN,10,ug/mL,"Inactivated Hepatitis B Virus Vaccine [EPC],Actively Acquired Immunity [PE],Hepatitis B Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient]",
0006-4999_a67e41dc-692e-4f4f-b931-36e4ea467d9c,0006-4999,VACCINE,ProQuad,,"Measles, Mumps, Rubella and Varicella Virus Vaccine Live","INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION",SUBCUTANEOUS,20050906,,BLA,BLA125108,Merck Sharp & Dohme Corp.,MEASLES VIRUS STRAIN ENDERS' ATTENUATED EDMONSTON LIVE ANTIGEN; MUMPS VIRUS STRAIN B LEVEL JERYL LYNN LIVE ANTIGEN; RUBELLA VIRUS STRAIN WISTAR RA 27/3 LIVE ANTIGEN; VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN,1000; 20000; 1000; 9772,[TCID_50]/.5mL; [TCID_50]/.5mL; [TCID_50]/.5mL; [PFU]/.5mL,"Live Attenuated Measles Virus Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Attenuated [Chemical/Ingredient],Measles Vaccine [Chemical/Ingredient],Live Attenuated Mumps Virus Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Attenuated [Chemical/Ingredient],Mumps Vaccine [Chemical/Ingredient],Live Attenuated Rubella Virus Vaccine [EPC],Actively Acquired Immunity [PE],Rubella Vaccine [Chemical/Ingredient],Vaccines, Attenuated [Chemical/Ingredient],Live Attenuated Varicella Zoster Virus Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Attenuated [Chemical/Ingredient],Chickenpox Vaccine [Chemical/Ingredient],Live Attenuated Herpes Zoster Virus Vaccine [EPC],Herpes Zoster Vaccine [Chemical/Ingredient]",
0006-5420_214a1afa-d839-4f61-99ad-1b65cf7c0b5f,0006-5420,STANDARDIZED ALLERGENIC,RAGWITEK,,Short Ragweed Pollen Allergen Extract,TABLET,SUBLINGUAL,20140417,,BLA,BLA125478,Merck Sharp & Dohme Corp.,AMBROSIA ARTEMISIIFOLIA POLLEN,12,[Amb'a'1'U]/1,"Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient]",
0006-5423_dc8ac7d3-52d0-4e6b-b301-04f0013ddbaf,0006-5423,HUMAN PRESCRIPTION DRUG,BRIDION,,sugammadex,"INJECTION, SOLUTION",INTRAVENOUS,20151215,,NDA,NDA022225,Merck Sharp & Dohme Corp.,SUGAMMADEX SODIUM,100,mg/mL,gamma-Cyclodextrins [Chemical/Ingredient],
0006-5424_b1cd0874-ad29-49d3-a15f-6631fbd75e9a,0006-5424,PLASMA DERIVATIVE,ANTIVENIN,,Latrodectus mactans,KIT,,20141201,,BLA,BLA101062,Merck Sharp & Dohme Corp.,,,,,
0006-5425_dc8ac7d3-52d0-4e6b-b301-04f0013ddbaf,0006-5425,HUMAN PRESCRIPTION DRUG,BRIDION,,sugammadex,"INJECTION, SOLUTION",INTRAVENOUS,20151215,,NDA,NDA022225,Merck Sharp & Dohme Corp.,SUGAMMADEX SODIUM,100,mg/mL,gamma-Cyclodextrins [Chemical/Ingredient],
0006-9117_cf56f56a-26fc-4add-9dcd-b7ef4842f3d8,0006-9117,HUMAN PRESCRIPTION DRUG,SINGULAIR,,montelukast sodium,"TABLET, FILM COATED",ORAL,19980220,,NDA,NDA020829,Merck Sharp & Dohme Corp.,MONTELUKAST SODIUM,10,mg/1,"Leukotriene Receptor Antagonist [EPC],Leukotriene Receptor Antagonists [MoA]",
0006-9275_cf56f56a-26fc-4add-9dcd-b7ef4842f3d8,0006-9275,HUMAN PRESCRIPTION DRUG,SINGULAIR,,montelukast sodium,"TABLET, CHEWABLE",ORAL,19980220,,NDA,NDA020830,Merck Sharp & Dohme Corp.,MONTELUKAST SODIUM,5,mg/1,"Leukotriene Receptor Antagonist [EPC],Leukotriene Receptor Antagonists [MoA]",
0007-3370_c4959761-0667-4cf6-bf8b-f45dfd7b90f3,0007-3370,HUMAN PRESCRIPTION DRUG,COREG,CR,carvedilol phosphate,"CAPSULE, EXTENDED RELEASE",ORAL,20070209,,NDA,NDA022012,GlaxoSmithKline LLC,CARVEDILOL PHOSPHATE,10,mg/1,"Adrenergic alpha-Antagonists [MoA],Adrenergic beta1-Antagonists [MoA],Adrenergic beta2-Antagonists [MoA],alpha-Adrenergic Blocker [EPC],beta-Adrenergic Blocker [EPC]",
0007-3371_c4959761-0667-4cf6-bf8b-f45dfd7b90f3,0007-3371,HUMAN PRESCRIPTION DRUG,COREG,CR,carvedilol phosphate,"CAPSULE, EXTENDED RELEASE",ORAL,20070206,,NDA,NDA022012,GlaxoSmithKline LLC,CARVEDILOL PHOSPHATE,20,mg/1,"Adrenergic alpha-Antagonists [MoA],Adrenergic beta1-Antagonists [MoA],Adrenergic beta2-Antagonists [MoA],alpha-Adrenergic Blocker [EPC],beta-Adrenergic Blocker [EPC]",
0007-3372_c4959761-0667-4cf6-bf8b-f45dfd7b90f3,0007-3372,HUMAN PRESCRIPTION DRUG,COREG,CR,carvedilol phosphate,"CAPSULE, EXTENDED RELEASE",ORAL,20070214,,NDA,NDA022012,GlaxoSmithKline LLC,CARVEDILOL PHOSPHATE,40,mg/1,"Adrenergic alpha-Antagonists [MoA],Adrenergic beta1-Antagonists [MoA],Adrenergic beta2-Antagonists [MoA],alpha-Adrenergic Blocker [EPC],beta-Adrenergic Blocker [EPC]",
0007-3373_c4959761-0667-4cf6-bf8b-f45dfd7b90f3,0007-3373,HUMAN PRESCRIPTION DRUG,COREG,CR,carvedilol phosphate,"CAPSULE, EXTENDED RELEASE",ORAL,20070220,,NDA,NDA022012,GlaxoSmithKline LLC,CARVEDILOL PHOSPHATE,80,mg/1,"Adrenergic alpha-Antagonists [MoA],Adrenergic beta1-Antagonists [MoA],Adrenergic beta2-Antagonists [MoA],alpha-Adrenergic Blocker [EPC],beta-Adrenergic Blocker [EPC]",
0007-3650_be3263c9-a501-4d62-b452-b572a365ce1d,0007-3650,HUMAN PRESCRIPTION DRUG,DYAZIDE,,hydrochlorothiazide and triamterene,CAPSULE,ORAL,19940330,,NDA,NDA016042,GlaxoSmithKline LLC,HYDROCHLOROTHIAZIDE; TRIAMTERENE,25; 37.5,mg/1; mg/1,"Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient],Decreased Renal K+ Excretion [PE],Increased Diuresis [PE],Potassium-sparing Diuretic [EPC]",
0007-4139_c5a7f342-854f-4b98-9c44-b7b0af20d85b,0007-4139,HUMAN PRESCRIPTION DRUG,COREG,,carvedilol,"TABLET, FILM COATED",ORAL,19970603,,NDA,NDA020297,GlaxoSmithKline LLC,CARVEDILOL,3.125,mg/1,"Adrenergic alpha-Antagonists [MoA],Adrenergic beta1-Antagonists [MoA],Adrenergic beta2-Antagonists [MoA],alpha-Adrenergic Blocker [EPC],beta-Adrenergic Blocker [EPC]",
0007-4140_c5a7f342-854f-4b98-9c44-b7b0af20d85b,0007-4140,HUMAN PRESCRIPTION DRUG,COREG,,carvedilol,"TABLET, FILM COATED",ORAL,19970603,,NDA,NDA020297,GlaxoSmithKline LLC,CARVEDILOL,6.25,mg/1,"Adrenergic alpha-Antagonists [MoA],Adrenergic beta1-Antagonists [MoA],Adrenergic beta2-Antagonists [MoA],alpha-Adrenergic Blocker [EPC],beta-Adrenergic Blocker [EPC]",
0007-4141_c5a7f342-854f-4b98-9c44-b7b0af20d85b,0007-4141,HUMAN PRESCRIPTION DRUG,COREG,,carvedilol,"TABLET, FILM COATED",ORAL,19970603,,NDA,NDA020297,GlaxoSmithKline LLC,CARVEDILOL,12.5,mg/1,"Adrenergic alpha-Antagonists [MoA],Adrenergic beta1-Antagonists [MoA],Adrenergic beta2-Antagonists [MoA],alpha-Adrenergic Blocker [EPC],beta-Adrenergic Blocker [EPC]",
0007-4142_c5a7f342-854f-4b98-9c44-b7b0af20d85b,0007-4142,HUMAN PRESCRIPTION DRUG,COREG,,carvedilol,"TABLET, FILM COATED",ORAL,19970603,,NDA,NDA020297,GlaxoSmithKline LLC,CARVEDILOL,25,mg/1,"Adrenergic alpha-Antagonists [MoA],Adrenergic beta1-Antagonists [MoA],Adrenergic beta2-Antagonists [MoA],alpha-Adrenergic Blocker [EPC],beta-Adrenergic Blocker [EPC]",
0007-4201_e068e1b9-885e-4404-a3ed-17497de9e886,0007-4201,HUMAN PRESCRIPTION DRUG,HYCAMTIN,,topotecan hydrochloride,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,19960607,,NDA,NDA020671,GlaxoSmithKline LLC,TOPOTECAN HYDROCHLORIDE,4,mg/4mL,"Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA]",
0007-4205_7113d074-3995-4ed4-adb8-fbd6ec053148,0007-4205,HUMAN PRESCRIPTION DRUG,HYCAMTIN,,topotecan hydrochloride,CAPSULE,ORAL,20080916,,NDA,NDA020981,GlaxoSmithKline LLC,TOPOTECAN HYDROCHLORIDE,0.25,mg/1,"Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA]",
0007-4207_7113d074-3995-4ed4-adb8-fbd6ec053148,0007-4207,HUMAN PRESCRIPTION DRUG,HYCAMTIN,,topotecan hydrochloride,CAPSULE,ORAL,20080916,,NDA,NDA020981,GlaxoSmithKline LLC,TOPOTECAN HYDROCHLORIDE,1,mg/1,"Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA]",
0007-4401_22b8c921-10d4-4a4f-9811-384d2b98853b,0007-4401,HUMAN PRESCRIPTION DRUG,ARRANON,,nelarabine,INJECTION,INTRAVENOUS,20060119,20181231,NDA,NDA021877,GlaxoSmithKline LLC,NELARABINE,5,mg/mL,"Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]",
0007-4407_334cd1c6-10af-4aaf-abfd-603b6eb3a832,0007-4407,HUMAN PRESCRIPTION DRUG,ARGATROBAN,,argatroban,"INJECTION, SOLUTION",INTRAVENOUS,20001128,,NDA,NDA020883,GlaxoSmithKline LLC,ARGATROBAN,100,mg/mL,"Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA]",
0007-4640_c7c46a73-1f77-45f6-ab60-1aa8f9e87463,0007-4640,HUMAN PRESCRIPTION DRUG,PROMACTA,,eltrombopag olamine,"TABLET, FILM COATED",ORAL,20081124,20190430,NDA,NDA022291,GlaxoSmithKline LLC,ELTROMBOPAG OLAMINE,25,mg/1,"Increased Megakaryocyte Maturation [PE],Increased Platelet Production [PE],Thrombopoietin Receptor Agonist [EPC],Thrombopoietin Receptor Agonists [MoA],Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],UGT1A1 Inhibitors [MoA],UGT1A3 Inhibitors [MoA],UGT1A4 Inhibitors [MoA],UGT1A6 Inhibitors [MoA],UGT1A9 Inhibitors [MoA],UGT2B7 Inhibitors [MoA],UGT2B15 Inhibitors [MoA]",
0007-4641_c7c46a73-1f77-45f6-ab60-1aa8f9e87463,0007-4641,HUMAN PRESCRIPTION DRUG,PROMACTA,,eltrombopag olamine,"TABLET, FILM COATED",ORAL,20081124,20190430,NDA,NDA022291,GlaxoSmithKline LLC,ELTROMBOPAG OLAMINE,50,mg/1,"Increased Megakaryocyte Maturation [PE],Increased Platelet Production [PE],Thrombopoietin Receptor Agonist [EPC],Thrombopoietin Receptor Agonists [MoA],Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],UGT1A1 Inhibitors [MoA],UGT1A3 Inhibitors [MoA],UGT1A4 Inhibitors [MoA],UGT1A6 Inhibitors [MoA],UGT1A9 Inhibitors [MoA],UGT2B7 Inhibitors [MoA],UGT2B15 Inhibitors [MoA]",
0007-4642_c7c46a73-1f77-45f6-ab60-1aa8f9e87463,0007-4642,HUMAN PRESCRIPTION DRUG,PROMACTA,,eltrombopag olamine,"TABLET, FILM COATED",ORAL,20090105,20190331,NDA,NDA022291,GlaxoSmithKline LLC,ELTROMBOPAG OLAMINE,75,mg/1,"Increased Megakaryocyte Maturation [PE],Increased Platelet Production [PE],Thrombopoietin Receptor Agonist [EPC],Thrombopoietin Receptor Agonists [MoA],Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],UGT1A1 Inhibitors [MoA],UGT1A3 Inhibitors [MoA],UGT1A4 Inhibitors [MoA],UGT1A6 Inhibitors [MoA],UGT1A9 Inhibitors [MoA],UGT2B7 Inhibitors [MoA],UGT2B15 Inhibitors [MoA]",
0007-4643_c7c46a73-1f77-45f6-ab60-1aa8f9e87463,0007-4643,HUMAN PRESCRIPTION DRUG,PROMACTA,,eltrombopag olamine,"TABLET, FILM COATED",ORAL,20120102,20190430,NDA,NDA022291,GlaxoSmithKline LLC,ELTROMBOPAG OLAMINE,12.5,mg/1,"Increased Megakaryocyte Maturation [PE],Increased Platelet Production [PE],Thrombopoietin Receptor Agonist [EPC],Thrombopoietin Receptor Agonists [MoA],Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],UGT1A1 Inhibitors [MoA],UGT1A3 Inhibitors [MoA],UGT1A4 Inhibitors [MoA],UGT1A6 Inhibitors [MoA],UGT1A9 Inhibitors [MoA],UGT2B7 Inhibitors [MoA],UGT2B15 Inhibitors [MoA]",
0007-4882_90dd44c2-bb4a-48c5-88d2-76a2e8028aa3,0007-4882,HUMAN PRESCRIPTION DRUG,REQUIP,XL,ropinirole hydrochloride,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,20081120,,NDA,NDA022008,GlaxoSmithKline LLC,ROPINIROLE HYDROCHLORIDE,12,mg/1,"Dopamine Agonists [MoA],Nonergot Dopamine Agonist [EPC]",
0007-4883_90dd44c2-bb4a-48c5-88d2-76a2e8028aa3,0007-4883,HUMAN PRESCRIPTION DRUG,REQUIP,XL,ropinirole hydrochloride,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,20090803,,NDA,NDA022008,GlaxoSmithKline LLC,ROPINIROLE HYDROCHLORIDE,6,mg/1,"Dopamine Agonists [MoA],Nonergot Dopamine Agonist [EPC]",
0007-4885_90dd44c2-bb4a-48c5-88d2-76a2e8028aa3,0007-4885,HUMAN PRESCRIPTION DRUG,REQUIP,XL,ropinirole hydrochloride,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,20080630,,NDA,NDA022008,GlaxoSmithKline LLC,ROPINIROLE HYDROCHLORIDE,2,mg/1,"Dopamine Agonists [MoA],Nonergot Dopamine Agonist [EPC]",
0007-4887_90dd44c2-bb4a-48c5-88d2-76a2e8028aa3,0007-4887,HUMAN PRESCRIPTION DRUG,REQUIP,XL,ropinirole hydrochloride,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,20080630,,NDA,NDA022008,GlaxoSmithKline LLC,ROPINIROLE HYDROCHLORIDE,4,mg/1,"Dopamine Agonists [MoA],Nonergot Dopamine Agonist [EPC]",
0007-4888_90dd44c2-bb4a-48c5-88d2-76a2e8028aa3,0007-4888,HUMAN PRESCRIPTION DRUG,REQUIP,XL,ropinirole hydrochloride,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,20080630,,NDA,NDA022008,GlaxoSmithKline LLC,ROPINIROLE HYDROCHLORIDE,8,mg/1,"Dopamine Agonists [MoA],Nonergot Dopamine Agonist [EPC]",
0007-4890_9f995485-18d5-46e8-81a3-c293a27c8500,0007-4890,HUMAN PRESCRIPTION DRUG,REQUIP,,ropinirole,"TABLET, FILM COATED",ORAL,19971010,,NDA,NDA020658,GlaxoSmithKline LLC,ROPINIROLE HYDROCHLORIDE,0.25,mg/1,"Dopamine Agonists [MoA],Nonergot Dopamine Agonist [EPC]",
0007-4891_9f995485-18d5-46e8-81a3-c293a27c8500,0007-4891,HUMAN PRESCRIPTION DRUG,REQUIP,,ropinirole,"TABLET, FILM COATED",ORAL,19971010,,NDA,NDA020658,GlaxoSmithKline LLC,ROPINIROLE HYDROCHLORIDE,0.5,mg/1,"Dopamine Agonists [MoA],Nonergot Dopamine Agonist [EPC]",
0007-4892_9f995485-18d5-46e8-81a3-c293a27c8500,0007-4892,HUMAN PRESCRIPTION DRUG,REQUIP,,ropinirole,"TABLET, FILM COATED",ORAL,19971001,,NDA,NDA020658,GlaxoSmithKline LLC,ROPINIROLE HYDROCHLORIDE,1,mg/1,"Dopamine Agonists [MoA],Nonergot Dopamine Agonist [EPC]",
0007-4893_9f995485-18d5-46e8-81a3-c293a27c8500,0007-4893,HUMAN PRESCRIPTION DRUG,REQUIP,,ropinirole,"TABLET, FILM COATED",ORAL,19971003,,NDA,NDA020658,GlaxoSmithKline LLC,ROPINIROLE HYDROCHLORIDE,2,mg/1,"Dopamine Agonists [MoA],Nonergot Dopamine Agonist [EPC]",
0007-4894_9f995485-18d5-46e8-81a3-c293a27c8500,0007-4894,HUMAN PRESCRIPTION DRUG,REQUIP,,ropinirole,"TABLET, FILM COATED",ORAL,19971010,,NDA,NDA020658,GlaxoSmithKline LLC,ROPINIROLE HYDROCHLORIDE,5,mg/1,"Dopamine Agonists [MoA],Nonergot Dopamine Agonist [EPC]",
0007-4895_9f995485-18d5-46e8-81a3-c293a27c8500,0007-4895,HUMAN PRESCRIPTION DRUG,REQUIP,,ropinirole,"TABLET, FILM COATED",ORAL,20010619,,NDA,NDA020658,GlaxoSmithKline LLC,ROPINIROLE HYDROCHLORIDE,3,mg/1,"Dopamine Agonists [MoA],Nonergot Dopamine Agonist [EPC]",
0007-4896_9f995485-18d5-46e8-81a3-c293a27c8500,0007-4896,HUMAN PRESCRIPTION DRUG,REQUIP,,ropinirole,"TABLET, FILM COATED",ORAL,19990921,,NDA,NDA020658,GlaxoSmithKline LLC,ROPINIROLE HYDROCHLORIDE,4,mg/1,"Dopamine Agonists [MoA],Nonergot Dopamine Agonist [EPC]",
0008-0045_d347a992-be44-4c96-8a13-185a4997d70f,0008-0045,HUMAN PRESCRIPTION DRUG,vinorelbine tartrate,,vinorelbine tartrate,"INJECTION, SOLUTION",INTRAVENOUS,20080213,,ANDA,ANDA178408,Wyeth Pharmaceuticals Company,VINORELBINE TARTRATE,10,mg/mL,"Vinca Alkaloid [EPC],Vinca Alkaloids [Chemical/Ingredient]",
0008-0100_ee6c1ea5-47ab-478b-996d-461022339832,0008-0100,HUMAN PRESCRIPTION DRUG,Besponsa,,inotuzumab ozogamicin,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20170818,,BLA,BLA761040,"Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.",INOTUZUMAB OZOGAMICIN,0.25,mg/mL,,
0008-0423_da5f96b0-5d06-4975-a2db-4e1c989385e0,0008-0423,HUMAN PRESCRIPTION DRUG,North American Coral Snake Antivenin (Equine),,Coral Snake (Micrurus Fulvius) Immune Globulin Antivenin (Equine),"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS,20161012,,BLA,BLA101099,"Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.",CORAL SNAKE (MICRURUS FULVIUS) IMMUNE GLOBULIN ANTIVENIN (EQUINE),250,[arb'U]/10mL,,
0008-0607_3c6741f3-f059-484f-91be-a77860557d68,0008-0607,HUMAN PRESCRIPTION DRUG,Pantoprazole Sodium,Delayed-Release,pantoprazole sodium,"TABLET, DELAYED RELEASE",ORAL,20080131,20171031,NDA,NDA020987,"Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.",PANTOPRAZOLE SODIUM,40,mg/1,"Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA]",
0008-0833_1a689d3e-3689-4f31-b5d1-f94b033a7a4e,0008-0833,HUMAN PRESCRIPTION DRUG,Effexor,XR,VENLAFAXINE HYDROCHLORIDE,"CAPSULE, EXTENDED RELEASE",ORAL,19971101,,NDA,NDA020699,"Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.",VENLAFAXINE HYDROCHLORIDE,75,mg/1,"Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]",
0008-0836_1a689d3e-3689-4f31-b5d1-f94b033a7a4e,0008-0836,HUMAN PRESCRIPTION DRUG,Effexor,XR,VENLAFAXINE HYDROCHLORIDE,"CAPSULE, EXTENDED RELEASE",ORAL,19971101,,NDA,NDA020699,"Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.",VENLAFAXINE HYDROCHLORIDE,150,mg/1,"Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]",
0008-0837_1a689d3e-3689-4f31-b5d1-f94b033a7a4e,0008-0837,HUMAN PRESCRIPTION DRUG,Effexor,XR,VENLAFAXINE HYDROCHLORIDE,"CAPSULE, EXTENDED RELEASE",ORAL,19971101,,NDA,NDA020699,"Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.",VENLAFAXINE HYDROCHLORIDE,37.5,mg/1,"Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]",
0008-0841_37ee1908-420a-4f4a-a5a9-b2a3870eda77,0008-0841,HUMAN PRESCRIPTION DRUG,Protonix,Delayed-Release,PANTOPRAZOLE SODIUM,"TABLET, DELAYED RELEASE",ORAL,20000501,,NDA,NDA020987,"Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.",PANTOPRAZOLE SODIUM,40,mg/1,"Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA]",
0008-0843_37ee1908-420a-4f4a-a5a9-b2a3870eda77,0008-0843,HUMAN PRESCRIPTION DRUG,Protonix,Delayed-Release,PANTOPRAZOLE SODIUM,"TABLET, DELAYED RELEASE",ORAL,20000501,,NDA,NDA020987,"Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.",PANTOPRAZOLE SODIUM,20,mg/1,"Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA]",
0008-0844_37ee1908-420a-4f4a-a5a9-b2a3870eda77,0008-0844,HUMAN PRESCRIPTION DRUG,Protonix,Delayed-Release,PANTOPRAZOLE SODIUM,"GRANULE, DELAYED RELEASE",ORAL,20080229,,NDA,NDA022020,"Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.",PANTOPRAZOLE SODIUM,40,mg/1,"Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA]",
0008-0923_81989ffb-0f02-4cc4-9d61-05fd58763b18,0008-0923,HUMAN PRESCRIPTION DRUG,Protonix,I.V.,PANTOPRAZOLE SODIUM,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS,20010501,,NDA,NDA020988,"Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.",PANTOPRAZOLE SODIUM,40,mg/10mL,"Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA]",
0008-0941_91d18ffa-b4b1-493e-816f-dfdc6bad33ad,0008-0941,HUMAN PRESCRIPTION DRUG,Protonix,I.V.,pantoprazole sodium,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS,20010501,,NDA,NDA020988,"Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.",PANTOPRAZOLE SODIUM,40,mg/10mL,"Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA]",
0008-1030_d3bb2f6c-e26b-4623-bd8b-300db4c5d713,0008-1030,HUMAN PRESCRIPTION DRUG,Rapamune,,SIROLIMUS,SOLUTION,ORAL,19990901,,NDA,NDA021083,"Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.",SIROLIMUS,1,mg/mL,"Decreased Immunologic Activity [PE],mTOR Inhibitor Immunosuppressant [EPC],mTOR Inhibitors [MoA],Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA]",
0008-1040_d3bb2f6c-e26b-4623-bd8b-300db4c5d713,0008-1040,HUMAN PRESCRIPTION DRUG,Rapamune,,SIROLIMUS,"TABLET, SUGAR COATED",ORAL,20100301,,NDA,NDA021110,"Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.",SIROLIMUS,0.5,mg/1,"Decreased Immunologic Activity [PE],mTOR Inhibitor Immunosuppressant [EPC],mTOR Inhibitors [MoA],Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA]",
0008-1041_d3bb2f6c-e26b-4623-bd8b-300db4c5d713,0008-1041,HUMAN PRESCRIPTION DRUG,Rapamune,,SIROLIMUS,"TABLET, SUGAR COATED",ORAL,20010701,,NDA,NDA021110,"Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.",SIROLIMUS,1,mg/1,"Decreased Immunologic Activity [PE],mTOR Inhibitor Immunosuppressant [EPC],mTOR Inhibitors [MoA],Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA]",
0008-1042_d3bb2f6c-e26b-4623-bd8b-300db4c5d713,0008-1042,HUMAN PRESCRIPTION DRUG,Rapamune,,SIROLIMUS,"TABLET, SUGAR COATED",ORAL,20010701,,NDA,NDA021110,"Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.",SIROLIMUS,2,mg/1,"Decreased Immunologic Activity [PE],mTOR Inhibitor Immunosuppressant [EPC],mTOR Inhibitors [MoA],Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA]",
0008-1123_132a44d9-7950-4536-8093-d03a6911c50c,0008-1123,HUMAN PRESCRIPTION DRUG,Duavee,,conjugated estrogens/bazedoxifene,"TABLET, FILM COATED",ORAL,20131003,,NDA,NDA022247,"Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.","ESTROGENS, CONJUGATED; BAZEDOXIFENE ACETATE",.45; 20,mg/1; mg/1,"Estrogen [EPC],Estrogen Receptor Agonists [MoA],Estrogens, Conjugated (USP) [Chemical/Ingredient],Estrogen Agonist/Antagonist [EPC],Selective Estrogen Receptor Modulators [MoA]",
0008-1179_3b4f7783-3213-4fe8-aa59-b244519aee56,0008-1179,HUMAN PRESCRIPTION DRUG,Torisel,,temsirolimus,KIT,,20070701,,NDA,NDA022088,"Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.",,,,,
0008-1210_2cca96fb-7f9f-4f2d-83ff-3cd6101f56e7,0008-1210,HUMAN PRESCRIPTION DRUG,Pristiq,Extended-Release,desvenlafaxine succinate,"TABLET, EXTENDED RELEASE",ORAL,20150401,,NDA,NDA021992,"Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.",DESVENLAFAXINE SUCCINATE,25,mg/1,"Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA]",
0008-1211_2cca96fb-7f9f-4f2d-83ff-3cd6101f56e7,0008-1211,HUMAN PRESCRIPTION DRUG,Pristiq,Extended-Release,desvenlafaxine succinate,"TABLET, EXTENDED RELEASE",ORAL,20080501,,NDA,NDA021992,"Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.",DESVENLAFAXINE SUCCINATE,50,mg/1,"Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA]",
0008-1222_2cca96fb-7f9f-4f2d-83ff-3cd6101f56e7,0008-1222,HUMAN PRESCRIPTION DRUG,Pristiq,Extended-Release,desvenlafaxine succinate,"TABLET, EXTENDED RELEASE",ORAL,20080501,,NDA,NDA021992,"Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.",DESVENLAFAXINE SUCCINATE,100,mg/1,"Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA]",
0008-2001_47c3327c-193e-4000-bd12-8f905f4e4ddb,0008-2001,HUMAN PRESCRIPTION DRUG,Protonix,I.V.,PANTOPRAZOLE SODIUM,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS,20140317,,NDA,NDA020988,"Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.",PANTOPRAZOLE SODIUM,40,mg/10mL,"Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA]",
0008-4001_36f56288-e0e8-4a7d-9e89-cd5b5e5bb037,0008-4001,HUMAN PRESCRIPTION DRUG,Protonix,I.V.,PANTOPRAZOLE SODIUM,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS,20130501,,NDA,NDA020988,"Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.",PANTOPRAZOLE SODIUM,40,mg/10mL,"Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA]",
0008-4117_b4a80867-83e7-4ce0-8023-4f02c6765b90,0008-4117,HUMAN PRESCRIPTION DRUG,Trecator,,ethionamide,"TABLET, FILM COATED",ORAL,20041108,,NDA,NDA013026,"Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.",ETHIONAMIDE,250,mg/1,Antimycobacterial [EPC],
0008-4510_da94b46a-1ee4-476a-bd6f-e60c52918c52,0008-4510,HUMAN PRESCRIPTION DRUG,Mylotarg,,gemtuzumab ozogamicin,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20170907,,BLA,BLA761060,"Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.",GEMTUZUMAB OZOGAMICIN,5,mg/5mL,CD33-directed Cytotoxin [EPC],
0008-4990_0129f084-5a59-4282-b27b-3f2dd31381fa,0008-4990,HUMAN PRESCRIPTION DRUG,Tygacil,,TIGECYCLINE,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20050601,,NDA,NDA021821,"Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.",TIGECYCLINE,50,mg/5mL,"Tetracycline-class Antibacterial [EPC],Tetracyclines [Chemical/Ingredient]",
0008-4994_10b9af3a-9a50-4cd2-92af-061b0159e9eb,0008-4994,HUMAN PRESCRIPTION DRUG,Tygacil,,TIGECYCLINE,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20170208,,NDA,NDA021821,"Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.",TIGECYCLINE,50,mg/5mL,"Tetracycline-class Antibacterial [EPC],Tetracyclines [Chemical/Ingredient]",
0009-0003_9f108946-8e00-4570-8335-2b6de7251a55,0009-0003,HUMAN PRESCRIPTION DRUG,SOLU-MEDROL,,methylprednisolone sodium succinate,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,19590402,,NDA,NDA011856,Pharmacia and Upjohn Company LLC,METHYLPREDNISOLONE SODIUM SUCCINATE,500,mg/mL,"Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]",
0009-0005_4644d33c-93fd-4d77-b8d2-bb586f616c98,0009-0005,HUMAN PRESCRIPTION DRUG,Solu-Cortef,,hydrocortisone sodium succinate,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,19550427,,NDA,NDA009866,Pharmacia and Upjohn Company LLC,HYDROCORTISONE SODIUM SUCCINATE,1000,mg/8mL,"Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]",
0009-0011_4644d33c-93fd-4d77-b8d2-bb586f616c98,0009-0011,HUMAN PRESCRIPTION DRUG,Solu-Cortef,,hydrocortisone sodium succinate,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,19550427,,NDA,NDA009866,Pharmacia and Upjohn Company LLC,HYDROCORTISONE SODIUM SUCCINATE,100,mg/2mL,"Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]",
0009-0012_dc373892-bb58-40c2-a2fd-0b6a90f6cf49,0009-0012,HUMAN PRESCRIPTION DRUG,CORTEF,,hydrocortisone,TABLET,ORAL,19521215,,NDA,NDA008697,Pharmacia and Upjohn Company LLC,HYDROCORTISONE,5,mg/1,"Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]",
0009-0013_4644d33c-93fd-4d77-b8d2-bb586f616c98,0009-0013,HUMAN PRESCRIPTION DRUG,Solu-Cortef,,hydrocortisone sodium succinate,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,19550427,,NDA,NDA009866,Pharmacia and Upjohn Company LLC,HYDROCORTISONE SODIUM SUCCINATE,250,mg/2mL,"Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]",
0009-0016_4644d33c-93fd-4d77-b8d2-bb586f616c98,0009-0016,HUMAN PRESCRIPTION DRUG,Solu-Cortef,,hydrocortisone sodium succinate,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,19550427,,NDA,NDA009866,Pharmacia and Upjohn Company LLC,HYDROCORTISONE SODIUM SUCCINATE,500,mg/4mL,"Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]",
0009-0017_63e93c08-0f2d-4a36-9fd7-d61c33a1baf2,0009-0017,HUMAN PRESCRIPTION DRUG,Halcion,,triazolam,TABLET,ORAL,19821115,,NDA,NDA017892,Pharmacia and Upjohn Company LLC,TRIAZOLAM,0.25,mg/1,"Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient]",CIV
0009-0018_9f108946-8e00-4570-8335-2b6de7251a55,0009-0018,HUMAN PRESCRIPTION DRUG,SOLU-MEDROL,,methylprednisolone sodium succinate,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,19590402,,NDA,NDA011856,Pharmacia and Upjohn Company LLC,METHYLPREDNISOLONE SODIUM SUCCINATE,1,g/mL,"Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]",
0009-0020_23d6d834-b9ea-48b7-83af-64794ab6a7dc,0009-0020,HUMAN PRESCRIPTION DRUG,Medrol,,methylprednisolone,TABLET,ORAL,20130920,,NDA,NDA011153,Pharmacia and Upjohn Company LLC,METHYLPREDNISOLONE,2,mg/1,"Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]",
0009-0022_23d6d834-b9ea-48b7-83af-64794ab6a7dc,0009-0022,HUMAN PRESCRIPTION DRUG,Medrol,,methylprednisolone,TABLET,ORAL,19571024,,NDA,NDA011153,Pharmacia and Upjohn Company LLC,METHYLPREDNISOLONE,8,mg/1,"Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]",
0009-0029_afc4f1e9-2318-41e3-aa36-91e5da3d62d2,0009-0029,HUMAN PRESCRIPTION DRUG,Xanax,,alprazolam,TABLET,ORAL,19811016,,NDA,NDA018276,Pharmacia and Upjohn Company LLC,ALPRAZOLAM,0.25,mg/1,"Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient]",CIV
0009-0031_dc373892-bb58-40c2-a2fd-0b6a90f6cf49,0009-0031,HUMAN PRESCRIPTION DRUG,CORTEF,,hydrocortisone,TABLET,ORAL,19521215,,NDA,NDA008697,Pharmacia and Upjohn Company LLC,HYDROCORTISONE,10,mg/1,"Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]",
0009-0039_9f108946-8e00-4570-8335-2b6de7251a55,0009-0039,HUMAN PRESCRIPTION DRUG,SOLU-MEDROL,,methylprednisolone sodium succinate,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,19590402,,NDA,NDA011856,Pharmacia and Upjohn Company LLC,METHYLPREDNISOLONE SODIUM SUCCINATE,40,mg/mL,"Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]",
0009-0039_cfac1182-2491-4371-a585-348acf0b4769,0009-0039,HUMAN PRESCRIPTION DRUG,Solu-Medrol,,methylprednisolone sodium succinate,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,19590402,,NDA,NDA011856,Pharmacia and Upjohn Company LLC,METHYLPREDNISOLONE SODIUM SUCCINATE,40,mg/mL,"Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]",
0009-0044_dc373892-bb58-40c2-a2fd-0b6a90f6cf49,0009-0044,HUMAN PRESCRIPTION DRUG,CORTEF,,hydrocortisone,TABLET,ORAL,19521215,,NDA,NDA008697,Pharmacia and Upjohn Company LLC,HYDROCORTISONE,20,mg/1,"Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]",
0009-0047_9f108946-8e00-4570-8335-2b6de7251a55,0009-0047,HUMAN PRESCRIPTION DRUG,SOLU-MEDROL,,methylprednisolone sodium succinate,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,19590402,,NDA,NDA011856,Pharmacia and Upjohn Company LLC,METHYLPREDNISOLONE SODIUM SUCCINATE,125,mg/mL,"Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]",
0009-0050_8e280ce3-d109-4622-a824-d8bbaa045147,0009-0050,HUMAN PRESCRIPTION DRUG,Provera,,medroxyprogesterone acetate,TABLET,ORAL,19590603,,NDA,NDA011839,Pharmacia and Upjohn Company LLC,MEDROXYPROGESTERONE ACETATE,10,mg/1,"Progesterone Congeners [Chemical/Ingredient],Progestin [EPC]",
0009-0055_afc4f1e9-2318-41e3-aa36-91e5da3d62d2,0009-0055,HUMAN PRESCRIPTION DRUG,Xanax,,alprazolam,TABLET,ORAL,19811016,,NDA,NDA018276,Pharmacia and Upjohn Company LLC,ALPRAZOLAM,0.5,mg/1,"Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient]",CIV
0009-0056_23d6d834-b9ea-48b7-83af-64794ab6a7dc,0009-0056,HUMAN PRESCRIPTION DRUG,Medrol,,methylprednisolone,TABLET,ORAL,19571024,,NDA,NDA011153,Pharmacia and Upjohn Company LLC,METHYLPREDNISOLONE,4,mg/1,"Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]",
0009-0057_b2692032-029d-4725-a3d2-6ed4b06aaefa,0009-0057,HUMAN PRESCRIPTION DRUG,Xanax,XR,alprazolam,"TABLET, EXTENDED RELEASE",ORAL,20030117,,NDA,NDA021434,Pharmacia and Upjohn Company LLC,ALPRAZOLAM,0.5,mg/1,"Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient]",CIV
0009-0059_b2692032-029d-4725-a3d2-6ed4b06aaefa,0009-0059,HUMAN PRESCRIPTION DRUG,Xanax,XR,alprazolam,"TABLET, EXTENDED RELEASE",ORAL,20030117,,NDA,NDA021434,Pharmacia and Upjohn Company LLC,ALPRAZOLAM,1,mg/1,"Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient]",CIV
0009-0064_8e280ce3-d109-4622-a824-d8bbaa045147,0009-0064,HUMAN PRESCRIPTION DRUG,Provera,,medroxyprogesterone acetate,TABLET,ORAL,19590603,,NDA,NDA011839,Pharmacia and Upjohn Company LLC,MEDROXYPROGESTERONE ACETATE,2.5,mg/1,"Progesterone Congeners [Chemical/Ingredient],Progestin [EPC]",
0009-0066_b2692032-029d-4725-a3d2-6ed4b06aaefa,0009-0066,HUMAN PRESCRIPTION DRUG,Xanax,XR,alprazolam,"TABLET, EXTENDED RELEASE",ORAL,20030117,,NDA,NDA021434,Pharmacia and Upjohn Company LLC,ALPRAZOLAM,2,mg/1,"Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient]",CIV
0009-0068_b2692032-029d-4725-a3d2-6ed4b06aaefa,0009-0068,HUMAN PRESCRIPTION DRUG,Xanax,XR,alprazolam,"TABLET, EXTENDED RELEASE",ORAL,20030117,,NDA,NDA021434,Pharmacia and Upjohn Company LLC,ALPRAZOLAM,3,mg/1,"Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient]",CIV
0009-0073_23d6d834-b9ea-48b7-83af-64794ab6a7dc,0009-0073,HUMAN PRESCRIPTION DRUG,Medrol,,methylprednisolone,TABLET,ORAL,19571024,,NDA,NDA011153,Pharmacia and Upjohn Company LLC,METHYLPREDNISOLONE,16,mg/1,"Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]",
0009-0085_16444270-09e9-4039-bfe8-d2bc9062e215,0009-0085,HUMAN PRESCRIPTION DRUG,Depo-Testosterone,,testosterone cypionate,"INJECTION, SOLUTION",INTRAMUSCULAR,20140701,,ANDA,ANDA085635,Pharmacia and Upjohn Company LLC,TESTOSTERONE CYPIONATE,100,mg/mL,"Androgen [EPC],Androgen Receptor Agonists [MoA],Androstanes [Chemical/Ingredient]",CIII
0009-0086_16444270-09e9-4039-bfe8-d2bc9062e215,0009-0086,HUMAN PRESCRIPTION DRUG,Depo-Testosterone,,testosterone cypionate,"INJECTION, SOLUTION",INTRAMUSCULAR,20140701,,ANDA,ANDA085635,Pharmacia and Upjohn Company LLC,TESTOSTERONE CYPIONATE,200,mg/mL,"Androgen [EPC],Androgen Receptor Agonists [MoA],Androstanes [Chemical/Ingredient]",CIII
0009-0090_afc4f1e9-2318-41e3-aa36-91e5da3d62d2,0009-0090,HUMAN PRESCRIPTION DRUG,Xanax,,alprazolam,TABLET,ORAL,19811016,,NDA,NDA018276,Pharmacia and Upjohn Company LLC,ALPRAZOLAM,1,mg/1,"Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient]",CIV
0009-0094_afc4f1e9-2318-41e3-aa36-91e5da3d62d2,0009-0094,HUMAN PRESCRIPTION DRUG,Xanax,,alprazolam,TABLET,ORAL,19811016,,NDA,NDA018276,Pharmacia and Upjohn Company LLC,ALPRAZOLAM,2,mg/1,"Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient]",CIV
0009-0176_23d6d834-b9ea-48b7-83af-64794ab6a7dc,0009-0176,HUMAN PRESCRIPTION DRUG,Medrol,,methylprednisolone,TABLET,ORAL,19571024,,NDA,NDA011153,Pharmacia and Upjohn Company LLC,METHYLPREDNISOLONE,32,mg/1,"Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]",
0009-0225_8102ccc4-0f6f-4fcf-a5e6-ada71e158615,0009-0225,HUMAN PRESCRIPTION DRUG,Cleocin Hydrochloride,,clindamycin hydrochloride,CAPSULE,ORAL,19700522,,NDA,NDA050162,Pharmacia and Upjohn Company LLC,CLINDAMYCIN HYDROCHLORIDE,150,mg/1,"Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient]",
0009-0233_a0593b12-3a06-4043-b533-223e9c001392,0009-0233,HUMAN PRESCRIPTION DRUG,Bacitracin,,Bacitracin,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR,19480729,,ANDA,ANDA060733,Pharmacia and Upjohn Company LLC,BACITRACIN A,5000,[USP'U]/mL,,
0009-0233_fdafa7dd-f9e7-47d4-b2d9-054d9fcc861e,0009-0233,HUMAN PRESCRIPTION DRUG,Bacitracin,,Bacitracin,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR,19480729,,ANDA,ANDA060733,Pharmacia and Upjohn Company LLC,BACITRACIN,5000,[USP'U]/mL,Decreased Cell Wall Synthesis &amp; Repair [PE],
0009-0234_5aed9542-6254-460a-a461-2b324a775cbd,0009-0234,HUMAN PRESCRIPTION DRUG,Bacitracin,,Bacitracin,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR,19480729,,ANDA,ANDA060733,Pharmacia and Upjohn Company LLC,BACITRACIN,5000,[USP'U]/mL,Decreased Cell Wall Synthesis &amp; Repair [PE],
0009-0241_d82a009a-6e8d-4469-99c0-9cb2b84f8421,0009-0241,HUMAN PRESCRIPTION DRUG,Bacitracin,,Bacitracin,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR,19480729,,ANDA,ANDA060733,Pharmacia and Upjohn Company LLC,BACITRACIN A,5000,[USP'U]/mL,,
0009-0260_a7effc61-c146-43e2-89ce-297c211a7975,0009-0260,HUMAN PRESCRIPTION DRUG,Colestid,,Colestipol Hydrochloride,"GRANULE, FOR SUSPENSION",ORAL,19770404,,NDA,NDA017563,Pharmacia and Upjohn Company LLC,COLESTIPOL HYDROCHLORIDE,5,g/5g,"Bile Acid Sequestrant [EPC],Bile-acid Binding Activity [MoA]",
0009-0271_2ac78160-8006-40b3-9635-59c6d008a4ec,0009-0271,HUMAN PRESCRIPTION DRUG,Depo-Estradiol,,estradiol cypionate,INJECTION,INTRAMUSCULAR,19790815,,ANDA,ANDA085470,Pharmacia and Upjohn Company LLC,ESTRADIOL CYPIONATE,5,mg/mL,"Estradiol Congeners [Chemical/Ingredient],Estrogen [EPC],Estrogen Receptor Agonists [MoA]",
0009-0274_195b9016-034a-48e1-8724-f4cf99eeb357,0009-0274,HUMAN PRESCRIPTION DRUG,Depo-Medrol,,methylprednisolone acetate,"INJECTION, SUSPENSION",INTRALESIONAL; INTRAMUSCULAR; INTRASYNOVIAL; SOFT TISSUE,19590528,,NDA,NDA011757,Pharmacia and Upjohn Company LLC,METHYLPREDNISOLONE ACETATE,20,mg/mL,"Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]",
0009-0280_195b9016-034a-48e1-8724-f4cf99eeb357,0009-0280,HUMAN PRESCRIPTION DRUG,Depo-Medrol,,methylprednisolone acetate,"INJECTION, SUSPENSION",INTRALESIONAL; INTRAMUSCULAR; INTRASYNOVIAL; SOFT TISSUE,19590528,,NDA,NDA011757,Pharmacia and Upjohn Company LLC,METHYLPREDNISOLONE ACETATE,40,mg/mL,"Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]",
0009-0280_d5c7d140-4ca4-4f25-ab21-1cb2ef2ab226,0009-0280,HUMAN PRESCRIPTION DRUG,Depo-Medrol,,methylprednisolone acetate,"INJECTION, SUSPENSION",INTRALESIONAL; INTRAMUSCULAR; INTRASYNOVIAL; SOFT TISSUE,19590528,,NDA,NDA011757,Pharmacia and Upjohn Company,METHYLPREDNISOLONE ACETATE,40,mg/mL,"Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]",
0009-0286_8e280ce3-d109-4622-a824-d8bbaa045147,0009-0286,HUMAN PRESCRIPTION DRUG,Provera,,medroxyprogesterone acetate,TABLET,ORAL,19590603,,NDA,NDA011839,Pharmacia and Upjohn Company LLC,MEDROXYPROGESTERONE ACETATE,5,mg/1,"Progesterone Congeners [Chemical/Ingredient],Progestin [EPC]",
0009-0302_bcee33c3-6db8-4ec0-b7b7-85c516cde450,0009-0302,HUMAN PRESCRIPTION DRUG,Cleocin Phosphate,,clindamycin phosphate,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,20140410,,NDA,NDA050441,Pharmacia and Upjohn Company LLC,CLINDAMYCIN PHOSPHATE,150,mg/mL,"Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient]",
0009-0306_195b9016-034a-48e1-8724-f4cf99eeb357,0009-0306,HUMAN PRESCRIPTION DRUG,Depo-Medrol,,methylprednisolone acetate,"INJECTION, SUSPENSION",INTRALESIONAL; INTRAMUSCULAR; INTRASYNOVIAL; SOFT TISSUE,19590528,,NDA,NDA011757,Pharmacia and Upjohn Company LLC,METHYLPREDNISOLONE ACETATE,80,mg/mL,"Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]",
0009-0306_d5c7d140-4ca4-4f25-ab21-1cb2ef2ab226,0009-0306,HUMAN PRESCRIPTION DRUG,Depo-Medrol,,methylprednisolone acetate,"INJECTION, SUSPENSION",INTRALESIONAL; INTRAMUSCULAR; INTRASYNOVIAL; SOFT TISSUE,19590528,,NDA,NDA011757,Pharmacia and Upjohn Company,METHYLPREDNISOLONE ACETATE,80,mg/mL,"Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]",
0009-0331_8102ccc4-0f6f-4fcf-a5e6-ada71e158615,0009-0331,HUMAN PRESCRIPTION DRUG,Cleocin Hydrochloride,,clindamycin hydrochloride,CAPSULE,ORAL,19700522,,NDA,NDA050162,Pharmacia and Upjohn Company LLC,CLINDAMYCIN HYDROCHLORIDE,75,mg/1,"Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient]",
0009-0341_0a039701-29e2-48ae-a8c1-875e30eb0c57,0009-0341,HUMAN PRESCRIPTION DRUG,Glynase,,glyburide,TABLET,ORAL,19920304,,NDA,NDA020051,Pharmacia and Upjohn Company LLC,GLYBURIDE,1.5,mg/1,"Sulfonylurea [EPC],Sulfonylurea Compounds [Chemical/Ingredient]",
0009-0347_b2f78f67-9064-4776-8787-c44145f8f18f,0009-0347,HUMAN PRESCRIPTION DRUG,Depo-Testosterone,,testosterone cypionate,"INJECTION, SOLUTION",INTRAMUSCULAR,19790725,,ANDA,ANDA085635,Pharmacia and Upjohn Company LLC,TESTOSTERONE CYPIONATE,100,mg/mL,"Androgen [EPC],Androgen Receptor Agonists [MoA],Androstanes [Chemical/Ingredient]",CIII
0009-0352_0a039701-29e2-48ae-a8c1-875e30eb0c57,0009-0352,HUMAN PRESCRIPTION DRUG,Glynase,,glyburide,TABLET,ORAL,19920304,,NDA,NDA020051,Pharmacia and Upjohn Company LLC,GLYBURIDE,3,mg/1,"Sulfonylurea [EPC],Sulfonylurea Compounds [Chemical/Ingredient]",
0009-0370_a7effc61-c146-43e2-89ce-297c211a7975,0009-0370,HUMAN PRESCRIPTION DRUG,Flavored Colestid,,Colestipol Hydrochloride,"GRANULE, FOR SUSPENSION",ORAL,19770404,,NDA,NDA017563,Pharmacia and Upjohn Company LLC,COLESTIPOL HYDROCHLORIDE,5,g/7.5g,"Bile Acid Sequestrant [EPC],Bile-acid Binding Activity [MoA]",
0009-0395_8102ccc4-0f6f-4fcf-a5e6-ada71e158615,0009-0395,HUMAN PRESCRIPTION DRUG,Cleocin Hydrochloride,,clindamycin hydrochloride,CAPSULE,ORAL,19700522,,NDA,NDA050162,Pharmacia and Upjohn Company LLC,CLINDAMYCIN HYDROCHLORIDE,300,mg/1,"Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient]",
0009-0417_b2f78f67-9064-4776-8787-c44145f8f18f,0009-0417,HUMAN PRESCRIPTION DRUG,Depo-Testosterone,,testosterone cypionate,"INJECTION, SOLUTION",INTRAMUSCULAR,19790725,,ANDA,ANDA085635,Pharmacia and Upjohn Company LLC,TESTOSTERONE CYPIONATE,200,mg/mL,"Androgen [EPC],Androgen Receptor Agonists [MoA],Androstanes [Chemical/Ingredient]",CIII
0009-0436_6acdd918-6c3b-4eb8-93f4-dafb72e47c76,0009-0436,HUMAN PRESCRIPTION DRUG,R-Gene,,Arginine Hydrochloride,"INJECTION, SOLUTION",INTRAVENOUS,19760615,,NDA,NDA016931,Pharmacia and Upjohn Company LLC,ARGININE HYDROCHLORIDE,10,g/100mL,,
0009-0450_c01764bb-6f06-4935-bb33-9cdad812d4c5,0009-0450,HUMAN PRESCRIPTION DRUG,Colestid,,Colestipol Hydrochloride,TABLET,ORAL,19940719,,NDA,NDA020222,Pharmacia and Upjohn Company LLC,COLESTIPOL HYDROCHLORIDE,1,g/1,"Bile Acid Sequestrant [EPC],Bile-acid Binding Activity [MoA]",
0009-0520_1eb10948-20f6-4615-aa91-bd9a26b4ffd9,0009-0520,HUMAN PRESCRIPTION DRUG,Depo-Testosterone,,testosterone cypionate,"INJECTION, SOLUTION",INTRAMUSCULAR,20140331,,ANDA,ANDA085635,Pharmacia and Upjohn Company LLC,TESTOSTERONE CYPIONATE,200,mg/mL,"Androgen [EPC],Androgen Receptor Agonists [MoA],Androstanes [Chemical/Ingredient]",CIII
0009-0555_55529020-c122-4964-92f9-5dfdb074d3ec,0009-0555,HUMAN PRESCRIPTION DRUG,Lincocin,,lincomycin hydrochloride,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCONJUNCTIVAL,19641229,,NDA,NDA050317,Pharmacia and Upjohn Company LLC,LINCOMYCIN HYDROCHLORIDE,300,mg/mL,,
0009-0602_bcee33c3-6db8-4ec0-b7b7-85c516cde450,0009-0602,HUMAN PRESCRIPTION DRUG,Cleocin Phosphate,,clindamycin phosphate,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,20140410,,NDA,NDA050441,Pharmacia and Upjohn Company LLC,CLINDAMYCIN PHOSPHATE,150,mg/mL,"Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient]",
0009-0626_4afa2a80-deb9-4452-bae9-10d76fe83e94,0009-0626,HUMAN PRESCRIPTION DRUG,Depo-Provera,,medroxyprogesterone acetate,"INJECTION, SUSPENSION",INTRAMUSCULAR,19601101,,NDA,NDA012541,Pharmacia and Upjohn Company LLC,MEDROXYPROGESTERONE ACETATE,400,mg/mL,"Progesterone Congeners [Chemical/Ingredient],Progestin [EPC]",
0009-0698_9f108946-8e00-4570-8335-2b6de7251a55,0009-0698,HUMAN PRESCRIPTION DRUG,SOLU-MEDROL,,methylprednisolone sodium succinate,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,19590402,,NDA,NDA011856,Pharmacia and Upjohn Company LLC,METHYLPREDNISOLONE SODIUM SUCCINATE,1,g/mL,"Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]",
0009-0728_49af8d95-871b-4576-8b6e-fcec897e882f,0009-0728,HUMAN PRESCRIPTION DRUG,Cleocin Phosphate,,clindamycin phosphate,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,19721002,,NDA,NDA050441,Pharmacia and Upjohn Company LLC,CLINDAMYCIN PHOSPHATE,150,mg/mL,"Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient]",
0009-0746_507f16c7-aa8f-42ec-aeca-ffe853f4cc06,0009-0746,HUMAN PRESCRIPTION DRUG,Depo-Provera,,medroxyprogesterone acetate,"INJECTION, SUSPENSION",INTRAMUSCULAR,19921029,,NDA,NDA020246,Pharmacia and Upjohn Company LLC,MEDROXYPROGESTERONE ACETATE,150,mg/mL,"Progesterone Congeners [Chemical/Ingredient],Progestin [EPC]",
0009-0758_9f108946-8e00-4570-8335-2b6de7251a55,0009-0758,HUMAN PRESCRIPTION DRUG,SOLU-MEDROL,,methylprednisolone sodium succinate,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,19590402,,NDA,NDA011856,Pharmacia and Upjohn Company LLC,METHYLPREDNISOLONE SODIUM SUCCINATE,500,mg/mL,"Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]",
0009-0760_5dce6eba-062f-4da3-a0bb-e0ff1de272b3,0009-0760,HUMAN PRESCRIPTION DRUG,Cleocin Pediatric,,clindamycin palmitate hydrochloride,"GRANULE, FOR SOLUTION",ORAL,19860417,,ANDA,ANDA062644,Pharmacia and Upjohn Company LLC,CLINDAMYCIN PALMITATE HYDROCHLORIDE,75,mg/5mL,"Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient]",
0009-0775_49af8d95-871b-4576-8b6e-fcec897e882f,0009-0775,HUMAN PRESCRIPTION DRUG,Cleocin Phosphate,,clindamycin phosphate,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,19721002,,NDA,NDA050441,Pharmacia and Upjohn Company LLC,CLINDAMYCIN PHOSPHATE,150,mg/mL,"Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient]",
0009-0796_9f108946-8e00-4570-8335-2b6de7251a55,0009-0796,HUMAN PRESCRIPTION DRUG,Solu-Medrol,,methylprednisolone sodium succinate,KIT,,19590402,,NDA,NDA011856,Pharmacia and Upjohn Company LLC,,,,,
0009-0825_4644d33c-93fd-4d77-b8d2-bb586f616c98,0009-0825,HUMAN PRESCRIPTION DRUG,Solu-Cortef,,hydrocortisone sodium succinate,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,19550427,,NDA,NDA009866,Pharmacia and Upjohn Company LLC,HYDROCORTISONE SODIUM SUCCINATE,100,mg/2mL,"Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]",
0009-0827_a75c4d74-e942-4558-9c88-5e828c0f1f68,0009-0827,HUMAN PRESCRIPTION DRUG,Prostin,E2,dinoprostone,SUPPOSITORY,VAGINAL,19780118,,NDA,NDA017810,Pharmacia and Upjohn Company LLC,DINOPROSTONE,20,mg/1,"Prostaglandin Analog [EPC],Prostaglandins [Chemical/Ingredient]",
0009-0856_8ed04ab4-e2f7-492f-bbef-fe6012c0b68c,0009-0856,HUMAN PRESCRIPTION DRUG,Hemabate,,carboprost tromethamine,"INJECTION, SOLUTION",INTRAMUSCULAR,19790109,,NDA,NDA017989,Pharmacia and Upjohn Company LLC,CARBOPROST TROMETHAMINE,250,ug/mL,"Prostaglandin Analog [EPC],Prostaglandins [Chemical/Ingredient]",
0009-0870_49af8d95-871b-4576-8b6e-fcec897e882f,0009-0870,HUMAN PRESCRIPTION DRUG,Cleocin Phosphate,,clindamycin phosphate,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,19721002,,NDA,NDA050441,Pharmacia and Upjohn Company LLC,CLINDAMYCIN PHOSPHATE,150,mg/mL,"Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient]",
0009-0901_bcee33c3-6db8-4ec0-b7b7-85c516cde450,0009-0901,HUMAN PRESCRIPTION DRUG,Cleocin Phosphate,,clindamycin phosphate,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,20140410,,NDA,NDA050441,Pharmacia and Upjohn Company LLC,CLINDAMYCIN PHOSPHATE,150,mg/mL,"Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient]",
0009-0902_49af8d95-871b-4576-8b6e-fcec897e882f,0009-0902,HUMAN PRESCRIPTION DRUG,Cleocin Phosphate,,clindamycin phosphate,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,19721002,,NDA,NDA050441,Pharmacia and Upjohn Company LLC,CLINDAMYCIN PHOSPHATE,150,mg/mL,"Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient]",
0009-1111_fdc79e21-b6ad-4d75-aa9f-cda9c3142a73,0009-1111,HUMAN PRESCRIPTION DRUG,Camptosar,,irinotecan hydrochloride,"INJECTION, SOLUTION",INTRAVENOUS,19960614,,NDA,NDA020571,Pharmacia and Upjohn Company LLC,IRINOTECAN HYDROCHLORIDE,20,mg/mL,"Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA]",
0009-3073_0f1820e6-28cb-4dd7-89ee-00583ebab35d,0009-3073,HUMAN PRESCRIPTION DRUG,Depo-Medrol,,methylprednisolone acetate,"INJECTION, SUSPENSION",INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE,19590528,,NDA,NDA011757,Pharmacia and Upjohn Company LLC,METHYLPREDNISOLONE ACETATE,40,mg/mL,"Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]",
0009-3073_48526b2b-3cef-4d67-8c38-d3e9fca1cf3d,0009-3073,HUMAN PRESCRIPTION DRUG,Depo-Medrol,,methylprednisolone acetate,"INJECTION, SUSPENSION",INTRALESIONAL; INTRAMUSCULAR; INTRASYNOVIAL; SOFT TISSUE,19590528,,NDA,NDA011757,Pharmacia and Upjohn Company LLC,METHYLPREDNISOLONE ACETATE,40,mg/mL,"Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]",
0009-3116_72c22002-c99b-4f31-8dfc-0932c0df9168,0009-3116,HUMAN PRESCRIPTION DRUG,Cleocin T,,clindamycin phosphate,SOLUTION,TOPICAL,19800620,,NDA,NDA050537,Pharmacia and Upjohn Company LLC,CLINDAMYCIN PHOSPHATE,10,mg/mL,"Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient]",
0009-3124_49af8d95-871b-4576-8b6e-fcec897e882f,0009-3124,HUMAN PRESCRIPTION DRUG,Cleocin Phosphate,,clindamycin phosphate,"INJECTION, SOLUTION",INTRAVENOUS,19871016,,ANDA,ANDA062803,Pharmacia and Upjohn Company LLC,CLINDAMYCIN PHOSPHATE,150,mg/mL,"Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient]",
0009-3169_fc8f9f72-2bfe-4926-8dd7-690e89dd9f0b,0009-3169,HUMAN PRESCRIPTION DRUG,PROSTIN,VR PEDIATRIC,alprostadil,"INJECTION, SOLUTION",INTRAVASCULAR; INTRAVENOUS,19811016,,NDA,NDA018484,Pharmacia and Upjohn Company LLC,ALPROSTADIL,500,ug/mL,"Genitourinary Arterial Vasodilation [PE],Prostaglandin Analog [EPC],Prostaglandin E1 Agonist [EPC],Prostaglandin Receptor Agonists [MoA],Prostaglandins [Chemical/Ingredient],Venous Vasodilation [PE]",
0009-3329_72c22002-c99b-4f31-8dfc-0932c0df9168,0009-3329,HUMAN PRESCRIPTION DRUG,Cleocin T,,clindamycin phosphate,LOTION,TOPICAL,19890531,,NDA,NDA050600,Pharmacia and Upjohn Company LLC,CLINDAMYCIN PHOSPHATE,10,mg/mL,"Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient]",
0009-3331_72c22002-c99b-4f31-8dfc-0932c0df9168,0009-3331,HUMAN PRESCRIPTION DRUG,Cleocin T,,clindamycin phosphate,GEL,TOPICAL,19870107,,NDA,NDA050615,Pharmacia and Upjohn Company LLC,CLINDAMYCIN PHOSPHATE,10,mg/g,"Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient]",
0009-3359_a8b3b500-a272-44bb-8eed-8f825a076573,0009-3359,HUMAN PRESCRIPTION DRUG,Prepidil,,dinoprostone,GEL,VAGINAL,19921209,,NDA,NDA019617,Pharmacia and Upjohn Company LLC,DINOPROSTONE,0.5,mg/3g,"Prostaglandin Analog [EPC],Prostaglandins [Chemical/Ingredient]",
0009-3375_49af8d95-871b-4576-8b6e-fcec897e882f,0009-3375,HUMAN PRESCRIPTION DRUG,Cleocin Phosphate,,clindamycin phosphate,"INJECTION, SOLUTION",INTRAVENOUS,19900830,,NDA,NDA050639,Pharmacia and Upjohn Company LLC,CLINDAMYCIN PHOSPHATE,12,mg/mL,"Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient]",
0009-3381_49af8d95-871b-4576-8b6e-fcec897e882f,0009-3381,HUMAN PRESCRIPTION DRUG,Cleocin Phosphate,,clindamycin phosphate,"INJECTION, SOLUTION",INTRAVENOUS,19900830,,NDA,NDA050639,Pharmacia and Upjohn Company LLC,CLINDAMYCIN PHOSPHATE,6,mg/mL,"Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient]",
0009-3382_49af8d95-871b-4576-8b6e-fcec897e882f,0009-3382,HUMAN PRESCRIPTION DRUG,Cleocin Phosphate,,clindamycin phosphate,"INJECTION, SOLUTION",INTRAVENOUS,19900830,,NDA,NDA050639,Pharmacia and Upjohn Company LLC,CLINDAMYCIN PHOSPHATE,18,mg/mL,"Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient]",
0009-3447_49af8d95-871b-4576-8b6e-fcec897e882f,0009-3447,HUMAN PRESCRIPTION DRUG,Cleocin Phosphate,,clindamycin phosphate,"INJECTION, SOLUTION",INTRAVENOUS,19871016,,ANDA,ANDA062803,Pharmacia and Upjohn Company LLC,CLINDAMYCIN PHOSPHATE,150,mg/mL,"Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient]",
0009-3448_6939ae7f-522a-45ea-8f22-efd094973b77,0009-3448,HUMAN PRESCRIPTION DRUG,Cleocin,,clindamycin phosphate,CREAM,VAGINAL,19920811,,NDA,NDA050680,Pharmacia and Upjohn Company LLC,CLINDAMYCIN PHOSPHATE,20,mg/g,"Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient]",
0009-3449_0a039701-29e2-48ae-a8c1-875e30eb0c57,0009-3449,HUMAN PRESCRIPTION DRUG,Glynase,,glyburide,TABLET,ORAL,19920304,,NDA,NDA020051,Pharmacia and Upjohn Company LLC,GLYBURIDE,6,mg/1,"Sulfonylurea [EPC],Sulfonylurea Compounds [Chemical/Ingredient]",
0009-3470_bcee33c3-6db8-4ec0-b7b7-85c516cde450,0009-3470,HUMAN PRESCRIPTION DRUG,Cleocin Phosphate,,clindamycin phosphate,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,20140926,,NDA,NDA050639,Pharmacia and Upjohn Company LLC,CLINDAMYCIN PHOSPHATE,6,mg/mL,"Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient]",
0009-3475_0f1820e6-28cb-4dd7-89ee-00583ebab35d,0009-3475,HUMAN PRESCRIPTION DRUG,Depo-Medrol,,methylprednisolone acetate,"INJECTION, SUSPENSION",INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE,19590528,,NDA,NDA011757,Pharmacia and Upjohn Company LLC,METHYLPREDNISOLONE ACETATE,80,mg/mL,"Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]",
0009-3475_48526b2b-3cef-4d67-8c38-d3e9fca1cf3d,0009-3475,HUMAN PRESCRIPTION DRUG,Depo-Medrol,,methylprednisolone acetate,"INJECTION, SUSPENSION",INTRALESIONAL; INTRAMUSCULAR; INTRASYNOVIAL; SOFT TISSUE,19590528,,NDA,NDA011757,Pharmacia and Upjohn Company LLC,METHYLPREDNISOLONE ACETATE,80,mg/mL,"Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]",
0009-3701_3ce01621-0e34-4f2d-8830-784de0d0bc9f,0009-3701,HUMAN PRESCRIPTION DRUG,Caverject,,Alprostadil,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRACAVERNOUS,19950706,,NDA,NDA020379,Pharmacia and Upjohn Company LLC,ALPROSTADIL,20.5,ug/mL,"Genitourinary Arterial Vasodilation [PE],Prostaglandin Analog [EPC],Prostaglandin E1 Agonist [EPC],Prostaglandin Receptor Agonists [MoA],Prostaglandins [Chemical/Ingredient],Venous Vasodilation [PE]",
0009-3794_1bbb1f6e-272b-444e-87da-90bf9bb2d2ed,0009-3794,HUMAN PRESCRIPTION DRUG,Corvert,,IBUTILIDE FUMARATE,"INJECTION, SOLUTION",INTRAVENOUS,19951228,,NDA,NDA020491,Pharmacia and Upjohn Company,IBUTILIDE FUMARATE,0.1,mg/mL,Antiarrhythmic [EPC],
0009-3794_1e246a71-3d4e-4737-bf9b-5a53e1772b49,0009-3794,HUMAN PRESCRIPTION DRUG,Corvert,,ibutilide fumarate,"INJECTION, SOLUTION",INTRAVENOUS,19951228,,NDA,NDA020491,Pharmacia and Upjohn Company LLC,IBUTILIDE FUMARATE,0.1,mg/mL,Antiarrhythmic [EPC],
0009-3794_387c1cc9-4afc-4a1a-82e4-cd0fb535a82c,0009-3794,HUMAN PRESCRIPTION DRUG,Corvert,,ibutilide fumarate,"INJECTION, SOLUTION",INTRAVENOUS,19951228,,NDA,NDA020491,Pharmacia and Upjohn Company LLC,IBUTILIDE FUMARATE,0.1,mg/mL,Antiarrhythmic [EPC],
0009-4541_c3566921-d549-46b6-b227-a72daaf73ad6,0009-4541,HUMAN PRESCRIPTION DRUG,Detrol,,tolterodine tartrate,"TABLET, FILM COATED",ORAL,19980325,,NDA,NDA020771,Pharmacia and Upjohn Company LLC,TOLTERODINE TARTRATE,1,mg/1,"Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA]",
0009-4544_c3566921-d549-46b6-b227-a72daaf73ad6,0009-4544,HUMAN PRESCRIPTION DRUG,Detrol,,tolterodine tartrate,"TABLET, FILM COATED",ORAL,19980325,,NDA,NDA020771,Pharmacia and Upjohn Company LLC,TOLTERODINE TARTRATE,2,mg/1,"Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA]",
0009-4709_2219a0ef-8b1c-48f8-947b-3be2798a6314,0009-4709,HUMAN PRESCRIPTION DRUG,Depo-SubQ Provera,,medroxyprogesterone acetate,"INJECTION, SUSPENSION",SUBCUTANEOUS,20050502,,NDA,NDA021583,Pharmacia and Upjohn Company LLC,MEDROXYPROGESTERONE ACETATE,104,mg/.65mL,"Progesterone Congeners [Chemical/Ingredient],Progestin [EPC]",
0009-4992_9beec729-f804-48e5-a137-19ca7d90d6a0,0009-4992,HUMAN PRESCRIPTION DRUG,Zyvox,,linezolid,"INJECTION, SOLUTION",INTRAVENOUS,20150706,,NDA,NDA021131,Pharmacia and Upjohn Company,LINEZOLID,600,mg/300mL,"Oxazolidinone Antibacterial [EPC],Oxazolidinones [Chemical/Ingredient]",
0009-5012_fe4b4aa6-600c-4715-a70d-1ed12e83f1f3,0009-5012,HUMAN PRESCRIPTION DRUG,Glyset,,miglitol,"TABLET, FILM COATED",ORAL,19961218,,NDA,NDA020682,Pharmacia and Upjohn Company LLC,MIGLITOL,25,mg/1,"alpha Glucosidase Inhibitors [MoA],alpha-Glucosidase Inhibitor [EPC]",
0009-5013_fe4b4aa6-600c-4715-a70d-1ed12e83f1f3,0009-5013,HUMAN PRESCRIPTION DRUG,Glyset,,miglitol,"TABLET, FILM COATED",ORAL,19961218,,NDA,NDA020682,Pharmacia and Upjohn Company LLC,MIGLITOL,50,mg/1,"alpha Glucosidase Inhibitors [MoA],alpha-Glucosidase Inhibitor [EPC]",
0009-5014_fe4b4aa6-600c-4715-a70d-1ed12e83f1f3,0009-5014,HUMAN PRESCRIPTION DRUG,Glyset,,miglitol,"TABLET, FILM COATED",ORAL,19961218,,NDA,NDA020682,Pharmacia and Upjohn Company LLC,MIGLITOL,100,mg/1,"alpha Glucosidase Inhibitors [MoA],alpha-Glucosidase Inhibitor [EPC]",
0009-5091_08349a5c-06af-4042-85cd-62d3f186d70a,0009-5091,HUMAN PRESCRIPTION DRUG,Ellence,,epirubicin hydrochloride,"INJECTION, SOLUTION",INTRAVENOUS,19990915,,NDA,NDA050778,Pharmacia and Upjohn Company LLC,EPIRUBICIN HYDROCHLORIDE,2,mg/mL,"Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA]",
0009-5093_08349a5c-06af-4042-85cd-62d3f186d70a,0009-5093,HUMAN PRESCRIPTION DRUG,Ellence,,epirubicin hydrochloride,"INJECTION, SOLUTION",INTRAVENOUS,19990915,,NDA,NDA050778,Pharmacia and Upjohn Company LLC,EPIRUBICIN HYDROCHLORIDE,2,mg/mL,"Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA]",
0009-5135_41ceaef4-f05b-459a-aed1-e6f9d8cc6e77,0009-5135,HUMAN PRESCRIPTION DRUG,Zyvox,,linezolid,"TABLET, FILM COATED",ORAL,20000418,,NDA,NDA021130,Pharmacia and Upjohn Company LLC,LINEZOLID,600,mg/1,"Oxazolidinone Antibacterial [EPC],Oxazolidinones [Chemical/Ingredient]",
0009-5136_41ceaef4-f05b-459a-aed1-e6f9d8cc6e77,0009-5136,HUMAN PRESCRIPTION DRUG,Zyvox,,linezolid,SUSPENSION,ORAL,20000418,,NDA,NDA021132,Pharmacia and Upjohn Company LLC,LINEZOLID,100,mg/5mL,"Oxazolidinone Antibacterial [EPC],Oxazolidinones [Chemical/Ingredient]",
0009-5137_41ceaef4-f05b-459a-aed1-e6f9d8cc6e77,0009-5137,HUMAN PRESCRIPTION DRUG,Zyvox,,linezolid,"INJECTION, SOLUTION",INTRAVENOUS,20000418,,NDA,NDA021131,Pharmacia and Upjohn Company LLC,LINEZOLID,200,mg/100mL,"Oxazolidinone Antibacterial [EPC],Oxazolidinones [Chemical/Ingredient]",
0009-5138_41ceaef4-f05b-459a-aed1-e6f9d8cc6e77,0009-5138,HUMAN PRESCRIPTION DRUG,Zyvox,,linezolid,"TABLET, FILM COATED",ORAL,20151012,,NDA,NDA021130,Pharmacia and Upjohn Company LLC,LINEZOLID,600,mg/1,"Oxazolidinone Antibacterial [EPC],Oxazolidinones [Chemical/Ingredient]",
0009-5139_41ceaef4-f05b-459a-aed1-e6f9d8cc6e77,0009-5139,HUMAN PRESCRIPTION DRUG,Zyvox,,linezolid,"INJECTION, SOLUTION",INTRAVENOUS,20000418,,NDA,NDA021131,Pharmacia and Upjohn Company LLC,LINEZOLID,400,mg/200mL,"Oxazolidinone Antibacterial [EPC],Oxazolidinones [Chemical/Ingredient]",
0009-5140_41ceaef4-f05b-459a-aed1-e6f9d8cc6e77,0009-5140,HUMAN PRESCRIPTION DRUG,Zyvox,,linezolid,"INJECTION, SOLUTION",INTRAVENOUS,20000418,,NDA,NDA021131,Pharmacia and Upjohn Company LLC,LINEZOLID,600,mg/300mL,"Oxazolidinone Antibacterial [EPC],Oxazolidinones [Chemical/Ingredient]",
0009-5176_1b61712a-f635-4cab-b80e-17396ca4cb4f,0009-5176,HUMAN PRESCRIPTION DRUG,SOMAVERT,,pegvisomant,KIT,,20030525,,NDA,NDA021106,Pharmacia and Upjohn Company LLC,,,,,
0009-5178_1b61712a-f635-4cab-b80e-17396ca4cb4f,0009-5178,HUMAN PRESCRIPTION DRUG,SOMAVERT,,pegvisomant,KIT,,20030525,,NDA,NDA021106,Pharmacia and Upjohn Company LLC,,,,,
0009-5180_1b61712a-f635-4cab-b80e-17396ca4cb4f,0009-5180,HUMAN PRESCRIPTION DRUG,SOMAVERT,,pegvisomant,KIT,,20030525,,NDA,NDA021106,Pharmacia and Upjohn Company LLC,,,,,
0009-5181_85f88e7f-2a54-42d2-ae5d-0969374b7ed4,0009-5181,HUMAN PRESCRIPTION DRUG,Caverject Impulse,,Alprostadil,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRACAVERNOUS,20020611,,NDA,NDA021212,Pharmacia and Upjohn Company LLC,ALPROSTADIL,10,ug/.5mL,"Genitourinary Arterial Vasodilation [PE],Prostaglandin Analog [EPC],Prostaglandin E1 Agonist [EPC],Prostaglandin Receptor Agonists [MoA],Prostaglandins [Chemical/Ingredient],Venous Vasodilation [PE]",
0009-5182_85f88e7f-2a54-42d2-ae5d-0969374b7ed4,0009-5182,HUMAN PRESCRIPTION DRUG,Caverject Impulse,,Alprostadil,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRACAVERNOUS,20020611,,NDA,NDA021212,Pharmacia and Upjohn Company LLC,ALPROSTADIL,20,ug/.5mL,"Genitourinary Arterial Vasodilation [PE],Prostaglandin Analog [EPC],Prostaglandin E1 Agonist [EPC],Prostaglandin Receptor Agonists [MoA],Prostaglandins [Chemical/Ingredient],Venous Vasodilation [PE]",
0009-5190_1f83c1a9-16b7-448f-a004-bf1b52b5e029,0009-5190,HUMAN PRESCRIPTION DRUG,Detrol LA,,tolterodine tartrate,"CAPSULE, EXTENDED RELEASE",ORAL,20000222,,NDA,NDA021228,Pharmacia and Upjohn Company LLC,TOLTERODINE TARTRATE,2,mg/1,"Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA]",
0009-5191_1f83c1a9-16b7-448f-a004-bf1b52b5e029,0009-5191,HUMAN PRESCRIPTION DRUG,Detrol LA,,tolterodine tartrate,"CAPSULE, EXTENDED RELEASE",ORAL,20000222,,NDA,NDA021228,Pharmacia and Upjohn Company LLC,TOLTERODINE TARTRATE,4,mg/1,"Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA]",
0009-5199_1b61712a-f635-4cab-b80e-17396ca4cb4f,0009-5199,HUMAN PRESCRIPTION DRUG,SOMAVERT,,pegvisomant,KIT,,20140731,,NDA,NDA021106,Pharmacia and Upjohn Company LLC,,,,,
0009-5200_1b61712a-f635-4cab-b80e-17396ca4cb4f,0009-5200,HUMAN PRESCRIPTION DRUG,SOMAVERT,,pegvisomant,KIT,,20140731,,NDA,NDA021106,Pharmacia and Upjohn Company LLC,,,,,
0009-5400_15c8d5ef-66cc-4845-b598-2d8667a43f33,0009-5400,HUMAN PRESCRIPTION DRUG,Nicotrol,,nicotine,INHALANT,RESPIRATORY (INHALATION),19970502,,NDA,NDA020714,Pharmacia and Upjohn Company LLC,NICOTINE,4,mg/1,"Cholinergic Nicotinic Agonist [EPC],Nicotine [Chemical/Ingredient]",
0009-5401_fa35156d-32d3-4eec-ac89-96bc762c6fd9,0009-5401,HUMAN PRESCRIPTION DRUG,Nicotrol,,nicotine,"SPRAY, METERED",NASAL,19960522,,NDA,NDA020385,Pharmacia and Upjohn Company LLC,NICOTINE,10,mg/mL,"Cholinergic Nicotinic Agonist [EPC],Nicotine [Chemical/Ingredient]",
0009-6582_49af8d95-871b-4576-8b6e-fcec897e882f,0009-6582,HUMAN PRESCRIPTION DRUG,Cleocin Phosphate (0009-6582) (Standalone),,clindamycin phosphate,"INJECTION, SOLUTION",INTRAVENOUS,19871016,,ANDA,ANDA062803,Pharmacia and Upjohn Company LLC,CLINDAMYCIN PHOSPHATE,150,mg/mL,"Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient]",
0009-6780_bcee33c3-6db8-4ec0-b7b7-85c516cde450,0009-6780,HUMAN PRESCRIPTION DRUG,Cleocin Phosphate,,clindamycin phosphate,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,20140926,,NDA,NDA050639,Pharmacia and Upjohn Company LLC,CLINDAMYCIN PHOSPHATE,12,mg/mL,"Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient]",
0009-7166_cb557552-f784-47ab-ae1c-279115b4f24b,0009-7166,HUMAN PRESCRIPTION DRUG,SOMAVERT,,pegvisomant,KIT,,20161001,,NDA,NDA021106,Pharmacia and Upjohn Company LLC,,,,,
0009-7168_cb557552-f784-47ab-ae1c-279115b4f24b,0009-7168,HUMAN PRESCRIPTION DRUG,SOMAVERT,,pegvisomant,KIT,,20161001,,NDA,NDA021106,Pharmacia and Upjohn Company LLC,,,,,
0009-7188_cb557552-f784-47ab-ae1c-279115b4f24b,0009-7188,HUMAN PRESCRIPTION DRUG,SOMAVERT,,pegvisomant,KIT,,20161001,,NDA,NDA021106,Pharmacia and Upjohn Company LLC,,,,,
0009-7199_cb557552-f784-47ab-ae1c-279115b4f24b,0009-7199,HUMAN PRESCRIPTION DRUG,SOMAVERT,,pegvisomant,KIT,,20161001,,NDA,NDA021106,Pharmacia and Upjohn Company LLC,,,,,
0009-7200_cb557552-f784-47ab-ae1c-279115b4f24b,0009-7200,HUMAN PRESCRIPTION DRUG,SOMAVERT,,pegvisomant,KIT,,20161001,,NDA,NDA021106,Pharmacia and Upjohn Company LLC,,,,,
0009-7224_a3d8c75d-5661-4919-b664-3e42f69eda00,0009-7224,PLASMA DERIVATIVE,Atgam,,EQUINE THYMOCYTE IMMUNE GLOBULIN,"INJECTION, SOLUTION",INTRAVENOUS,19811117,,BLA,BLA103676,Pharmacia and Upjohn Company LLC,EQUINE THYMOCYTE IMMUNE GLOBULIN,50,mg/mL,"Immunoglobulin G [EPC],Lymphocyte Function Alteration [PE],Increased T Lymphocyte Destruction [PE],Antibody-Surface Protein Interactions [MoA],Immunoglobulins [Chemical/Ingredient]",
0009-7376_507f16c7-aa8f-42ec-aeca-ffe853f4cc06,0009-7376,HUMAN PRESCRIPTION DRUG,Depo-Provera,,medroxyprogesterone acetate,"INJECTION, SUSPENSION",INTRAMUSCULAR,19921029,,NDA,NDA020246,Pharmacia and Upjohn Company LLC,MEDROXYPROGESTERONE ACETATE,150,mg/mL,"Progesterone Congeners [Chemical/Ingredient],Progestin [EPC]",
0009-7529_d3019f01-037e-4812-b0a9-19f7cfa014ca,0009-7529,HUMAN PRESCRIPTION DRUG,Camptosar,,irinotecan hydrochloride,"INJECTION, SOLUTION",INTRAVENOUS,19960614,,NDA,NDA020571,Pharmacia and Upjohn Company LLC,IRINOTECAN HYDROCHLORIDE,20,mg/mL,"Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA]",
0009-7663_bf595fdf-018a-465c-b957-096633b6f8bf,0009-7663,HUMAN PRESCRIPTION DRUG,Aromasin,,exemestane,TABLET,ORAL,19991021,,NDA,NDA020753,Pharmacia and Upjohn Company LLC,EXEMESTANE,25,mg/1,"Aromatase Inhibitor [EPC],Aromatase Inhibitors [MoA]",
0009-7667_266e7858-a666-43bb-a090-849970287713,0009-7667,HUMAN PRESCRIPTION DRUG,Cleocin,,clindamycin phosphate,SUPPOSITORY,VAGINAL,19990813,,NDA,NDA050767,Pharmacia and Upjohn Company LLC,CLINDAMYCIN PHOSPHATE,100,mg/1,"Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient]",
0009-7686_3ce01621-0e34-4f2d-8830-784de0d0bc9f,0009-7686,HUMAN PRESCRIPTION DRUG,Caverject,,Alprostadil,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRACAVERNOUS,19950706,,NDA,NDA020379,Pharmacia and Upjohn Company LLC,ALPROSTADIL,41.1,ug/mL,"Genitourinary Arterial Vasodilation [PE],Prostaglandin Analog [EPC],Prostaglandin E1 Agonist [EPC],Prostaglandin Receptor Agonists [MoA],Prostaglandins [Chemical/Ingredient],Venous Vasodilation [PE]",
0009-7807_4ee972e0-6abe-4536-87a2-69d58c3e6384,0009-7807,HUMAN PRESCRIPTION DRUG,Zyvox,,linezolid,"INJECTION, SOLUTION",INTRAVENOUS,20150218,,NDA,NDA021131,Pharmacia and Upjohn Company LLC,LINEZOLID,600,mg/300mL,"Oxazolidinone Antibacterial [EPC],Oxazolidinones [Chemical/Ingredient]",
0009-9890_bcee33c3-6db8-4ec0-b7b7-85c516cde450,0009-9890,HUMAN PRESCRIPTION DRUG,Cleocin Phosphate,,clindamycin phosphate,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,20140926,,NDA,NDA050639,Pharmacia and Upjohn Company LLC,CLINDAMYCIN PHOSPHATE,18,mg/mL,"Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient]",
0013-0101_8500bcff-4683-44f9-aed0-257e9451a5fd,0013-0101,HUMAN PRESCRIPTION DRUG,Azulfidine,,Sulfasalazine,TABLET,ORAL,19500620,,NDA,NDA007073,Pharmacia and Upjohn Company LLC,SULFASALAZINE,500,mg/1,"Aminosalicylate [EPC],Aminosalicylic Acids [Chemical/Ingredient]",
0013-0102_19030cfc-9aec-4ffa-bccc-3220a0767056,0013-0102,HUMAN PRESCRIPTION DRUG,Azulfidine,EN-tabs,Sulfasalazine,"TABLET, DELAYED RELEASE",ORAL,19500620,,NDA,NDA007073,Pharmacia and Upjohn Company LLC,SULFASALAZINE,500,mg/1,"Aminosalicylate [EPC],Aminosalicylic Acids [Chemical/Ingredient]",
0013-0132_89ad27c2-a441-4607-9356-3bcf7c015368,0013-0132,HUMAN PRESCRIPTION DRUG,Emcyt,,estramustine phosphate sodium,CAPSULE,ORAL,19920101,,NDA,NDA018045,Pharmacia and Upjohn Company LLC,ESTRAMUSTINE PHOSPHATE SODIUM,140,mg/1,"Alkylating Activity [MoA],Alkylating Drug [EPC],Estradiol [Chemical/Ingredient],Nitrogen Mustard Compounds [Chemical/Ingredient]",
0013-1114_f391848e-f7da-4786-a2ff-9b9f941913cb,0013-1114,HUMAN PRESCRIPTION DRUG,Cyklokapron,,tranexamic acid,"INJECTION, SOLUTION",INTRAVENOUS,19861230,,NDA,NDA019281,Pharmacia and Upjohn Company LLC,TRANEXAMIC ACID,100,mg/mL,"Antifibrinolytic Agent [EPC],Decreased Fibrinolysis [PE]",
0013-2150_2885948b-3daf-4d27-8d27-196ce7474294,0013-2150,HUMAN PRESCRIPTION DRUG,Estring,,estradiol,RING,VAGINAL,19960426,,NDA,NDA020472,Pharmacia and Upjohn Company LLC,ESTRADIOL,2,mg/1,"Estradiol Congeners [Chemical/Ingredient],Estrogen [EPC],Estrogen Receptor Agonists [MoA]",
0013-2576_d15f2f64-0955-42cb-9203-2cf11692011d,0013-2576,HUMAN PRESCRIPTION DRUG,Idamycin PFS,,idarubicin hydrochloride,SOLUTION,INTRAVENOUS,19970217,,NDA,NDA050734,Pharmacia and Upjohn Company LLC,IDARUBICIN HYDROCHLORIDE,1,mg/mL,"Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA]",
0013-2586_d15f2f64-0955-42cb-9203-2cf11692011d,0013-2586,HUMAN PRESCRIPTION DRUG,Idamycin PFS,,idarubicin hydrochloride,SOLUTION,INTRAVENOUS,19970217,,NDA,NDA050734,Pharmacia and Upjohn Company LLC,IDARUBICIN HYDROCHLORIDE,1,mg/mL,"Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA]",
0013-2596_d15f2f64-0955-42cb-9203-2cf11692011d,0013-2596,HUMAN PRESCRIPTION DRUG,Idamycin PFS,,idarubicin hydrochloride,SOLUTION,INTRAVENOUS,19970217,,NDA,NDA050734,Pharmacia and Upjohn Company LLC,IDARUBICIN HYDROCHLORIDE,1,mg/mL,"Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA]",
0013-2626_dfe97f6c-4d01-45bd-b292-8dc923969c8a,0013-2626,HUMAN PRESCRIPTION DRUG,GENOTROPIN,,somatropin,KIT,,19951220,,NDA,NDA020280,Pharmacia and Upjohn Company LLC,,,,,
0013-2646_dfe97f6c-4d01-45bd-b292-8dc923969c8a,0013-2646,HUMAN PRESCRIPTION DRUG,GENOTROPIN,,somatropin,KIT,,19951220,,NDA,NDA020280,Pharmacia and Upjohn Company LLC,,,,,
0013-2649_dfe97f6c-4d01-45bd-b292-8dc923969c8a,0013-2649,HUMAN PRESCRIPTION DRUG,GENOTROPIN,,somatropin,KIT,,19951220,,NDA,NDA020280,Pharmacia and Upjohn Company LLC,,,,,
0013-2650_dfe97f6c-4d01-45bd-b292-8dc923969c8a,0013-2650,HUMAN PRESCRIPTION DRUG,GENOTROPIN,,somatropin,KIT,,19951220,,NDA,NDA020280,Pharmacia and Upjohn Company LLC,,,,,
0013-2651_dfe97f6c-4d01-45bd-b292-8dc923969c8a,0013-2651,HUMAN PRESCRIPTION DRUG,GENOTROPIN,,somatropin,KIT,,19951220,,NDA,NDA020280,Pharmacia and Upjohn Company LLC,,,,,
0013-2652_dfe97f6c-4d01-45bd-b292-8dc923969c8a,0013-2652,HUMAN PRESCRIPTION DRUG,GENOTROPIN,,somatropin,KIT,,19951220,,NDA,NDA020280,Pharmacia and Upjohn Company LLC,,,,,
0013-2653_dfe97f6c-4d01-45bd-b292-8dc923969c8a,0013-2653,HUMAN PRESCRIPTION DRUG,GENOTROPIN,,somatropin,KIT,,19951220,,NDA,NDA020280,Pharmacia and Upjohn Company LLC,,,,,
0013-2654_dfe97f6c-4d01-45bd-b292-8dc923969c8a,0013-2654,HUMAN PRESCRIPTION DRUG,GENOTROPIN,,somatropin,KIT,,19951220,,NDA,NDA020280,Pharmacia and Upjohn Company LLC,,,,,
0013-2655_dfe97f6c-4d01-45bd-b292-8dc923969c8a,0013-2655,HUMAN PRESCRIPTION DRUG,GENOTROPIN,,somatropin,KIT,,19951220,,NDA,NDA020280,Pharmacia and Upjohn Company LLC,,,,,
0013-2656_dfe97f6c-4d01-45bd-b292-8dc923969c8a,0013-2656,HUMAN PRESCRIPTION DRUG,GENOTROPIN,,somatropin,KIT,,19951220,,NDA,NDA020280,Pharmacia and Upjohn Company LLC,,,,,
0013-2657_dfe97f6c-4d01-45bd-b292-8dc923969c8a,0013-2657,HUMAN PRESCRIPTION DRUG,GENOTROPIN,,somatropin,KIT,,19951220,,NDA,NDA020280,Pharmacia and Upjohn Company LLC,,,,,
0013-2658_dfe97f6c-4d01-45bd-b292-8dc923969c8a,0013-2658,HUMAN PRESCRIPTION DRUG,GENOTROPIN,,somatropin,KIT,,19951220,,NDA,NDA020280,Pharmacia and Upjohn Company LLC,,,,,
0013-5301_e70773f5-44be-4251-96ce-542555385a15,0013-5301,HUMAN PRESCRIPTION DRUG,Mycobutin,,rifabutin,CAPSULE,ORAL,19921223,,NDA,NDA050689,Pharmacia and Upjohn Company LLC,RIFABUTIN,150,mg/1,"Rifamycin Antimycobacterial [EPC],Rifamycins [Chemical/Ingredient]",
0013-8303_341a853e-1bd6-4ba0-a851-5ee05c2024e0,0013-8303,HUMAN PRESCRIPTION DRUG,Xalatan,,latanoprost,SOLUTION,OPHTHALMIC,19950320,,NDA,NDA020597,Pharmacia and Upjohn Company LLC,LATANOPROST,50,ug/mL,"Prostaglandin Analog [EPC],Prostaglandins [Chemical/Ingredient]",
0013-8717_464537a7-86e4-436a-aa6e-696402312ee1,0013-8717,HUMAN PRESCRIPTION DRUG,Zinecard,,dexrazoxane,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,19950526,,NDA,NDA020212,Pharmacia and Upjohn Company LLC,DEXRAZOXANE HYDROCHLORIDE,250,mg/25mL,Cytoprotective Agent [EPC],
0013-8727_464537a7-86e4-436a-aa6e-696402312ee1,0013-8727,HUMAN PRESCRIPTION DRUG,Zinecard,,dexrazoxane,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,19950526,,NDA,NDA020212,Pharmacia and Upjohn Company LLC,DEXRAZOXANE HYDROCHLORIDE,500,mg/50mL,Cytoprotective Agent [EPC],
0015-0508_ebbcea19-43e2-4fee-9329-7b33cb7da6b1,0015-0508,HUMAN PRESCRIPTION DRUG,MEGACE,,MEGESTROL ACETATE,SUSPENSION,ORAL,20090601,,NDA,NDA020264,"E.R. Squibb & Sons, L.L.C.",MEGESTROL ACETATE,40,mg/mL,"Progesterone Congeners [Chemical/Ingredient],Progestin [EPC]",
0015-1910_73ce7912-af71-4c80-bec0-f4fa546aa197,0015-1910,HUMAN PRESCRIPTION DRUG,IXEMPRA,,ixabepilone,KIT,,20071016,20171031,NDA,NDA022065,"E.R. Squibb & Sons, L.L.C.",,,,,
0015-1911_73ce7912-af71-4c80-bec0-f4fa546aa197,0015-1911,HUMAN PRESCRIPTION DRUG,IXEMPRA,,ixabepilone,KIT,,20071016,20171031,NDA,NDA022065,"E.R. Squibb & Sons, L.L.C.",,,,,
0015-3080_f7300281-bca8-4dba-ba90-258712a76093,0015-3080,HUMAN PRESCRIPTION DRUG,LYSODREN,,MITOTANE,TABLET,ORAL,20090601,,NDA,NDA016885,"E.R. Squibb & Sons, L.L.C.",MITOTANE,500,mg/1,Cytochrome P450 3A4 Inducers [MoA],
0015-3404_313e8121-bbc5-4317-8e2e-c3a5b1a86996,0015-3404,HUMAN PRESCRIPTION DRUG,ETOPOPHOS,,etoposide phosphate,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20090601,,NDA,NDA020457,"E.R. Squibb & Sons, L.L.C.",ETOPOSIDE PHOSPHATE,100,mg/1,"Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA]",
0019-0862_dd585c37-4a03-4158-9217-40a8ca4544db,0019-0862,HUMAN PRESCRIPTION DRUG,Cysto-Conray II,,Iothalamate meglumine,INJECTION,URETERAL,20101008,,NDA,NDA017057,Liebel-Flarsheim Company LLC,IOTHALAMATE MEGLUMINE,172,mg/mL,"Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA]",
0019-0952_e80407fa-3e59-461f-a0ab-c30384294c58,0019-0952,HUMAN PRESCRIPTION DRUG,Conray 30,,Iothalamate Meglumine,INJECTION,INTRAVASCULAR,20120326,,NDA,NDA016983,Liebel-Flarsheim Company LLC,IOTHALAMATE MEGLUMINE,300,mg/mL,"Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA]",
0019-0953_2e644c0b-a56c-4759-9376-fc25f6a1cea0,0019-0953,HUMAN PRESCRIPTION DRUG,Conray,,iothalamate meglumine,INJECTION,INTRAVASCULAR,20031014,,NDA,NDA013295,Liebel-Flarsheim Company LLC,IOTHALAMATE MEGLUMINE,600,mg/mL,"Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA]",
0019-1177_35c3b4f7-803a-4827-9b0e-4bfeed2b57bf,0019-1177,HUMAN PRESCRIPTION DRUG,OPTIMARK,,GADOVERSETAMIDE,"INJECTION, SOLUTION",INTRAVENOUS,20101210,,NDA,NDA020975,Liebel-Flarsheim Company LLC,GADOVERSETAMIDE,0.5,mmol/mL,"Gadolinium-based Contrast Agent [EPC],Magnetic Resonance Contrast Activity [MoA]",
0019-1177_7e2d1a09-1e7c-4198-b0cb-5a0fbf2f3609,0019-1177,HUMAN PRESCRIPTION DRUG,OPTIMARK,,gadoversetamide,"INJECTION, SOLUTION",INTRAVENOUS,20120122,,NDA,NDA020976,Liebel-Flarsheim Company LLC,GADOVERSETAMIDE,0.5,mmol/mL,"Gadolinium-based Contrast Agent [EPC],Magnetic Resonance Contrast Activity [MoA]",
0019-1177_afe538c1-eb7d-4f5f-b83b-b73e6a055e54,0019-1177,HUMAN PRESCRIPTION DRUG,OPTIMARK,,gadoversetamide,"INJECTION, SOLUTION",INTRAVENOUS,20120122,,NDA,NDA020937,Liebel-Flarsheim Company LLC,GADOVERSETAMIDE,0.5,mmol/mL,"Gadolinium-based Contrast Agent [EPC],Magnetic Resonance Contrast Activity [MoA]",
0019-1188_44fdbc1f-4809-4fa0-954b-b38988d88940,0019-1188,HUMAN PRESCRIPTION DRUG,SODIUM CHLORIDE,,sodium chloride,INJECTION,INTRAVASCULAR,20120901,,NDA,NDA021569,Liebel-Flarsheim Company LLC,SODIUM CHLORIDE,0.9,mg/mL,"Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA]",
0019-1317_45fa8c09-b79d-47c9-9c1a-53422e90925b,0019-1317,HUMAN PRESCRIPTION DRUG,MD-76R,,Diatrizoate meglumine and Diatrizoate sodium,SOLUTION,INTRAVENOUS,19890929,,NDA,NDA019292,Liebel-Flarsheim Company LLC,DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM,660; 100,mg/mL; mg/mL,"Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA],Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA]",
0019-1323_301a35b0-6c40-4445-8faf-b7bd4f8d5967,0019-1323,HUMAN PRESCRIPTION DRUG,Optiray,320,Ioversol,INJECTION,INTRA-ARTERIAL; INTRAVENOUS,20120304,,NDA,NDA019710,Liebel-Flarsheim Company LLC,IOVERSOL,678,mg/mL,"Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA]",
0019-1323_60c1d4ac-3c8b-43d7-b84e-1b674a130053,0019-1323,HUMAN PRESCRIPTION DRUG,Optiray,320,Ioversol,INJECTION,INTRA-ARTERIAL; INTRAVENOUS,20111017,,NDA,NDA020923,Liebel-Flarsheim Company LLC,IOVERSOL,678,mg/mL,"Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA]",
0019-1324_301a35b0-6c40-4445-8faf-b7bd4f8d5967,0019-1324,HUMAN PRESCRIPTION DRUG,Optiray,240,Ioversol,INJECTION,INTRA-ARTERIAL; INTRAVENOUS,20120304,,NDA,NDA019710,Liebel-Flarsheim Company LLC,IOVERSOL,509,mg/mL,"Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA]",
0019-1332_301a35b0-6c40-4445-8faf-b7bd4f8d5967,0019-1332,HUMAN PRESCRIPTION DRUG,Optiray,300,Ioversol,INJECTION,INTRA-ARTERIAL; INTRAVENOUS,20120304,,NDA,NDA019710,Liebel-Flarsheim Company LLC,IOVERSOL,636,mg/mL,"Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA]",
0019-1332_60c1d4ac-3c8b-43d7-b84e-1b674a130053,0019-1332,HUMAN PRESCRIPTION DRUG,Optiray,300,Ioversol,INJECTION,INTRA-ARTERIAL; INTRAVENOUS,20111017,,NDA,NDA020923,Liebel-Flarsheim Company LLC,IOVERSOL,636,mg/mL,"Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA]",
0019-1333_301a35b0-6c40-4445-8faf-b7bd4f8d5967,0019-1333,HUMAN PRESCRIPTION DRUG,Optiray,350,Ioversol,INJECTION,INTRA-ARTERIAL; INTRAVENOUS,20120304,,NDA,NDA019710,Liebel-Flarsheim Company LLC,IOVERSOL,741,mg/mL,"Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA]",
0019-1333_60c1d4ac-3c8b-43d7-b84e-1b674a130053,0019-1333,HUMAN PRESCRIPTION DRUG,Optiray,350,Ioversol,INJECTION,INTRA-ARTERIAL; INTRAVENOUS,20111017,,NDA,NDA020923,Liebel-Flarsheim Company LLC,IOVERSOL,741,mg/mL,"Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA]",
0019-3183_c03aaec4-d659-4805-ae8d-0b582bd72505,0019-3183,HUMAN PRESCRIPTION DRUG,Conray 43,,iothalamate meglumine,INJECTION,INTRAVASCULAR,20101011,,NDA,NDA013295,Liebel-Flarsheim Company LLC,IOTHALAMATE MEGLUMINE,430,mg/mL,"Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA]",
0019-4816_0be468dc-3655-45ce-bcfb-a489086f3c87,0019-4816,HUMAN PRESCRIPTION DRUG,MD GASTROVIEW,,diatrizoate meglumine and diatrizoate sodium,SOLUTION,ORAL; RECTAL,20090831,,ANDA,ANDA087388,Liebel-Flarsheim Company LLC,DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM,600; 100,mg/mL; mg/mL,"Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA],Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA]",
0023-0042_ca6ba093-8b7e-455a-b9ab-74e249420add,0023-0042,HUMAN PRESCRIPTION DRUG,TAZORAC,,tazarotene,GEL,CUTANEOUS,19970801,,NDA,NDA020600,"Allergan, Inc.",TAZAROTENE,1,mg/g,"Retinoid [EPC],Retinoids [Chemical/Ingredient]",
0023-0066_a26a1cd1-2903-4fc8-ad34-86ae16459f15,0023-0066,HUMAN PRESCRIPTION DRUG,PRED-G,,gentamicin sulfate and prednisolone acetate,OINTMENT,OPHTHALMIC,19900101,,NDA,NDA050612,"Allergan, Inc.",GENTAMICIN SULFATE; PREDNISOLONE ACETATE,3; 6,mg/g; mg/g,"Aminoglycoside Antibacterial [EPC],Aminoglycosides [Chemical/Ingredient],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]",
0023-0106_e7437506-4ebf-4292-83f1-c6bcab47bda1,0023-0106,HUMAN PRESCRIPTION DRUG,PRED-G,,"gentamicin, prednisolone acetate",SUSPENSION/ DROPS,OPHTHALMIC,19900219,,NDA,NDA050586,"Allergan, Inc.",GENTAMICIN; PREDNISOLONE ACETATE,3; 10,mg/mL; mg/mL,"Aminoglycoside Antibacterial [EPC],Aminoglycosides [Chemical/Ingredient],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]",
0023-0240_7326fd66-dc91-4686-a7b6-c1def9f74767,0023-0240,HUMAN OTC DRUG,REFRESH P.M.,,"mineral oil, petrolatum",OINTMENT,OPHTHALMIC,19900423,,OTC MONOGRAPH FINAL,part349,"Allergan, Inc.",MINERAL OIL; PETROLATUM,425; 573,mg/g; mg/g,,
0023-0312_33707096-4210-49e2-953d-23c5c0c1cf48,0023-0312,HUMAN OTC DRUG,REFRESH LACRI-LUBE,,"mineral oil, petrolatum",OINTMENT,OPHTHALMIC,19771215,,OTC MONOGRAPH FINAL,part349,"Allergan, Inc.",MINERAL OIL; PETROLATUM,425; 568,mg/g; mg/g,,
0023-0313_b7b076a9-d41c-438c-8e03-4a0d94605419,0023-0313,HUMAN PRESCRIPTION DRUG,BLEPHAMIDE,,sulfacetamide sodium and prednisolone acetate,OINTMENT,OPHTHALMIC,19870101,,ANDA,ANDA087748,"Allergan, Inc.",SULFACETAMIDE SODIUM; PREDNISOLONE ACETATE,100; 2,mg/g; mg/g,"Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Sulfonamide Antibacterial [EPC],Sulfonamides [Chemical/Ingredient]",
0023-0316_9c77b0ad-2660-4ef1-bd0c-c98c80310633,0023-0316,HUMAN PRESCRIPTION DRUG,FML,,fluorometholone,OINTMENT,OPHTHALMIC,19851209,,NDA,NDA017760,"Allergan, Inc.",FLUOROMETHOLONE,1,mg/g,"Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]",
0023-0403_3dcbdeaa-82fd-4ec8-b426-bbef0a5d59c4,0023-0403,HUMAN OTC DRUG,REFRESH PLUS,,carboxymethylcellulose sodium,SOLUTION/ DROPS,OPHTHALMIC,19961009,,OTC MONOGRAPH FINAL,part349,"Allergan, Inc.",CARBOXYMETHYLCELLULOSE SODIUM,5,mg/mL,,
0023-0506_f69da0e3-a73e-45b7-820b-2efff98b5af2,0023-0506,HUMAN OTC DRUG,REFRESH Classic,,"Polyvinyl Alcohol, Povidone",SOLUTION/ DROPS,OPHTHALMIC,19850912,,OTC MONOGRAPH FINAL,part349,"Allergan, Inc.",POLYVINYL ALCOHOL; POVIDONE,14; 6,mg/mL; mg/mL,,
0023-0752_e5745dfa-8032-4b70-b5a8-38b801bd1adc,0023-0752,HUMAN PRESCRIPTION DRUG,Asacol,,mesalamine,"TABLET, DELAYED RELEASE",ORAL,19920401,,NDA,NDA019651,"Allergan, Inc.",MESALAMINE,400,mg/1,"Aminosalicylate [EPC],Aminosalicylic Acids [Chemical/Ingredient]",
0023-0798_0fbfc3b3-9bd9-4bea-8f5d-0edaa8505c99,0023-0798,HUMAN OTC DRUG,REFRESH TEARS,,carboxymethylcellulose sodium,SOLUTION/ DROPS,OPHTHALMIC,19970516,,OTC MONOGRAPH FINAL,part349,"Allergan, Inc.",CARBOXYMETHYLCELLULOSE SODIUM,5,mg/mL,,
0023-1145_eebadb66-8ade-4b4e-a120-638212e429a9,0023-1145,HUMAN PRESCRIPTION DRUG,BOTOX,,onabotulinumtoxinA,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRADERMAL; INTRAMUSCULAR,19891215,,BLA,BLA103000,"Allergan, Inc.",BOTULINUM TOXIN TYPE A,100,[USP'U]/1,"Acetylcholine Release Inhibitor [EPC],Acetylcholine Release Inhibitors [MoA]",
0023-2181_c3d6f9f9-77f8-4f00-a435-59320ec5e6c8,0023-2181,HUMAN PRESCRIPTION DRUG,Acular,,Ketorolac Tromethamine,SOLUTION/ DROPS,OPHTHALMIC,19921201,,NDA,NDA019700,"Allergan, Inc.",KETOROLAC TROMETHAMINE,5,mg/mL,"Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Cyclooxygenase Inhibitor [EPC]",
0023-3205_87403afb-5e81-49e7-832f-ac98b765ed5c,0023-3205,HUMAN PRESCRIPTION DRUG,LUMIGAN,,bimatoprost,SOLUTION/ DROPS,OPHTHALMIC,20100910,,NDA,NDA022184,"Allergan, Inc.",BIMATOPROST,0.1,mg/mL,"Prostaglandin Analog [EPC],Prostaglandins [Chemical/Ingredient]",
0023-3240_37b995e8-8e66-4d9b-b027-d58c053c7364,0023-3240,HUMAN OTC DRUG,REFRESH OPTIVE,,carboxymethylcellulose sodium and glycerin,SOLUTION/ DROPS,OPHTHALMIC,20060906,,OTC MONOGRAPH FINAL,part349,"Allergan, Inc.",CARBOXYMETHYLCELLULOSE SODIUM; GLYCERIN,5; 9,mg/mL; mg/mL,,
0023-3348_95e19b00-4334-44d1-9726-487bf786bdff,0023-3348,HUMAN PRESCRIPTION DRUG,OZURDEX,,dexamethasone,IMPLANT,INTRAVITREAL,20090901,,NDA,NDA022315,"Allergan, Inc.",DEXAMETHASONE,0.7,mg/1,"Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]",
0023-3416_5d54b37d-334b-4034-9df1-f360d0b74783,0023-3416,HUMAN OTC DRUG,Refresh Optive,,"Carboxymethylcellulose Sodium, Glycerin",SOLUTION/ DROPS,OPHTHALMIC,20080822,,OTC MONOGRAPH FINAL,part349,"Allergan, Inc.",CARBOXYMETHYLCELLULOSE SODIUM; GLYCERIN,5; 9,mg/mL; mg/mL,,
0023-3459_9bf01981-aae8-4c1b-8c6e-e6fa157891bf,0023-3459,HUMAN OTC DRUG,VIVITE Daily Facial Moisturizer with Sunscreen SPF 30,,"octinoxate, octisalate, oxybenzone",LOTION,TOPICAL,20080519,,OTC MONOGRAPH NOT FINAL,part352,"Allergan, Inc.",OCTINOXATE; OCTISALATE; OXYBENZONE,75; 50; 60,mg/mL; mg/mL; mg/mL,,
0023-3507_96918342-3667-470b-86c0-d2640e4a5467,0023-3507,HUMAN PRESCRIPTION DRUG,ACUVAIL,,ketorolac tromethamine,SOLUTION/ DROPS,OPHTHALMIC,20090801,,NDA,NDA022427,"Allergan, Inc.",KETOROLAC TROMETHAMINE,4.5,mg/mL,"Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Cyclooxygenase Inhibitor [EPC]",
0023-3615_2ced5ec1-e50f-45ae-acdf-db50920f2d38,0023-3615,HUMAN PRESCRIPTION DRUG,ZYMAXID,,gatifloxacin,SOLUTION/ DROPS,OPHTHALMIC,20100519,,NDA,NDA022548,"Allergan, Inc.",GATIFLOXACIN,5,mg/mL,"Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient]",
0023-3616_c38a4d54-cf63-4c26-bbc4-756cb328f3c0,0023-3616,HUMAN PRESCRIPTION DRUG,LATISSE,,bimatoprost,SOLUTION/ DROPS,OPHTHALMIC,20090126,,NDA,NDA022369,"Allergan, Inc.",BIMATOPROST,0.3,mg/mL,"Prostaglandin Analog [EPC],Prostaglandins [Chemical/Ingredient]",
0023-3670_959d3017-c7b5-434e-bc00-370c3f27bb21,0023-3670,HUMAN PRESCRIPTION DRUG,ACZONE,,dapsone,GEL,TOPICAL,20090624,,NDA,NDA021794,"Allergan, Inc.",DAPSONE,50,mg/g,"Sulfone [EPC],Sulfones [Chemical/Ingredient]",
0023-3919_58f75fa7-b008-4f19-88a1-cf0785a871bc,0023-3919,HUMAN PRESCRIPTION DRUG,BOTOX Cosmetic,,onabotulinumtoxinA,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAMUSCULAR,20080715,,BLA,BLA103000,"Allergan, Inc.",BOTULINUM TOXIN TYPE A,50,[USP'U]/1,"Acetylcholine Release Inhibitor [EPC],Acetylcholine Release Inhibitors [MoA]",
0023-3921_eebadb66-8ade-4b4e-a120-638212e429a9,0023-3921,HUMAN PRESCRIPTION DRUG,BOTOX,,onabotulinumtoxinA,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRADERMAL; INTRAMUSCULAR,20100111,,BLA,BLA103000,"Allergan, Inc.",BOTULINUM TOXIN TYPE A,200,[USP'U]/1,"Acetylcholine Release Inhibitor [EPC],Acetylcholine Release Inhibitors [MoA]",
0023-4290_048d073a-4490-4c4f-a867-099ab0f7b339,0023-4290,HUMAN PRESCRIPTION DRUG,LASTACAFT,,alcaftadine,SOLUTION/ DROPS,OPHTHALMIC,20101101,,NDA,NDA022134,"Allergan, Inc.",ALCAFTADINE,2.5,mg/mL,"Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC]",
0023-4307_91ab3412-e204-49b0-97fc-3e3cbce7524b,0023-4307,HUMAN OTC DRUG,REFRESH OPTIVE Advanced,,"carboxymethylcellulose sodium, glycerin, and polysorbate 80",SOLUTION/ DROPS,OPHTHALMIC,20111130,,OTC MONOGRAPH FINAL,part349,"Allergan, Inc.",CARBOXYMETHYLCELLULOSE SODIUM; GLYCERIN; POLYSORBATE 80,5; 10; 5,mg/mL; mg/mL; mg/mL,,
0023-4385_15540135-9b4e-4539-911d-ec0a00379143,0023-4385,HUMAN PRESCRIPTION DRUG,BETAGAN,,levobunolol hydrochloride,SOLUTION/ DROPS,OPHTHALMIC,19860724,,NDA,NDA019219,"Allergan, Inc.",LEVOBUNOLOL HYDROCHLORIDE,5,mg/mL,"Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC]",
0023-4491_e600f562-8c1c-48a4-bc74-2fcb405fac4a,0023-4491,HUMAN OTC DRUG,REFRESH OPTIVE Advanced,,"carboxymethylcellulose sodium, glycerin, polysorbate 80",SOLUTION/ DROPS,OPHTHALMIC,20130115,,OTC MONOGRAPH FINAL,part349,"Allergan, Inc.",CARBOXYMETHYLCELLULOSE SODIUM; GLYCERIN; POLYSORBATE 80,5; 10; 5,mg/mL; mg/mL; mg/mL,,
0023-4554_e7f9d92e-898b-494b-94fe-7516c0a92a5a,0023-4554,HUMAN OTC DRUG,REFRESH CELLUVISC,,carboxymethylcellulose sodium,GEL,OPHTHALMIC,19891004,,OTC MONOGRAPH FINAL,part349,"Allergan, Inc.",CARBOXYMETHYLCELLULOSE SODIUM,10,mg/mL,,
0023-4857_0cabbfd5-ec30-44a9-9f64-2532fa0cfe07,0023-4857,HUMAN PRESCRIPTION DRUG,VANIQA,,eflornithine hydrochloride,CREAM,TOPICAL,20130601,,NDA,NDA021145,"Allergan, Inc.",EFLORNITHINE HYDROCHLORIDE,139,mg/g,"Antiprotozoal [EPC],Decarboxylase Inhibitor [EPC],Decarboxylase Inhibitors [MoA]",
0023-4948_b1d568c7-6251-4d63-8bb5-de5a7b450b63,0023-4948,HUMAN OTC DRUG,SKIN MEDICA Purifying Foaming Wash,,salicylic acid,LIQUID,TOPICAL,20130101,,OTC MONOGRAPH FINAL,part333D,"Allergan, Inc.",SALICYLIC ACID,20,mg/mL,,
0023-4953_76d3e6b9-77a9-40c2-84c9-3bcc173be9b4,0023-4953,HUMAN OTC DRUG,SkinMedica TNS Ultimate Daily Moisturizer Sunscreen SPF 20,,"octinoxate, zinc oxide",CREAM,TOPICAL,20130101,,OTC MONOGRAPH NOT FINAL,part352,"Allergan, Inc.",OCTINOXATE; ZINC OXIDE,75; 53,mg/g; mg/g,,
0023-4963_0d9101b5-ef9e-421a-8ae8-c614b4cf425d,0023-4963,HUMAN OTC DRUG,SkinMedica Daily Physical Defense SPF 30 Sunscreen,,"Titanium Dioxide, zinc oxide",CREAM,TOPICAL,20130101,,OTC MONOGRAPH NOT FINAL,part352,"Allergan, Inc.",TITANIUM DIOXIDE; ZINC OXIDE,73; 34,mg/g; mg/g,,
0023-4964_2e3b5888-b8e2-4c52-9f53-f777701a603b,0023-4964,HUMAN OTC DRUG,SkinMedica Environmental Defense Sunscreen SPF 50,,"Octinoxate, Octisalate, Octocrylene, Oxybenzone, Zinc Oxide",CREAM,TOPICAL,20130101,,OTC MONOGRAPH NOT FINAL,part352,"Allergan, Inc.",OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE; ZINC OXIDE,75; 50; 20; 60; 33,mg/g; mg/g; mg/g; mg/g; mg/g,,
0023-4965_757fa897-abad-43a3-8f73-facd8bb0f521,0023-4965,HUMAN OTC DRUG,SkinMedica Acne Treatment,,benzoyl peroxide,LOTION,TOPICAL,20130101,,OTC MONOGRAPH NOT FINAL,part333D,"Allergan, Inc.",BENZOYL PEROXIDE,25,mg/g,,
0023-5206_f516257a-e63e-4163-8696-4eb7bb11a667,0023-5206,HUMAN PRESCRIPTION DRUG,"ACZONE (dapsone) Gel, 7.5%",,dapsone,GEL,TOPICAL,20160226,,NDA,NDA207154,"Allergan, Inc.",DAPSONE,75,mg/g,"Sulfone [EPC],Sulfones [Chemical/Ingredient]",
0023-5300_10f41d1d-bc01-4190-9830-a58b4a3f81e6,0023-5300,HUMAN PRESCRIPTION DRUG,RHOFADE,,Oxymetazoline Hydrochloride,CREAM,TOPICAL,20170118,,NDA,NDA208552,Allergan,OXYMETAZOLINE HYDROCHLORIDE,10,mg/g,"Vasoconstrictor [EPC],Vasoconstriction [PE],Increased Sympathetic Activity [PE],Imidazolines [Chemical/Ingredient]",
0023-5301_e579186c-6dfc-41c3-9cc9-a32d36352507,0023-5301,HUMAN PRESCRIPTION DRUG,Restasis MultiDose,,cyclosporine,EMULSION,OPHTHALMIC,20161110,,NDA,NDA050790,"Allergan, Inc.",CYCLOSPORINE,0.5,mg/mL,"Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA]",
0023-5459_400f0434-d2ab-41db-9add-fb5fd6cd5e7a,0023-5459,HUMAN OTC DRUG,REFRESH OPTIVE Gel Drops,,carboxymethylcellulose sodium and glycerin,SOLUTION/ DROPS,OPHTHALMIC,20150930,,OTC MONOGRAPH FINAL,part349,"Allergan, INC",CARBOXYMETHYLCELLULOSE SODIUM; GLYCERIN,10; 9,mg/mL; mg/mL,,
0023-5494_32d24109-9abd-4e22-8d65-de50c341d7e7,0023-5494,HUMAN OTC DRUG,TOTAL DEFENSE REPAIR BROAD SPECTRUM SPF 34 Sunscreen,,"Octinoxate, Octisalate and Zinc Oxide",LOTION,TOPICAL,20150615,,OTC MONOGRAPH NOT FINAL,part352,"Allergan, Inc.",OCTINOXATE; OCTISALATE; ZINC OXIDE,75; 30; 80,mg/g; mg/g; mg/g,,
0023-5497_2a052df3-78df-4fc6-9c3f-4ed2e40a396a,0023-5497,HUMAN OTC DRUG,TOTAL DEFENSE REPAIR BROAD SPECTRUM SPF 34 Sunscreen (Tinted),,"Octinoxate, Octisalate, Titanium dioxide and Zinc Oxide",LOTION,TOPICAL,20150615,,OTC MONOGRAPH NOT FINAL,part352,"Allergan, Inc.",OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE,75; 30; 35; 80,mg/g; mg/g; mg/g; mg/g,,
0023-5501_ed10f6cb-2240-46fc-9ea2-dbc983173a6f,0023-5501,HUMAN OTC DRUG,TOTAL DEFENSE REPAIR BROAD SPECTRUM SPF 50 Sunscreen,,"Homosalate, Octinoxate, Octisalate and Zinc Oxide",LOTION,TOPICAL,20150615,,OTC MONOGRAPH NOT FINAL,part352,"Allergan, Inc.",HOMOSALATE; OCTINOXATE; OCTISALATE; ZINC OXIDE,60; 75; 50; 10,mg/g; mg/g; mg/g; mg/g,,
0023-5665_037f4cd5-5e99-4d3d-9722-812054ce0546,0023-5665,HUMAN OTC DRUG,Essential Defense Vital Hydration Broad Spectrum SPF 36 Sunscreen Tinted,,"Octinoxate, Octisalate, Zinc Oxide",LOTION,TOPICAL,20160301,,OTC MONOGRAPH NOT FINAL,part352,"Allergan, Inc.",OCTINOXATE; OCTISALATE; ZINC OXIDE,75; 30; 80,mg/g; mg/g; mg/g,,
0023-5675_81c5789e-a2d0-4825-9e50-522562e73fce,0023-5675,HUMAN OTC DRUG,Essential Defense Mineral Shield Broad Spectrum SPF 32 TINTED Sunscreen,,Titanium Dioxide and Zinc Oxide,LOTION,TOPICAL,20160316,,OTC MONOGRAPH NOT FINAL,part352,"Allergan, Inc.",TITANIUM DIOXIDE; ZINC OXIDE,50; 60,mg/g; mg/g,,
0023-5679_89dfeebb-fab7-470c-9fa5-5aee87e7045b,0023-5679,HUMAN OTC DRUG,Essential Defense Active Broad Spectrum SPF 50 Sunscreen,,"Homosalate, Octinoxate, Octisalate and Zinc Oxide",LOTION,TOPICAL,20160316,,OTC MONOGRAPH NOT FINAL,part352,"Allergan, Inc.",HOMOSALATE; OCTINOXATE; OCTISALATE; ZINC OXIDE,60; 75; 50; 100,mg/g; mg/g; mg/g; mg/g,,
0023-5703_50d14433-cfa1-4dea-bca7-bdb071638194,0023-5703,HUMAN OTC DRUG,Essential Defense Mineral Shield Broad Spectrum SPF 35 Sunscreen,,Titanium Dioxide and Zinc oxide,LOTION,TOPICAL,20160316,,OTC MONOGRAPH NOT FINAL,part352,"Allergan, Inc.",TITANIUM DIOXIDE; ZINC OXIDE,50; 60,mg/g; mg/g,,
0023-5738_832cc9a1-e194-4203-aa96-991a3286e1a6,0023-5738,HUMAN OTC DRUG,Essential Defense Everyday Clear Broad Spectrum SPF 47 Sunscreen,,Zinc Oxide and Octinoxate,LOTION,TOPICAL,20160316,,OTC MONOGRAPH NOT FINAL,part352,"Allergan, Inc.",ZINC OXIDE; OCTINOXATE,120; 75,mg/g; mg/g,,
0023-5773_bad13e61-f80c-47f1-a061-f779694e6d56,0023-5773,HUMAN OTC DRUG,REFRESH OPTIVE Mega-3,,"Carboxymethylcellulose sodium, Glycerin and Polysorbate 80",SOLUTION/ DROPS,OPHTHALMIC,20170530,,OTC MONOGRAPH FINAL,part349,"Allergan, Inc.",CARBOXYMETHYLCELLULOSE SODIUM; GLYCERIN; POLYSORBATE 80,5; 10; 5,mg/mL; mg/mL; mg/mL,,
0023-5812_eaf66d81-5c25-404f-a191-3584124f098b,0023-5812,HUMAN PRESCRIPTION DRUG,GELNIQUE,,oxybutynin chloride,GEL,TRANSDERMAL,20170401,,NDA,NDA022204,"Allergan, Inc.",OXYBUTYNIN CHLORIDE,100,mg/g,"Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA]",
0023-5853_406e9b70-cd62-4418-b188-5e6524f52d51,0023-5853,HUMAN PRESCRIPTION DRUG,Delzicol,,mesalamine,"CAPSULE, DELAYED RELEASE",ORAL,20160516,,NDA,NDA204412,"Allergan, Inc.",MESALAMINE,400,mg/1,"Aminosalicylate [EPC],Aminosalicylic Acids [Chemical/Ingredient]",
0023-5858_bd4a5328-e0fd-4a6c-8ab9-91ccd591c16c,0023-5858,HUMAN PRESCRIPTION DRUG,LILETTA,,Levonorgestrel,INTRAUTERINE DEVICE,INTRAUTERINE,20160531,,NDA,NDA206229,"Allergan, Inc.",LEVONORGESTREL,52,mg/1,"Inhibit Ovum Fertilization [PE],Progesterone Congeners [Chemical/Ingredient],Progesterone Congeners [Chemical/Ingredient],Progestin [EPC],Progestin-containing Intrauterine Device [EPC]",
0023-5861_eaf66d81-5c25-404f-a191-3584124f098b,0023-5861,HUMAN PRESCRIPTION DRUG,GELNIQUE,,oxybutynin chloride,GEL,TRANSDERMAL,20170401,,NDA,NDA022204,"Allergan, Inc.",OXYBUTYNIN CHLORIDE,100,mg/g,"Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA]",
0023-5862_65355748-4145-4827-862c-fae9b6cecd68,0023-5862,HUMAN PRESCRIPTION DRUG,Taytulla,,"norethindrone acetate and ethinyl estradiol, and ferrous fumarate",KIT,,20160501,,NDA,NDA204426,"Allergan, Inc.",,,,,
0023-5868_73855eef-00a2-4e3e-9bd7-345b2e679b3d,0023-5868,HUMAN PRESCRIPTION DRUG,Femring,,estradiol acetate,RING,VAGINAL,20160502,,NDA,NDA021367,"Allergan, Inc.",ESTRADIOL ACETATE,0.05,mg/d,"Estradiol Congeners [Chemical/Ingredient],Estrogen [EPC],Estrogen Receptor Agonists [MoA]",
0023-5869_73855eef-00a2-4e3e-9bd7-345b2e679b3d,0023-5869,HUMAN PRESCRIPTION DRUG,Femring,,estradiol acetate,RING,VAGINAL,20160502,,NDA,NDA021367,"Allergan, Inc.",ESTRADIOL ACETATE,0.1,mg/d,"Estradiol Congeners [Chemical/Ingredient],Estrogen [EPC],Estrogen Receptor Agonists [MoA]",
0023-5870_acf749c1-e4bb-4459-b5bc-a9fc497c9823,0023-5870,HUMAN PRESCRIPTION DRUG,Cordran,,Flurandrenolide,TAPE,TOPICAL,20160815,,NDA,NDA016455,"Allergan, Inc.",FLURANDRENOLIDE,4,ug/cm2,"Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]",
0023-5874_12f03cb0-1ed2-45e8-b432-2ef5dcf4faa7,0023-5874,HUMAN PRESCRIPTION DRUG,Byvalson,,nebivolol hydrochloride and valsartan,"TABLET, FILM COATED",ORAL,20160603,,NDA,NDA206302,"Allergan, Inc",NEBIVOLOL HYDROCHLORIDE; VALSARTAN,5; 80,mg/1; mg/1,"Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC],Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC]",
0023-5901_7e083ad0-ee99-4e1d-b13a-48786dd3d14d,0023-5901,HUMAN PRESCRIPTION DRUG,Asacol HD,,mesalamine,"TABLET, DELAYED RELEASE",ORAL,20080528,,NDA,NDA021830,"Allergan, Inc.",MESALAMINE,800,mg/1,"Aminosalicylate [EPC],Aminosalicylic Acids [Chemical/Ingredient]",
0023-5902_2fafba3a-f920-439c-a39a-efa83712e6c1,0023-5902,HUMAN PRESCRIPTION DRUG,Trelstar,,triptorelin pamoate,KIT,,20000615,,NDA,NDA020715,"Allergan, Inc.",,,,,
0023-5904_2fafba3a-f920-439c-a39a-efa83712e6c1,0023-5904,HUMAN PRESCRIPTION DRUG,Trelstar,,triptorelin pamoate,KIT,,20010629,,NDA,NDA021288,"Allergan, Inc.",,,,,
0023-5906_2fafba3a-f920-439c-a39a-efa83712e6c1,0023-5906,HUMAN PRESCRIPTION DRUG,Trelstar,,triptorelin pamoate,KIT,,20100311,,NDA,NDA022437,"Allergan, Inc.",,,,,
0023-5920_21b14ebe-ab63-48b5-8306-4392398b15e2,0023-5920,HUMAN PRESCRIPTION DRUG,Nuvessa,,metronidazole,GEL,VAGINAL,20150101,,NDA,NDA205223,"Allergan, Inc.",METRONIDAZOLE,65,mg/5g,"Nitroimidazole Antimicrobial [EPC],Nitroimidazoles [Chemical/Ingredient]",
0023-5970_83697cee-7db6-4b24-a606-7ee2cf757157,0023-5970,HUMAN PRESCRIPTION DRUG,FEMCON Fe,,"norethindrone and ethinyl estradiol, and ferrous fumarate",KIT,,20061101,,NDA,NDA021490,"Allergan, Inc.",,,,,
0023-5990_067e4283-05f5-462e-a0f3-c2b243478c24,0023-5990,HUMAN PRESCRIPTION DRUG,Androderm,,Testosterone,PATCH,TRANSDERMAL,19950929,,NDA,NDA020489,"Allergan, Inc.",TESTOSTERONE,2,mg/d,"Androgen [EPC],Androgen Receptor Agonists [MoA],Androstanes [Chemical/Ingredient]",CIII
0023-5992_067e4283-05f5-462e-a0f3-c2b243478c24,0023-5992,HUMAN PRESCRIPTION DRUG,Androderm,,Testosterone,PATCH,TRANSDERMAL,19950929,,NDA,NDA020489,"Allergan, Inc.",TESTOSTERONE,4,mg/d,"Androgen [EPC],Androgen Receptor Agonists [MoA],Androstanes [Chemical/Ingredient]",CIII
0023-6002_5b392851-6e6d-4e36-bfa7-5f0504703e46,0023-6002,HUMAN PRESCRIPTION DRUG,Norco,,Hydrocodone Bitartrate and Acetaminophen,TABLET,ORAL,20160501,,ANDA,ANDA040099,"Allergan, Inc.",HYDROCODONE BITARTRATE; ACETAMINOPHEN,5; 325,mg/1; mg/1,"Opioid Agonist [EPC],Opioid Agonists [MoA]",CII
0023-6010_5e6ed4d3-8635-4d2c-8359-9b7446a6604d,0023-6010,HUMAN PRESCRIPTION DRUG,Fiorinal with Codeine,,"Butalbital, Aspirin, Caffeine, and Codeine Phosphate",CAPSULE,ORAL,19901026,,NDA,NDA019429,"Allergan, Inc.",BUTALBITAL; ASPIRIN; CAFFEINE; CODEINE PHOSPHATE,50; 325; 40; 50,mg/1; mg/1; mg/1; mg/1,"Barbiturate [EPC],Barbiturates [Chemical/Ingredient],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Methylxanthine [EPC],Xanthines [Chemical/Ingredient],Full Opioid Agonists [MoA],Opioid Agonist [EPC]",CIII
0023-6011_3fca7a7d-b89b-4143-be19-f2be942986f5,0023-6011,HUMAN PRESCRIPTION DRUG,Kadian,,morphine sulfate,"CAPSULE, EXTENDED RELEASE",ORAL,20090407,,NDA,NDA020616,"Allergan, Inc.",MORPHINE SULFATE,10,mg/1,"Full Opioid Agonists [MoA],Opioid Agonist [EPC]",CII
0023-6012_3fca7a7d-b89b-4143-be19-f2be942986f5,0023-6012,HUMAN PRESCRIPTION DRUG,Kadian,,morphine sulfate,"CAPSULE, EXTENDED RELEASE",ORAL,20090407,,NDA,NDA020616,"Allergan, Inc.",MORPHINE SULFATE,20,mg/1,"Full Opioid Agonists [MoA],Opioid Agonist [EPC]",CII
0023-6013_3fca7a7d-b89b-4143-be19-f2be942986f5,0023-6013,HUMAN PRESCRIPTION DRUG,Kadian,,morphine sulfate,"CAPSULE, EXTENDED RELEASE",ORAL,20090407,,NDA,NDA020616,"Allergan, Inc.",MORPHINE SULFATE,30,mg/1,"Full Opioid Agonists [MoA],Opioid Agonist [EPC]",CII
0023-6014_3fca7a7d-b89b-4143-be19-f2be942986f5,0023-6014,HUMAN PRESCRIPTION DRUG,Kadian,,morphine sulfate,"CAPSULE, EXTENDED RELEASE",ORAL,20120507,,NDA,NDA020616,"Allergan, Inc.",MORPHINE SULFATE,40,mg/1,"Full Opioid Agonists [MoA],Opioid Agonist [EPC]",CII
0023-6015_3fca7a7d-b89b-4143-be19-f2be942986f5,0023-6015,HUMAN PRESCRIPTION DRUG,Kadian,,morphine sulfate,"CAPSULE, EXTENDED RELEASE",ORAL,20090407,,NDA,NDA020616,"Allergan, Inc.",MORPHINE SULFATE,50,mg/1,"Full Opioid Agonists [MoA],Opioid Agonist [EPC]",CII
0023-6016_3fca7a7d-b89b-4143-be19-f2be942986f5,0023-6016,HUMAN PRESCRIPTION DRUG,Kadian,,morphine sulfate,"CAPSULE, EXTENDED RELEASE",ORAL,20090407,,NDA,NDA020616,"Allergan, Inc.",MORPHINE SULFATE,60,mg/1,"Full Opioid Agonists [MoA],Opioid Agonist [EPC]",CII
0023-6017_3fca7a7d-b89b-4143-be19-f2be942986f5,0023-6017,HUMAN PRESCRIPTION DRUG,Kadian,,morphine sulfate,"CAPSULE, EXTENDED RELEASE",ORAL,20090407,,NDA,NDA020616,"Allergan, Inc.",MORPHINE SULFATE,80,mg/1,"Full Opioid Agonists [MoA],Opioid Agonist [EPC]",CII
0023-6018_3fca7a7d-b89b-4143-be19-f2be942986f5,0023-6018,HUMAN PRESCRIPTION DRUG,Kadian,,morphine sulfate,"CAPSULE, EXTENDED RELEASE",ORAL,20090407,,NDA,NDA020616,"Allergan, Inc.",MORPHINE SULFATE,100,mg/1,"Full Opioid Agonists [MoA],Opioid Agonist [EPC]",CII
0023-6019_3fca7a7d-b89b-4143-be19-f2be942986f5,0023-6019,HUMAN PRESCRIPTION DRUG,Kadian,,morphine sulfate,"CAPSULE, EXTENDED RELEASE",ORAL,20090407,,NDA,NDA020616,"Allergan, Inc.",MORPHINE SULFATE,200,mg/1,"Full Opioid Agonists [MoA],Opioid Agonist [EPC]",CII
0023-6021_5b392851-6e6d-4e36-bfa7-5f0504703e46,0023-6021,HUMAN PRESCRIPTION DRUG,Norco,,Hydrocodone Bitartrate and Acetaminophen,TABLET,ORAL,20130312,,ANDA,ANDA040148,"Allergan, Inc.",HYDROCODONE BITARTRATE; ACETAMINOPHEN,7.5; 325,mg/1; mg/1,"Opioid Agonist [EPC],Opioid Agonists [MoA]",CII
0023-6022_5b392851-6e6d-4e36-bfa7-5f0504703e46,0023-6022,HUMAN PRESCRIPTION DRUG,Norco,,Hydrocodone Bitartrate and Acetaminophen,TABLET,ORAL,20130312,,ANDA,ANDA040148,"Allergan, Inc.",HYDROCODONE BITARTRATE; ACETAMINOPHEN,10; 325,mg/1; mg/1,"Opioid Agonist [EPC],Opioid Agonists [MoA]",CII
0023-6030_f8487b99-7655-492e-acaf-7eaf1026466e,0023-6030,HUMAN PRESCRIPTION DRUG,GENERESS Fe,,norethindrone and ethinyl estradiol and ferrous fumarate,KIT,ORAL,20111223,,NDA,NDA022573,"Allergan, Inc.",,,,,
0023-6112_7a5b1fc7-b87b-4c12-b579-93a3b8609515,0023-6112,HUMAN PRESCRIPTION DRUG,Zenpep,,"PANCRELIPASE LIPASE, PANCRELIPASE PROTEASE, PANCRELIPASE AMYLASE","CAPSULE, DELAYED RELEASE",ORAL,20170826,,NDA,NDA022210,"Allergan, Inc.",PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE; PANCRELIPASE AMYLASE,20000; 68000; 109000,[USP'U]/1; [USP'U]/1; [USP'U]/1,,
0023-7824_d4e588bc-ab78-4f31-9867-a2d6921c58b7,0023-7824,HUMAN PRESCRIPTION DRUG,Polytrim,,polymyxin b sulfate and trimethoprim sulfate,SOLUTION/ DROPS,OPHTHALMIC,19900123,,NDA,NDA050567,"Allergan, Inc.",POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE,100000; 1,[USP'U]/mL; mg/mL,"Polymyxin-class Antibacterial [EPC],Polymyxins [Chemical/Ingredient],Dihydrofolate Reductase Inhibitor Antibacterial [EPC],Dihydrofolate Reductase Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA]",
0023-8335_ca6ba093-8b7e-455a-b9ab-74e249420add,0023-8335,HUMAN PRESCRIPTION DRUG,TAZORAC,,tazarotene,GEL,CUTANEOUS,19970801,,NDA,NDA020600,"Allergan, Inc.",TAZAROTENE,0.5,mg/g,"Retinoid [EPC],Retinoids [Chemical/Ingredient]",
0023-8694_d7a96fba-04c1-4af1-9e4b-6e22d4e1fdd0,0023-8694,HUMAN PRESCRIPTION DRUG,AZELEX,,azelaic acid,CREAM,CUTANEOUS,19960321,,NDA,NDA020428,"Allergan, Inc.",AZELAIC ACID,0.2,g/g,"Decreased Protein Synthesis [PE],Decreased Sebaceous Gland Activity [PE]",
0023-8842_2f35a2aa-54f1-4abb-b1be-056b17a0d3c5,0023-8842,HUMAN PRESCRIPTION DRUG,ALOCRIL,,nedocromil sodium,SOLUTION/ DROPS,OPHTHALMIC,20000203,,NDA,NDA021009,"Allergan, Inc.",NEDOCROMIL SODIUM,20,mg/mL,"Decreased Histamine Release [PE],Mast Cell Stabilizer [EPC]",
0023-9155_bb6d822b-d39b-40ac-b40c-b29289176c70,0023-9155,HUMAN PRESCRIPTION DRUG,TAZORAC,,tazarotene,CREAM,CUTANEOUS,20001115,,NDA,NDA021184,"Allergan, Inc.",TAZAROTENE,0.5,mg/g,"Retinoid [EPC],Retinoids [Chemical/Ingredient]",
0023-9156_bb6d822b-d39b-40ac-b40c-b29289176c70,0023-9156,HUMAN PRESCRIPTION DRUG,TAZORAC,,tazarotene,CREAM,CUTANEOUS,20001113,,NDA,NDA021184,"Allergan, Inc.",TAZAROTENE,1,mg/g,"Retinoid [EPC],Retinoids [Chemical/Ingredient]",
0023-9163_5a4081c8-5d62-44b3-b72f-36c03f2c86a8,0023-9163,HUMAN PRESCRIPTION DRUG,RESTASIS,,cyclosporine,EMULSION,OPHTHALMIC,20030401,,NDA,NDA050790,"Allergan, Inc.",CYCLOSPORINE,0.5,mg/mL,"Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA]",
0023-9177_5aef5742-0096-4aee-ab72-1f21d83a3f23,0023-9177,HUMAN PRESCRIPTION DRUG,ALPHAGAN P,,brimonidine tartrate,SOLUTION/ DROPS,OPHTHALMIC,20010710,,NDA,NDA021262,"Allergan, Inc.",BRIMONIDINE TARTRATE,1.5,mg/mL,"Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC]",
0023-9201_75ad94a2-5508-443e-8143-2bb27a7e2466,0023-9201,HUMAN PRESCRIPTION DRUG,ELESTAT,,epinastine hydrochloride,SOLUTION/ DROPS,OPHTHALMIC,20040119,,NDA,NDA021565,"Allergan, Inc.",EPINASTINE HYDROCHLORIDE,0.5,mg/mL,"Adrenergic Agonists [MoA],Adrenergic Receptor Agonist [EPC],Decreased Histamine Release [PE],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Inhibitor [EPC]",
0023-9205_29dd09ac-bec3-4956-b98a-28d254e496e2,0023-9205,HUMAN OTC DRUG,REFRESH LIQUIGEL,,Carboxymethylcellulose sodium,GEL,OPHTHALMIC,20011004,,OTC MONOGRAPH FINAL,part349,"Allergan, Inc.",CARBOXYMETHYLCELLULOSE SODIUM,10,mg/mL,,
0023-9211_923b2701-ec40-40c4-85cb-f6642b687d12,0023-9211,HUMAN PRESCRIPTION DRUG,COMBIGAN,,"brimonidine tartrate, timolol maleate",SOLUTION/ DROPS,OPHTHALMIC,20071114,,NDA,NDA021398,"Allergan, Inc.",BRIMONIDINE TARTRATE; TIMOLOL MALEATE,2; 5,mg/mL; mg/mL,"Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC],Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC]",
0023-9232_58f75fa7-b008-4f19-88a1-cf0785a871bc,0023-9232,HUMAN PRESCRIPTION DRUG,BOTOX Cosmetic,,onabotulinumtoxinA,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAMUSCULAR,20080520,,BLA,BLA103000,"Allergan, Inc.",BOTULINUM TOXIN TYPE A,100,[USP'U]/1,"Acetylcholine Release Inhibitor [EPC],Acetylcholine Release Inhibitors [MoA]",
0023-9236_a2e46dae-939c-4984-a003-59e0d00f18b4,0023-9236,HUMAN PRESCRIPTION DRUG,AVAGE,,tazarotene,CREAM,CUTANEOUS,20030107,,NDA,NDA021184,"Allergan, Inc.",TAZAROTENE,1,mg/g,"Retinoid [EPC],Retinoids [Chemical/Ingredient]",
0023-9277_afd04991-4a94-41a7-94dc-2fcb5a632ede,0023-9277,HUMAN PRESCRIPTION DRUG,ACULAR LS,,ketorolac tromethamine,SOLUTION/ DROPS,OPHTHALMIC,20030819,,NDA,NDA021528,"Allergan, Inc.",KETOROLAC TROMETHAMINE,4,mg/mL,"Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Cyclooxygenase Inhibitor [EPC]",
0023-9321_5aef5742-0096-4aee-ab72-1f21d83a3f23,0023-9321,HUMAN PRESCRIPTION DRUG,ALPHAGAN P,,brimonidine tartrate,SOLUTION/ DROPS,OPHTHALMIC,20060125,,NDA,NDA021770,"Allergan, Inc.",BRIMONIDINE TARTRATE,1,mg/mL,"Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC]",
0024-0335_4b1bd4df-00b7-4620-9dc5-bce675a412eb,0024-0335,HUMAN PRESCRIPTION DRUG,Demerol,,Meperidine Hydrochloride,TABLET,ORAL,19421110,,NDA,NDA005010,sanofi-aventis U.S. LLC,MEPERIDINE HYDROCHLORIDE,50,mg/1,"Full Opioid Agonists [MoA],Opioid Agonist [EPC]",CII
0024-0335_e880e6cc-4018-4bea-a722-b8c94a588b34,0024-0335,HUMAN PRESCRIPTION DRUG,Demerol,,Meperidine Hydrochloride,TABLET,ORAL,20130401,,NDA,NDA005010,sanofi-aventis U.S. LLC,MEPERIDINE HYDROCHLORIDE,50,mg/1,"Full Opioid Agonists [MoA],Opioid Agonist [EPC]",CII
0024-0337_4b1bd4df-00b7-4620-9dc5-bce675a412eb,0024-0337,HUMAN PRESCRIPTION DRUG,Demerol,,Meperidine Hydrochloride,TABLET,ORAL,19421110,,NDA,NDA005010,sanofi-aventis U.S. LLC,MEPERIDINE HYDROCHLORIDE,100,mg/1,"Full Opioid Agonists [MoA],Opioid Agonist [EPC]",CII
0024-0337_e880e6cc-4018-4bea-a722-b8c94a588b34,0024-0337,HUMAN PRESCRIPTION DRUG,Demerol,,Meperidine Hydrochloride,TABLET,ORAL,20120521,,NDA,NDA005010,sanofi-aventis U.S. LLC,MEPERIDINE HYDROCHLORIDE,100,mg/1,"Full Opioid Agonists [MoA],Opioid Agonist [EPC]",CII
0024-0393_f62652bd-9c05-486a-a753-ed2972f1cfde,0024-0393,HUMAN PRESCRIPTION DRUG,DRISDOL,,Ergocalciferol,"CAPSULE, LIQUID FILLED",ORAL,19741111,,NDA,NDA003444,sanofi-aventis U.S. LLC,ERGOCALCIFEROL,1.25,mg/1,"Ergocalciferols [Chemical/Ingredient],Provitamin D2 Compound [EPC]",
0024-0590_1dcf6847-980e-4e6f-a5ae-926a1706e248,0024-0590,HUMAN PRESCRIPTION DRUG,ELOXATIN,,oxaliplatin,"INJECTION, SOLUTION, CONCENTRATE",INTRAVENOUS,20060602,,NDA,NDA021759,sanofi-aventis U.S. LLC,OXALIPLATIN,5,mg/mL,"Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient]",
0024-0591_1dcf6847-980e-4e6f-a5ae-926a1706e248,0024-0591,HUMAN PRESCRIPTION DRUG,ELOXATIN,,oxaliplatin,"INJECTION, SOLUTION, CONCENTRATE",INTRAVENOUS,20060602,,NDA,NDA021759,sanofi-aventis U.S. LLC,OXALIPLATIN,5,mg/mL,"Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient]",
0024-1535_1d226524-68e6-4137-930c-7d2760c7ff39,0024-1535,HUMAN PRESCRIPTION DRUG,Phisohex,,hexachlorophene,EMULSION,TOPICAL,19760611,,NDA,NDA006882,sanofi-aventis U.S. LLC,HEXACHLOROPHENE,30,mg/mL,Antiseptic [EPC],
0024-1562_c91c752e-ad6d-4b17-b1b5-2edc8a86856c,0024-1562,HUMAN PRESCRIPTION DRUG,Plaquenil,,Hydroxychloroquine Sulfate,"TABLET, FILM COATED",ORAL,19550418,,NDA,NDA009768,sanofi-aventis U.S. LLC,HYDROXYCHLOROQUINE SULFATE,200,mg/1,"Antirheumatic Agent [EPC],Antimalarial [EPC]",
0024-1596_e98f9e68-e83d-43f1-8add-a0b9cc5614b9,0024-1596,HUMAN PRESCRIPTION DRUG,Primaquine Phosphate,,Primaquine Phosphate,"TABLET, FILM COATED",ORAL,20110415,,NDA,NDA008316,sanofi-aventis U.S. LLC,PRIMAQUINE PHOSPHATE,15,mg/1,Antimalarial [EPC],
0024-2792_d4a8b488-b33f-456d-bb00-4932fe4cebda,0024-2792,HUMAN PRESCRIPTION DRUG,Ferrlecit,,sodium ferric gluconate complex,INJECTION,INTRAVENOUS,20110301,,NDA,NDA020955,sanofi-aventis U.S. LLC,SODIUM FERRIC GLUCONATE COMPLEX,12.5,mg/mL,"Iron [Chemical/Ingredient],Parenteral Iron Replacement [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA]",
0024-2794_586f2e14-e9ca-4669-ad40-54ec070ec78e,0024-2794,HUMAN PRESCRIPTION DRUG,Ferrlecit,,sodium ferric gluconate complex,INJECTION,INTRAVENOUS,20140707,,NDA,NDA020955,sanofi-aventis U.S. LLC,SODIUM FERRIC GLUCONATE COMPLEX,12.5,mg/mL,"Iron [Chemical/Ingredient],Parenteral Iron Replacement [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA]",
0024-4142_63ea5a96-12b8-47be-8977-8c40ff8f5b5f,0024-4142,HUMAN PRESCRIPTION DRUG,Multaq,,Dronedarone,"TABLET, FILM COATED",ORAL,20090701,,NDA,NDA022425,sanofi-aventis U.S. LLC,DRONEDARONE,400,mg/1,"Antiarrhythmic [EPC],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA]",
0024-5150_3917e906-51a8-4162-850b-e1b2b25141eb,0024-5150,HUMAN PRESCRIPTION DRUG,Elitek,,rasburicase,KIT,,20020712,,BLA,BLA103946,sanofi-aventis U.S. LLC,,,,,
0024-5151_3917e906-51a8-4162-850b-e1b2b25141eb,0024-5151,HUMAN PRESCRIPTION DRUG,Elitek,,rasburicase,KIT,,20060601,,BLA,BLA103940,sanofi-aventis U.S. LLC,,,,,
0024-5401_7c53c16e-bd14-4a14-8194-c6146e86e203,0024-5401,HUMAN PRESCRIPTION DRUG,Ambien,,zolpidem tartrate,"TABLET, FILM COATED",ORAL,19930401,,NDA,NDA019908,sanofi-aventis U.S. LLC,ZOLPIDEM TARTRATE,5,mg/1,"gamma-Aminobutyric Acid-ergic Agonist [EPC],GABA A Agonists [MoA],Pyridines [Chemical/Ingredient],Central Nervous System Depression [PE]",CIV
0024-5421_7c53c16e-bd14-4a14-8194-c6146e86e203,0024-5421,HUMAN PRESCRIPTION DRUG,Ambien,,zolpidem tartrate,"TABLET, FILM COATED",ORAL,19930401,,NDA,NDA019908,sanofi-aventis U.S. LLC,ZOLPIDEM TARTRATE,10,mg/1,"gamma-Aminobutyric Acid-ergic Agonist [EPC],GABA A Agonists [MoA],Pyridines [Chemical/Ingredient],Central Nervous System Depression [PE]",CIV
0024-5501_6eba91c0-7665-4af2-925e-c9a722687eb5,0024-5501,HUMAN PRESCRIPTION DRUG,Ambien,CR,zolpidem tartrate,"TABLET, COATED",ORAL,20050919,,NDA,NDA021774,sanofi-aventis U.S. LLC,ZOLPIDEM TARTRATE,6.25,mg/1,"gamma-Aminobutyric Acid-ergic Agonist [EPC],GABA A Agonists [MoA],Pyridines [Chemical/Ingredient],Central Nervous System Depression [PE]",CIV
0024-5521_6eba91c0-7665-4af2-925e-c9a722687eb5,0024-5521,HUMAN PRESCRIPTION DRUG,Ambien,CR,zolpidem tartrate,"TABLET, COATED",ORAL,20050919,,NDA,NDA021774,sanofi-aventis U.S. LLC,ZOLPIDEM TARTRATE,12.5,mg/1,"gamma-Aminobutyric Acid-ergic Agonist [EPC],GABA A Agonists [MoA],Pyridines [Chemical/Ingredient],Central Nervous System Depression [PE]",CIV
0024-5745_8c1a83cb-bcbb-40a1-ab02-7d6917f76dd8,0024-5745,HUMAN PRESCRIPTION DRUG,ADLYXIN,,Lixisenatide,KIT,,20160727,,NDA,NDA208471,Sanofi-Aventis U.S. LLC,,,,,
0024-5747_8c1a83cb-bcbb-40a1-ab02-7d6917f76dd8,0024-5747,HUMAN PRESCRIPTION DRUG,ADLYXIN,,Lixisenatide,"INJECTION, SOLUTION",SUBCUTANEOUS,20160727,,NDA,NDA208471,Sanofi-Aventis U.S. LLC,LIXISENATIDE,100,ug/mL,"GLP-1 Receptor Agonist [EPC],Glucagon-Like Peptide 1 [Chemical/Ingredient],Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]",
0024-5761_b2344ff5-503c-429b-936d-369ed80f485c,0024-5761,HUMAN PRESCRIPTION DRUG,Soliqua 100/33,,insulin glargine and lixisenatide,"INJECTION, SOLUTION",SUBCUTANEOUS,20161121,,NDA,NDA208673,Sanofi-Aventis U.S. LLC,INSULIN GLARGINE; LIXISENATIDE,100; 33,U/mL; ug/mL,"Insulin [Chemical/Ingredient],Insulin Analog [EPC],GLP-1 Receptor Agonist [EPC],Glucagon-Like Peptide 1 [Chemical/Ingredient],Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]",
0024-5800_226af22f-7dd3-4c63-a40f-0c1635868d8e,0024-5800,HUMAN PRESCRIPTION DRUG,Xyzal,,levocetirizine dihydrochloride,"TABLET, FILM COATED",ORAL,20070809,,NDA,NDA022064,Sanofi-Aventis U.S. LLC,LEVOCETIRIZINE DIHYDROCHLORIDE,5,mg/1,"Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC]",
0024-5801_226af22f-7dd3-4c63-a40f-0c1635868d8e,0024-5801,HUMAN PRESCRIPTION DRUG,Xyzal,,levocetirizine dihydrochloride,SOLUTION,ORAL,20080402,,NDA,NDA022157,Sanofi-Aventis U.S. LLC,LEVOCETIRIZINE DIHYDROCHLORIDE,0.5,mg/mL,"Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC]",
0024-5812_c25bf565-8061-450a-9217-a7a280ee0424,0024-5812,HUMAN PRESCRIPTION DRUG,Aplenzin,,bupropion hydrobromide,"TABLET, EXTENDED RELEASE",ORAL,20090330,,NDA,NDA022108,sanofi-aventis U.S. LLC,BUPROPION HYDROBROMIDE,522,mg/1,"Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA]",
0024-5824_173e8368-c8e4-4147-ba5c-6b934ec717ab,0024-5824,HUMAN PRESCRIPTION DRUG,Jevtana,,cabazitaxel,KIT,,20100617,,NDA,NDA201023,Sanofi-Aventis U.S. LLC,,,,,
0024-5840_31d60114-8140-4427-a086-ee306d3bc458,0024-5840,HUMAN PRESCRIPTION DRUG,ZALTRAP,,ziv-aflibercept,"SOLUTION, CONCENTRATE",INTRAVENOUS,20120803,,BLA,BLA125418,sanofi-aventis U.S. LLC,AFLIBERCEPT,100,mg/4mL,,
0024-5841_31d60114-8140-4427-a086-ee306d3bc458,0024-5841,HUMAN PRESCRIPTION DRUG,ZALTRAP,,ziv-aflibercept,"SOLUTION, CONCENTRATE",INTRAVENOUS,20120803,,BLA,BLA125418,sanofi-aventis U.S. LLC,AFLIBERCEPT,200,mg/8mL,,
0024-5843_aca63889-1042-411c-8cc1-f4d5c0ee4f44,0024-5843,HUMAN PRESCRIPTION DRUG,Leukine,,SARGRAMOSTIM,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS; SUBCUTANEOUS,19910501,,BLA,BLA103362,sanofi-aventis U.S. LLC,SARGRAMOSTIM,250,ug/mL,"Granulocyte Colony-Stimulating Factor [Chemical/Ingredient],Granulocyte-Macrophage Colony-Stimulating Factor [Chemical/Ingredient],Increased Myeloid Cell Production [PE],Leukocyte Growth Factor [EPC]",
0024-5844_aca63889-1042-411c-8cc1-f4d5c0ee4f44,0024-5844,HUMAN PRESCRIPTION DRUG,Leukine,,SARGRAMOSTIM,LIQUID,INTRAVENOUS; SUBCUTANEOUS,19961201,,BLA,BLA103362,sanofi-aventis U.S. LLC,SARGRAMOSTIM,500,ug/mL,"Granulocyte Colony-Stimulating Factor [Chemical/Ingredient],Granulocyte-Macrophage Colony-Stimulating Factor [Chemical/Ingredient],Increased Myeloid Cell Production [PE],Leukocyte Growth Factor [EPC]",
0024-5850_93df66af-a5f2-41eb-98d3-000f295b9967,0024-5850,HUMAN PRESCRIPTION DRUG,Avapro,,irbesartan,TABLET,ORAL,20130101,,NDA,NDA020757,sanofi-aventis U.S. LLC,IRBESARTAN,75,mg/1,"Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC]",
0024-5851_93df66af-a5f2-41eb-98d3-000f295b9967,0024-5851,HUMAN PRESCRIPTION DRUG,Avapro,,irbesartan,TABLET,ORAL,20130101,,NDA,NDA020757,sanofi-aventis U.S. LLC,IRBESARTAN,150,mg/1,"Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC]",
0024-5852_93df66af-a5f2-41eb-98d3-000f295b9967,0024-5852,HUMAN PRESCRIPTION DRUG,Avapro,,irbesartan,TABLET,ORAL,20130101,,NDA,NDA020757,sanofi-aventis U.S. LLC,IRBESARTAN,300,mg/1,"Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC]",
0024-5855_5396d173-b323-49b5-b0ba-bf2e6a6e1967,0024-5855,HUMAN PRESCRIPTION DRUG,Avalide,,irbesartan and hydrochlorothiazide,"TABLET, FILM COATED",ORAL,20130101,,NDA,NDA020758,sanofi-aventis U.S. LLC,IRBESARTAN; HYDROCHLOROTHIAZIDE,150; 12.5,mg/1; mg/1,"Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient]",
0024-5856_5396d173-b323-49b5-b0ba-bf2e6a6e1967,0024-5856,HUMAN PRESCRIPTION DRUG,Avalide,,irbesartan and hydrochlorothiazide,"TABLET, FILM COATED",ORAL,20130101,,NDA,NDA020758,sanofi-aventis U.S. LLC,IRBESARTAN; HYDROCHLOROTHIAZIDE,300; 12.5,mg/1; mg/1,"Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient]",
0024-5860_84e0d5b2-8c35-487f-af64-7198a124c632,0024-5860,HUMAN PRESCRIPTION DRUG,Clolar,,clofarabine,INJECTION,INTRAVENOUS,20130401,,NDA,NDA021673,sanofi-aventis U.S. LLC,CLOFARABINE,1,mg/mL,"Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]",
0024-5862_88f93cdb-26f8-414a-8ad6-96ca0d098ec1,0024-5862,HUMAN PRESCRIPTION DRUG,Mozobil,,PLERIXAFOR,SOLUTION,SUBCUTANEOUS,20130901,,NDA,NDA022311,sanofi-aventis U.S. LLC,PLERIXAFOR,24,mg/1.2mL,"Hematopoietic Stem Cell Mobilizer [EPC],Increased Hematopoietic Stem Cell Mobilization [PE]",
0024-5869_d3fbaa04-d53c-4833-96b5-7688d4efbfb3,0024-5869,HUMAN PRESCRIPTION DRUG,TOUJEO,,insulin glargine,"INJECTION, SOLUTION",SUBCUTANEOUS,20150225,,NDA,NDA206538,Sanofi-Aventis U.S. LLC,INSULIN GLARGINE,300,U/mL,"Insulin [Chemical/Ingredient],Insulin Analog [EPC]",
0024-5874_596bfcee-8076-4cb8-a100-317f23c3c570,0024-5874,HUMAN PRESCRIPTION DRUG,Afrezza,,Insulin Human,"POWDER, METERED",RESPIRATORY (INHALATION),20140711,,NDA,NDA022472,Sanofi-Aventis U.S. LLC,INSULIN HUMAN,4,1-Jan,"Insulin [Chemical/Ingredient],Insulin [EPC]",
0024-5882_596bfcee-8076-4cb8-a100-317f23c3c570,0024-5882,HUMAN PRESCRIPTION DRUG,Afrezza,,Insulin Human,KIT,,20140711,,NDA,NDA022472,Sanofi-Aventis U.S. LLC,,,,,
0024-5884_596bfcee-8076-4cb8-a100-317f23c3c570,0024-5884,HUMAN PRESCRIPTION DRUG,Afrezza,,Insulin Human,KIT,,20140711,,NDA,NDA022472,Sanofi-Aventis U.S. LLC,,,,,
0024-5894_596bfcee-8076-4cb8-a100-317f23c3c570,0024-5894,HUMAN PRESCRIPTION DRUG,Afrezza,,Insulin Human,KIT,,20140711,,NDA,NDA022472,Sanofi-Aventis U.S. LLC,,,,,
0024-5901_27748799-89b9-4496-bbba-2c2f43889eb9,0024-5901,HUMAN PRESCRIPTION DRUG,Praluent,,alirocumab,"INJECTION, SOLUTION",SUBCUTANEOUS,20150724,,BLA,BLA125559,Sanofi-Aventis U.S. LLC,ALIROCUMAB,75,mg/mL,"PCSK9 Inhibitor [EPC],PCSK9 Inhibitors [MoA],Antibodies, Monoclonal [Chemical/Ingredient]",
0024-5902_27748799-89b9-4496-bbba-2c2f43889eb9,0024-5902,HUMAN PRESCRIPTION DRUG,Praluent,,alirocumab,"INJECTION, SOLUTION",SUBCUTANEOUS,20150724,,BLA,BLA125559,Sanofi-Aventis U.S. LLC,ALIROCUMAB,150,mg/mL,"PCSK9 Inhibitor [EPC],PCSK9 Inhibitors [MoA],Antibodies, Monoclonal [Chemical/Ingredient]",
0024-5903_27748799-89b9-4496-bbba-2c2f43889eb9,0024-5903,HUMAN PRESCRIPTION DRUG,Praluent,,alirocumab,"INJECTION, SOLUTION",SUBCUTANEOUS,20150724,,BLA,BLA125559,Sanofi-Aventis U.S. LLC,ALIROCUMAB,75,mg/mL,"PCSK9 Inhibitor [EPC],PCSK9 Inhibitors [MoA],Antibodies, Monoclonal [Chemical/Ingredient]",
0024-5904_27748799-89b9-4496-bbba-2c2f43889eb9,0024-5904,HUMAN PRESCRIPTION DRUG,Praluent,,alirocumab,"INJECTION, SOLUTION",SUBCUTANEOUS,20150724,,BLA,BLA125559,Sanofi-Aventis U.S. LLC,ALIROCUMAB,150,mg/mL,"PCSK9 Inhibitor [EPC],PCSK9 Inhibitors [MoA],Antibodies, Monoclonal [Chemical/Ingredient]",
0024-5908_322dfe38-b3af-4520-8e38-b45d992ea7c1,0024-5908,HUMAN PRESCRIPTION DRUG,KEVZARA,,sarilumab,"INJECTION, SOLUTION",SUBCUTANEOUS,20170522,,BLA,BLA761037,sanofi-aventis U.S. LLC,SARILUMAB,150,mg/1.14mL,"Interleukin 6 Receptor Antagonists [MoA],Interleukin-6 Receptor Antagonist [EPC]",
0024-5910_322dfe38-b3af-4520-8e38-b45d992ea7c1,0024-5910,HUMAN PRESCRIPTION DRUG,KEVZARA,,sarilumab,"INJECTION, SOLUTION",SUBCUTANEOUS,20170522,,BLA,BLA761037,sanofi-aventis U.S. LLC,SARILUMAB,200,mg/1.14mL,"Interleukin 6 Receptor Antagonists [MoA],Interleukin-6 Receptor Antagonist [EPC]",
0024-5914_86b96b61-2578-4ca0-8dc9-b13aee0932d8,0024-5914,HUMAN PRESCRIPTION DRUG,Dupixent,,Dupilumab,"INJECTION, SOLUTION",SUBCUTANEOUS,20170328,,BLA,BLA761055,sanofi-aventis U.S. LLC,DUPILUMAB,300,mg/2mL,,
0024-5917_e1373b20-fc33-4690-8811-cfe6c7f3af96,0024-5917,HUMAN PRESCRIPTION DRUG,Clolar,,clofarabine,INJECTION,INTRAVENOUS,20170701,,NDA,NDA021673,sanofi-aventis U.S. LLC,CLOFARABINE,1,mg/mL,"Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]",
0025-0061_5e563986-cde8-42dc-90a9-948eb712daf3,0025-0061,HUMAN PRESCRIPTION DRUG,Lomotil,,diphenoxylate hydrochloride and atropine sulfate,TABLET,ORAL,19600915,,NDA,NDA012462,G.D. Searle LLC Division of Pfizer Inc,DIPHENOXYLATE HYDROCHLORIDE; ATROPINE SULFATE,2.5; .025,mg/1; mg/1,"Antidiarrheal [EPC],Anticholinergic [EPC],Cholinergic Antagonists [MoA],Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA]",CV
0025-0166_34a25b9f-0e93-4436-9bda-4283b0e43d5f,0025-0166,HUMAN PRESCRIPTION DRUG,Synarel,,nafarelin acetate,"SPRAY, METERED",NASAL,19900213,,NDA,NDA019886,G.D. Searle LLC Division of Pfizer Inc,NAFARELIN ACETATE,2,mg/mL,"Gonadotropin Releasing Hormone Receptor Agonist [EPC],Gonadotropin Releasing Hormone Receptor Agonists [MoA]",
0025-1001_609553a1-1ebc-497b-8c95-77ad2346b1ad,0025-1001,HUMAN PRESCRIPTION DRUG,Aldactone,,spironolactone,"TABLET, FILM COATED",ORAL,19600121,,NDA,NDA012151,G.D. Searle LLC Division of Pfizer Inc,SPIRONOLACTONE,25,mg/1,"Aldosterone Antagonist [EPC],Aldosterone Antagonists [MoA]",
0025-1011_39c8d364-9df4-42ef-8e59-a792691f02f2,0025-1011,HUMAN PRESCRIPTION DRUG,ALDACTAZIDE,,spironolactone and hydrochlorothiazide,"TABLET, FILM COATED",ORAL,19780101,,NDA,NDA012616,G.D. Searle LLC Division of Pfizer Inc,SPIRONOLACTONE; HYDROCHLOROTHIAZIDE,25; 25,mg/1; mg/1,"Aldosterone Antagonist [EPC],Aldosterone Antagonists [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient]",
0025-1021_39c8d364-9df4-42ef-8e59-a792691f02f2,0025-1021,HUMAN PRESCRIPTION DRUG,ALDACTAZIDE,,spironolactone and hydrochlorothiazide,"TABLET, FILM COATED",ORAL,19780101,,NDA,NDA012616,G.D. Searle LLC Division of Pfizer Inc,SPIRONOLACTONE; HYDROCHLOROTHIAZIDE,50; 50,mg/1; mg/1,"Aldosterone Antagonist [EPC],Aldosterone Antagonists [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient]",
0025-1031_609553a1-1ebc-497b-8c95-77ad2346b1ad,0025-1031,HUMAN PRESCRIPTION DRUG,Aldactone,,spironolactone,"TABLET, FILM COATED",ORAL,19600121,,NDA,NDA012151,G.D. Searle LLC Division of Pfizer Inc,SPIRONOLACTONE,100,mg/1,"Aldosterone Antagonist [EPC],Aldosterone Antagonists [MoA]",
0025-1041_609553a1-1ebc-497b-8c95-77ad2346b1ad,0025-1041,HUMAN PRESCRIPTION DRUG,Aldactone,,spironolactone,"TABLET, FILM COATED",ORAL,19600121,,NDA,NDA012151,G.D. Searle LLC Division of Pfizer Inc,SPIRONOLACTONE,50,mg/1,"Aldosterone Antagonist [EPC],Aldosterone Antagonists [MoA]",
0025-1381_fb232bdf-8642-4790-845a-e0bbd5c936eb,0025-1381,HUMAN PRESCRIPTION DRUG,Daypro,,oxaprozin,"TABLET, FILM COATED",ORAL,19921029,,NDA,NDA018841,G.D. Searle LLC Division of Pfizer Inc,OXAPROZIN,600,mg/1,"Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC]",
0025-1411_33928d44-f279-41ab-a3e9-210d78240f63,0025-1411,HUMAN PRESCRIPTION DRUG,ARTHROTEC,,diclofenac sodium and misoprostol,"TABLET, FILM COATED",ORAL,19971224,,NDA,NDA020607,G.D. Searle LLC Division of Pfizer Inc,DICLOFENAC SODIUM; MISOPROSTOL,50; 200,mg/1; ug/1,"Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Prostaglandin E1 Analog [EPC],Prostaglandins E, Synthetic [Chemical/Ingredient]",
0025-1421_33928d44-f279-41ab-a3e9-210d78240f63,0025-1421,HUMAN PRESCRIPTION DRUG,ARTHROTEC,,diclofenac sodium and misoprostol,"TABLET, FILM COATED",ORAL,19971224,,NDA,NDA020607,G.D. Searle LLC Division of Pfizer Inc,DICLOFENAC SODIUM; MISOPROSTOL,75; 200,mg/1; ug/1,"Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Prostaglandin E1 Analog [EPC],Prostaglandins E, Synthetic [Chemical/Ingredient]",
0025-1451_9a73f122-b428-4185-b106-f28cbda767cd,0025-1451,HUMAN PRESCRIPTION DRUG,Cytotec,,misoprostol,TABLET,ORAL,19861227,,NDA,NDA019268,G.D. Searle LLC Division of Pfizer Inc,MISOPROSTOL,100,ug/1,"Prostaglandin E1 Analog [EPC],Prostaglandins E, Synthetic [Chemical/Ingredient]",
0025-1461_9a73f122-b428-4185-b106-f28cbda767cd,0025-1461,HUMAN PRESCRIPTION DRUG,Cytotec,,misoprostol,TABLET,ORAL,19861227,,NDA,NDA019268,G.D. Searle LLC Division of Pfizer Inc,MISOPROSTOL,200,ug/1,"Prostaglandin E1 Analog [EPC],Prostaglandins E, Synthetic [Chemical/Ingredient]",
0025-1515_daa962c6-7114-4d13-b896-bdaf9a22b8a4,0025-1515,HUMAN PRESCRIPTION DRUG,CELEBREX,,Celecoxib,CAPSULE,ORAL,19981002,,NDA,NDA020998,G.D. Searle LLC Division of Pfizer Inc,CELECOXIB,50,mg/1,"Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC]",
0025-1520_daa962c6-7114-4d13-b896-bdaf9a22b8a4,0025-1520,HUMAN PRESCRIPTION DRUG,CELEBREX,,Celecoxib,CAPSULE,ORAL,19981002,,NDA,NDA020998,G.D. Searle LLC Division of Pfizer Inc,CELECOXIB,100,mg/1,"Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC]",
0025-1525_daa962c6-7114-4d13-b896-bdaf9a22b8a4,0025-1525,HUMAN PRESCRIPTION DRUG,CELEBREX,,Celecoxib,CAPSULE,ORAL,19981002,,NDA,NDA020998,G.D. Searle LLC Division of Pfizer Inc,CELECOXIB,200,mg/1,"Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC]",
0025-1530_daa962c6-7114-4d13-b896-bdaf9a22b8a4,0025-1530,HUMAN PRESCRIPTION DRUG,CELEBREX,,Celecoxib,CAPSULE,ORAL,19981002,,NDA,NDA020998,G.D. Searle LLC Division of Pfizer Inc,CELECOXIB,400,mg/1,"Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC]",
0025-1710_feacab8c-ea58-4552-8c99-811905f17aa1,0025-1710,HUMAN PRESCRIPTION DRUG,Inspra,,eplerenone,"TABLET, FILM COATED",ORAL,20020927,,NDA,NDA021437,G.D. Searle LLC Division of Pfizer Inc,EPLERENONE,25,mg/1,"Aldosterone Antagonist [EPC],Aldosterone Antagonists [MoA]",
0025-1720_feacab8c-ea58-4552-8c99-811905f17aa1,0025-1720,HUMAN PRESCRIPTION DRUG,Inspra,,eplerenone,"TABLET, FILM COATED",ORAL,20020927,,NDA,NDA021437,G.D. Searle LLC Division of Pfizer Inc,EPLERENONE,50,mg/1,"Aldosterone Antagonist [EPC],Aldosterone Antagonists [MoA]",
0025-1821_af803539-f500-43fa-badc-c1afea501926,0025-1821,HUMAN PRESCRIPTION DRUG,Flagyl,,Metronidazole,"TABLET, FILM COATED",ORAL,19630718,,NDA,NDA012623,G.D. Searle LLC Division of Pfizer Inc,METRONIDAZOLE,500,mg/1,"Nitroimidazole Antimicrobial [EPC],Nitroimidazoles [Chemical/Ingredient]",
0025-1831_af803539-f500-43fa-badc-c1afea501926,0025-1831,HUMAN PRESCRIPTION DRUG,Flagyl,,Metronidazole,"TABLET, FILM COATED",ORAL,19630718,,NDA,NDA012623,G.D. Searle LLC Division of Pfizer Inc,METRONIDAZOLE,250,mg/1,"Nitroimidazole Antimicrobial [EPC],Nitroimidazoles [Chemical/Ingredient]",
0025-1851_44711546-8b3a-4cb9-9c3c-03b1b2ed8031,0025-1851,HUMAN PRESCRIPTION DRUG,CALAN,,verapamil hydrochloride,"TABLET, FILM COATED",ORAL,19840910,,NDA,NDA018817,G.D. Searle LLC Division of Pfizer Inc,VERAPAMIL HYDROCHLORIDE,80,mg/1,"Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA]",
0025-1861_44711546-8b3a-4cb9-9c3c-03b1b2ed8031,0025-1861,HUMAN PRESCRIPTION DRUG,CALAN,,verapamil hydrochloride,"TABLET, FILM COATED",ORAL,19840910,,NDA,NDA018817,G.D. Searle LLC Division of Pfizer Inc,VERAPAMIL HYDROCHLORIDE,120,mg/1,"Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA]",
0025-1891_9b1b09cc-305f-443d-b549-8dc420c4add4,0025-1891,HUMAN PRESCRIPTION DRUG,CALAN SR,,verapamil hydrochloride,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,19861216,,NDA,NDA019152,G.D. Searle LLC Division of Pfizer Inc,VERAPAMIL HYDROCHLORIDE,240,mg/1,"Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA]",
0025-1901_9b1b09cc-305f-443d-b549-8dc420c4add4,0025-1901,HUMAN PRESCRIPTION DRUG,CALAN SR,,verapamil hydrochloride,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,19910306,,NDA,NDA019152,G.D. Searle LLC Division of Pfizer Inc,VERAPAMIL HYDROCHLORIDE,120,mg/1,"Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA]",
0025-1911_9b1b09cc-305f-443d-b549-8dc420c4add4,0025-1911,HUMAN PRESCRIPTION DRUG,CALAN SR,,verapamil hydrochloride,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,19891215,,NDA,NDA019152,G.D. Searle LLC Division of Pfizer Inc,VERAPAMIL HYDROCHLORIDE,180,mg/1,"Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA]",
0025-1942_3d59eb5e-2769-401d-a42a-83fe8cbd2f98,0025-1942,HUMAN PRESCRIPTION DRUG,Flagyl,,metronidazole,CAPSULE,ORAL,19950503,,NDA,NDA020334,G.D. Searle LLC Division of Pfizer Inc,METRONIDAZOLE,375,mg/1,"Nitroimidazole Antimicrobial [EPC],Nitroimidazoles [Chemical/Ingredient]",
0025-2732_234e0244-3072-4717-9de9-026d6e1f0642,0025-2732,HUMAN PRESCRIPTION DRUG,Norpace CR,,disopyramide phosphate,"CAPSULE, EXTENDED RELEASE",ORAL,19820720,,NDA,NDA018655,G.D. Searle LLC Division of Pfizer Inc,DISOPYRAMIDE PHOSPHATE,100,mg/1,Antiarrhythmic [EPC],
0025-2742_234e0244-3072-4717-9de9-026d6e1f0642,0025-2742,HUMAN PRESCRIPTION DRUG,Norpace CR,,disopyramide phosphate,"CAPSULE, EXTENDED RELEASE",ORAL,19820720,,NDA,NDA018655,G.D. Searle LLC Division of Pfizer Inc,DISOPYRAMIDE PHOSPHATE,150,mg/1,Antiarrhythmic [EPC],
0025-2752_234e0244-3072-4717-9de9-026d6e1f0642,0025-2752,HUMAN PRESCRIPTION DRUG,Norpace,,disopyramide phosphate,"CAPSULE, GELATIN COATED",ORAL,19770901,,NDA,NDA017447,G.D. Searle LLC Division of Pfizer Inc,DISOPYRAMIDE PHOSPHATE,100,mg/1,Antiarrhythmic [EPC],
0025-2762_234e0244-3072-4717-9de9-026d6e1f0642,0025-2762,HUMAN PRESCRIPTION DRUG,Norpace,,disopyramide phosphate,"CAPSULE, GELATIN COATED",ORAL,19770901,,NDA,NDA017447,G.D. Searle LLC Division of Pfizer Inc,DISOPYRAMIDE PHOSPHATE,150,mg/1,Antiarrhythmic [EPC],
0026-3782_6739e1a6-57a4-405f-9c39-dbe9ff2811c5,0026-3782,PLASMA DERIVATIVE,Kogenate FS,,Antihemophilic Factor (Recombinant),KIT,,20000626,,BLA,BLA103332,Bayer HealthCare LLC,,,,,
0026-3782_8e2e96c3-5e01-4a74-89ec-7426eafd8432,0026-3782,PLASMA DERIVATIVE,Kogenate FS,,Antihemophilic Factor (Recombinant),KIT,,20130626,,BLA,BLA103332,Bayer HealthCare LLC,,,,,
0026-3783_6739e1a6-57a4-405f-9c39-dbe9ff2811c5,0026-3783,PLASMA DERIVATIVE,Kogenate FS,,Antihemophilic Factor (Recombinant),KIT,,20000626,,BLA,BLA103332,Bayer HealthCare LLC,,,,,
0026-3783_8e2e96c3-5e01-4a74-89ec-7426eafd8432,0026-3783,PLASMA DERIVATIVE,Kogenate FS,,Antihemophilic Factor (Recombinant),KIT,,20130626,,BLA,BLA103332,Bayer HealthCare LLC,,,,,
0026-3785_6739e1a6-57a4-405f-9c39-dbe9ff2811c5,0026-3785,PLASMA DERIVATIVE,Kogenate FS,,Antihemophilic Factor (Recombinant),KIT,,20000626,,BLA,BLA103332,Bayer HealthCare LLC,,,,,
0026-3785_8e2e96c3-5e01-4a74-89ec-7426eafd8432,0026-3785,PLASMA DERIVATIVE,Kogenate FS,,Antihemophilic Factor (Recombinant),KIT,,20130626,,BLA,BLA103332,Bayer HealthCare LLC,,,,,
0026-3786_6739e1a6-57a4-405f-9c39-dbe9ff2811c5,0026-3786,PLASMA DERIVATIVE,Kogenate FS,,Antihemophilic Factor (Recombinant),KIT,,20070607,,BLA,BLA103332,Bayer HealthCare LLC,,,,,
0026-3786_8e2e96c3-5e01-4a74-89ec-7426eafd8432,0026-3786,PLASMA DERIVATIVE,Kogenate FS,,Antihemophilic Factor (Recombinant),KIT,,20130626,,BLA,BLA103332,Bayer HealthCare LLC,,,,,
0026-3787_6739e1a6-57a4-405f-9c39-dbe9ff2811c5,0026-3787,PLASMA DERIVATIVE,Kogenate FS,,Antihemophilic Factor (Recombinant),KIT,,20090731,,BLA,BLA103332,Bayer HealthCare LLC,,,,,
0026-3787_8e2e96c3-5e01-4a74-89ec-7426eafd8432,0026-3787,PLASMA DERIVATIVE,Kogenate FS,,Antihemophilic Factor (Recombinant),KIT,,20130626,,BLA,BLA103332,Bayer HealthCare LLC,,,,,
0026-3792_73f76a18-1095-4480-80d8-ed13963a171d,0026-3792,PLASMA DERIVATIVE,Kogenate FS,,Antihemophilic Factor (Recombinant),KIT,,20051117,,BLA,BLA103332,Bayer HealthCare LLC,,,,,
0026-3793_73f76a18-1095-4480-80d8-ed13963a171d,0026-3793,PLASMA DERIVATIVE,Kogenate FS,,Antihemophilic Factor (Recombinant),KIT,,20051117,,BLA,BLA103332,Bayer HealthCare LLC,,,,,
0026-3795_73f76a18-1095-4480-80d8-ed13963a171d,0026-3795,PLASMA DERIVATIVE,Kogenate FS,,Antihemophilic Factor (Recombinant),KIT,,20051117,,BLA,BLA103332,Bayer HealthCare LLC,,,,,
0026-3796_73f76a18-1095-4480-80d8-ed13963a171d,0026-3796,PLASMA DERIVATIVE,Kogenate FS,,Antihemophilic Factor (Recombinant),KIT,,20080704,,BLA,BLA103332,Bayer HealthCare LLC,,,,,
0026-3797_73f76a18-1095-4480-80d8-ed13963a171d,0026-3797,PLASMA DERIVATIVE,Kogenate FS,,Antihemophilic Factor (Recombinant),KIT,,20090731,,BLA,BLA103332,Bayer HealthCare LLC,,,,,
0026-3821_4a955882-cba3-4222-ac20-2199b7eebc5c,0026-3821,PLASMA DERIVATIVE,Kovaltry,,Antihemophilic Factor (Recombinant),KIT,,20160317,,BLA,BLA125574,Bayer HealthCare LLC,,,,,
0026-3822_4a955882-cba3-4222-ac20-2199b7eebc5c,0026-3822,PLASMA DERIVATIVE,Kovaltry,,Antihemophilic Factor (Recombinant),KIT,,20160317,,BLA,BLA125574,Bayer HealthCare LLC,,,,,
0026-3824_4a955882-cba3-4222-ac20-2199b7eebc5c,0026-3824,PLASMA DERIVATIVE,Kovaltry,,Antihemophilic Factor (Recombinant),KIT,,20160317,,BLA,BLA125574,Bayer HealthCare LLC,,,,,
0026-3826_4a955882-cba3-4222-ac20-2199b7eebc5c,0026-3826,PLASMA DERIVATIVE,Kovaltry,,Antihemophilic Factor (Recombinant),KIT,,20160317,,BLA,BLA125574,Bayer HealthCare LLC,,,,,
0026-3828_4a955882-cba3-4222-ac20-2199b7eebc5c,0026-3828,PLASMA DERIVATIVE,Kovaltry,,Antihemophilic Factor (Recombinant),KIT,,20160317,,BLA,BLA125574,Bayer HealthCare LLC,,,,,
0029-1526_87d918ac-d06c-47ee-8e88-fd7e81fea513,0029-1526,HUMAN PRESCRIPTION DRUG,BACTROBAN,,mupirocin calcium,OINTMENT,TOPICAL,19960410,,NDA,NDA050703,GlaxoSmithKline LLC,MUPIROCIN CALCIUM,20,mg/g,"RNA Synthetase Inhibitor Antibacterial [EPC],RNA Synthetase Inhibitors [MoA]",
0029-1527_2e79be7c-78c8-4f11-bcc5-1fc05bfffe75,0029-1527,HUMAN PRESCRIPTION DRUG,BACTROBAN,,mupirocin calcium,CREAM,TOPICAL,19980123,,NDA,NDA050746,GlaxoSmithKline LLC,MUPIROCIN CALCIUM,20,mg/g,"RNA Synthetase Inhibitor Antibacterial [EPC],RNA Synthetase Inhibitors [MoA]",
0031-2234_4d975f93-20f1-486d-b57d-8555f5e36e46,0031-2234,HUMAN OTC DRUG,CHILDRENS DIMETAPP COLD AND COUGH,,"brompheniramine maleate, dextromethorphan HBr, phenylephrine HCl",LIQUID,ORAL,20060523,,OTC MONOGRAPH FINAL,part341,Richmond Division of Wyeth,BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE,1; 5; 2.5,mg/5mL; mg/5mL; mg/5mL,,
0031-2235_67764bf0-af50-4689-8f4a-7fc2d8687dc2,0031-2235,HUMAN OTC DRUG,CHILDRENS DIMETAPP COLD AND ALLERGY,,"brompheniramine maleate, phenylephrine HCl",LIQUID,ORAL,20070207,,OTC MONOGRAPH FINAL,part341,Richmond Division of Wyeth,BROMPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE,1; 2.5,mg/5mL; mg/5mL,,
0031-2238_059a3e6e-ea98-b0c5-ba27-b7cbbdedc917,0031-2238,HUMAN OTC DRUG,CHILDRENS DIMETAPP LONG ACTING COUGH PLUS COLD,,"chlorpheniramine maleate, dextromethorphan HBr",LIQUID,ORAL,20050304,,OTC MONOGRAPH FINAL,part341,Richmond Division of Wyeth,CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE,1; 7.5,mg/mL; mg/5mL,,
0031-2247_04a7f8bc-3d81-569e-7c7d-9c276a497072,0031-2247,HUMAN OTC DRUG,CHILDRENS DIMETAPP NIGHTTIME COLD AND CONGESTION,,"diphenhydramine HCl, phenylephrine HCl",LIQUID,ORAL,20071101,,OTC MONOGRAPH FINAL,part341,"Richmond Division of Wyeth LLC, a subsidiary of Pfizer Inc.",DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE,6.25; 2.5,mg/5mL; mg/5mL,,
0031-2249_bc20445e-2f92-432e-9677-095369ffe3ee,0031-2249,HUMAN OTC DRUG,Childrens Dimetapp Multi-Symptom Cold and Flu,,"acetaminophen, diphenhydramine hydrochloride, phenylephrine hydrochloride",LIQUID,ORAL,20140701,,OTC MONOGRAPH FINAL,part341,Richmond Division of Wyeth,ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE,320; 12.5; 5,mg/10mL; mg/10mL; mg/10mL,,
0031-2295_f5eb7058-3396-4ba1-b2ed-31b9e3745e5f,0031-2295,HUMAN OTC DRUG,Childrens Dimetapp Multi-Symptom Cold Relief Dye-Free,,"brompheniramine maleate, dextromethorphan hbr, phenylephrine hcl",SOLUTION,ORAL,20160601,,OTC MONOGRAPH FINAL,part341,Richmond Division of Wyeth,BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE,2; 10; 5,mg/10mL; mg/10mL; mg/10mL,,
0031-8649_ab8a877b-879d-4dd2-be2f-d6e14f447022,0031-8649,HUMAN OTC DRUG,Robitussin Medi-Soothers Cough DM,,dextromethorphan hydrobromide and menthol,LOZENGE,ORAL,20140901,,OTC MONOGRAPH FINAL,part341,Richmond Division of Wyeth,"DEXTROMETHORPHAN HYDROBROMIDE; MENTHOL, UNSPECIFIED FORM",5; 5,mg/1; mg/1,,
0031-8655_adf0f894-ec19-49ea-8ee4-061e14ab22bd,0031-8655,HUMAN OTC DRUG,Robitussin 12 Hour Cough Relief,,dextromethorphan polistirex,"SUSPENSION, EXTENDED RELEASE",ORAL,20150701,,ANDA,ANDA091135,Richmond Division of Wyeth,DEXTROMETHORPHAN HYDROBROMIDE,30,mg/5mL,,
0031-8692_642899c4-4322-408e-aa1d-33ab66cb4613,0031-8692,HUMAN OTC DRUG,Childrens Robitussin Nighttime Cough Long-Acting DM,,"chlorpheniramine maleate, dextromethorphan hydrobromide",SOLUTION,ORAL,20140701,,OTC MONOGRAPH FINAL,part341,Richmond Division of Wyeth,CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE,2; 15,mg/10mL; mg/10mL,,
0031-8693_becb4025-b63e-f2ea-9d11-d51fdf4e5c13,0031-8693,HUMAN OTC DRUG,CHILDRENS ROBITUSSIN COUGH AND COLD LONG-ACTING,,"chlorpheniramine maleate, dextrometrorphan HBr",LIQUID,ORAL,20040101,,OTC MONOGRAPH FINAL,part341,Richmond Division of Wyeth,CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE,1; 7.5,mg/5mL; mg/5mL,,
0031-8694_6825904c-3eb9-400f-9c58-dba76cb108d5,0031-8694,HUMAN OTC DRUG,Childrens Robitussin Cough Long-Acting,,dextromethorphan hydrobromide,LIQUID,ORAL,20040101,,OTC MONOGRAPH FINAL,part341,Richmond Division of Wyeth,DEXTROMETHORPHAN HYDROBROMIDE,7.5,mg/5mL,,
0031-8712_eac4dd2a-959b-1214-f17c-70cb896f9f48,0031-8712,HUMAN OTC DRUG,ROBITUSSIN TO GO COUGH AND CHEST CONGESTION DM,,"dextromethorphan HBr, guaifenesin",LIQUID,ORAL,20070731,,OTC MONOGRAPH FINAL,part341,Richmond Division of Wyeth,DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN,2; 20,mg/mL; mg/mL,,
0031-8713_55f6e151-92cf-438a-8272-47aaa9b761bc,0031-8713,HUMAN OTC DRUG,ROBITUSSIN TO GO COUGH AND COLD CF,,"dextromethorphan HBr, guaifenesin, phenylephrine HCl",SOLUTION,ORAL,20080107,,OTC MONOGRAPH FINAL,part341,Richmond Division of Wyeth,DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE,20; 200; 10,mg/10mL; mg/10mL; mg/10mL,,
0031-8715_2339a569-7c5f-4a8e-80e5-037eca03240a,0031-8715,HUMAN OTC DRUG,Childrens Robitussin Cough and Chest Congestion DM,,"dextromethorphan hydrobromide, guaifenesin",LIQUID,ORAL,20140701,,OTC MONOGRAPH FINAL,part341,Richmond Division of Wyeth,DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN,5; 100,mg/5mL; mg/5mL,,
0031-8716_dfc8529c-e381-41db-a702-67ca548c3be7,0031-8716,HUMAN OTC DRUG,Childrens Robitussin Cough and Cold CF,,"dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride",LIQUID,ORAL,20090901,,OTC MONOGRAPH FINAL,part341,Richmond Division of Wyeth,DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE,5; 50; 2.5,mg/5mL; mg/5mL; mg/5mL,,
0031-8717_7957def3-7e2d-426e-918c-38cf16f47c22,0031-8717,HUMAN OTC DRUG,Robitussin Maximum Strength Nighttime Cough DM,,DEXTROMETHORPHAN HYDROBROMIDE and DOXYLAMINE SUCCINATE,LIQUID,ORAL,20130301,,OTC MONOGRAPH FINAL,part341,Richmond Division of Wyeth,DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE,30; 12.5,mg/10mL; mg/10mL,,
0031-8718_542f2c29-a567-4776-aeb6-451f613d0cb9,0031-8718,HUMAN OTC DRUG,Robitussin Maximum Strength Nighttime Cough DM,,"dextromethorphan hydrobromide, doxylamine succinate",SOLUTION,ORAL,20160601,,OTC MONOGRAPH FINAL,part341,Richmond Division of Wyeth,DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE,30; 12.5,mg/20mL; mg/20mL,,
0031-8719_50cf5ade-1f3e-43a2-adaf-1d4a305b5215,0031-8719,HUMAN OTC DRUG,Robitussin Maximum Strength Cough Plus Chest Congestion DM,,dextromethorphan hydrobromide and guaifenesin,"CAPSULE, LIQUID FILLED",ORAL,20130523,,OTC MONOGRAPH FINAL,part341,Richmond Division of Wyeth,DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN,10; 200,mg/1; mg/1,,
0031-8721_95223329-9780-4950-ac4d-8de865d31432,0031-8721,HUMAN OTC DRUG,ROBITUSSIN PEAK COLD DAYTIME COLD PLUS FLU,,"ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE","CAPSULE, LIQUID FILLED",ORAL,20120415,,OTC MONOGRAPH FINAL,part341,Richmond Division of Wyeth,ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE,325; 10; 5,mg/1; mg/1; mg/1,,
0031-8722_bd07047f-e2b7-4784-86db-24994b4c12dc,0031-8722,HUMAN OTC DRUG,ROBITUSSIN PEAK COLD NIGHTTIME COLD PLUS FLU,,"Acetaminophen, DEXTROMETHORPHAN HYDROBROMIDE, and DOXYLAMINE SUCCINATE","CAPSULE, LIQUID FILLED",ORAL,20120415,,OTC MONOGRAPH FINAL,part341,Richmond Division of Wyeth,ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE,325; 15; 6.25,mg/1; mg/1; mg/1,,
0031-8724_79db3cc6-0367-4120-9b42-68ff68b0e807,0031-8724,HUMAN OTC DRUG,Robitussin Mucus Plus Chest Congestion,,Guaifenesin,LIQUID,ORAL,20120718,,OTC MONOGRAPH FINAL,part341,Richmond Division of Wyeth,GUAIFENESIN,200,mg/10mL,,
0031-8725_b75af3dd-1e38-4ce2-99c0-73a7267727a7,0031-8725,HUMAN OTC DRUG,Childrens Robitussin 12 Hour Cough Relief,,dextromethorphan polistirex,"SUSPENSION, EXTENDED RELEASE",ORAL,20160705,,ANDA,ANDA091135,Richmond Division of Wyeth,DEXTROMETHORPHAN HYDROBROMIDE,30,mg/5mL,,
0031-8726_b75af3dd-1e38-4ce2-99c0-73a7267727a7,0031-8726,HUMAN OTC DRUG,Childrens Robitussin 12 Hour Cough Relief,,dextromethorphan polistirex,"SUSPENSION, EXTENDED RELEASE",ORAL,20160705,,ANDA,ANDA091135,Richmond Division of Wyeth,DEXTROMETHORPHAN HYDROBROMIDE,30,mg/5mL,,
0031-8731_3f5205c9-9029-3555-0993-e19624354ada,0031-8731,HUMAN OTC DRUG,ROBITUSSIN PEAK COLD NASAL RELIEF,,"acetaminophen, phenylephrine HCl",TABLET,ORAL,20110606,,OTC MONOGRAPH FINAL,part341,Richmond Division of Wyeth,ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE,325; 5,mg/1; mg/1,,
0031-8732_8140f56b-469c-d437-b26b-d5d9517a8829,0031-8732,HUMAN OTC DRUG,ROBITUSSIN PEAK COLD NIGHTTIME NASAL RELIEF,,"acetaminophen, chlorpheniramine maleate, phenylephrine HCl",TABLET,ORAL,20110606,,OTC MONOGRAPH FINAL,part341,Richmond Division of Wyeth,ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE,325; 2; 5,mg/1; mg/1; mg/1,,
0031-8734_1b7e5948-97dc-a4ae-e545-2c8adb0e4003,0031-8734,HUMAN OTC DRUG,ROBITUSSIN PEAK COLD MAXIMUM STRENGTH MULTI-SYMPTOM COLD,,"dextromethorphan HBr, guaifenesin, phenylephrine HCl",LIQUID,ORAL,20110615,,OTC MONOGRAPH FINAL,part341,Richmond Division of Wyeth,DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE,10; 200; 5,mg/5mL; mg/5mL; mg/5mL,,
0031-8735_06753c55-eac0-9317-b80f-714989238eca,0031-8735,HUMAN OTC DRUG,ROBITUSSIN PEAK COLD NIGHTTIME MULTI-SYMPTOM COLD,,"acetaminophen, diphenhydramine HCl, phenylephrine HCl",LIQUID,ORAL,20110615,,OTC MONOGRAPH FINAL,part341,Richmond Division of Wyeth,ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE,160; 6.25; 2.5,mg/5mL; mg/5mL; mg/5mL,,
0031-8736_d20ad7d5-8371-4b87-b668-533adf2c6d8b,0031-8736,HUMAN OTC DRUG,Robitussin Peak Cold Cough Plus Chest Congestion DM,,dextromethorphan hydrobromide and guaifenesin,SOLUTION,ORAL,20110615,,OTC MONOGRAPH FINAL,part341,Richmond Division of Wyeth,DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN,10; 100,mg/5mL; mg/5mL,,
0031-8737_d20ad7d5-8371-4b87-b668-533adf2c6d8b,0031-8737,HUMAN OTC DRUG,Robitussin Peak Cold Sugar-Free Cough Plus Chest Congestion DM,,dextromethorphan hydrobromide and guaifenesin,SOLUTION,ORAL,20110615,,OTC MONOGRAPH FINAL,part341,Richmond Division of Wyeth,DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN,10; 100,mg/5mL; mg/5mL,,
0031-8738_165677e7-8b6e-4c64-8012-b786fec53bf1,0031-8738,HUMAN OTC DRUG,ROBITUSSIN PEAK COLD MAXIMUM STRENGTH COUGH PLUS CHEST CONGESTION DM,,"dextromethorphan hydrobromide, guaifenesin",SOLUTION,ORAL,20110615,,OTC MONOGRAPH FINAL,part341,Richmond Division of Wyeth,DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN,20; 400,mg/10mL; mg/10mL,,
0031-8739_c8475e99-011e-4a3a-88b4-aca3477fba41,0031-8739,HUMAN OTC DRUG,ROBITUSSIN MAXIMUM STRENGTH COUGH PLUS CHEST CONGESTION DM,,"dextromethorphan hydrobromide, guaifenesin",SOLUTION,ORAL,20160601,,OTC MONOGRAPH FINAL,part341,Richmond Division of Wyeth,DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN,20; 400,mg/20mL; mg/20mL,,
0031-8740_03f9663b-f98d-b611-4c83-9c3b643e7a31,0031-8740,HUMAN OTC DRUG,ROBITUSSIN LINGERING COLD LONG-ACTING COUGH,,dextromethorphan HBr,LIQUID,ORAL,20110615,,OTC MONOGRAPH FINAL,part341,Richmond Division of Wyeth,DEXTROMETHORPHAN HYDROBROMIDE,15,mg/5mL,,
0031-8741_e2441138-42ac-4201-8b80-a86c9afd5b8f,0031-8741,HUMAN OTC DRUG,ROBITUSSIN LINGERING COLD LONG-ACTING COUGHGELS,,dextromethorphan hbr,"CAPSULE, LIQUID FILLED",ORAL,20110606,,OTC MONOGRAPH FINAL,part341,Richmond Division of Wyeth,DEXTROMETHORPHAN HYDROBROMIDE,15,mg/1,,
0031-8742_5cc98f97-8f38-43ee-b3ab-c6258384803e,0031-8742,HUMAN OTC DRUG,Robitussin Peak Cold Multi-Symptom Cold,,"dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride",LIQUID,ORAL,20110612,,OTC MONOGRAPH FINAL,part341,Richmond Division of Wyeth,DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE,10; 100; 5,mg/5mL; mg/5mL; mg/5mL,,
0031-8750_8a2f886c-5fac-42e6-a47e-d036ada6afff,0031-8750,HUMAN OTC DRUG,Robitussin Maximum Strength Severe Cough Plus Sore Throat,,"acetaminophen, dextromethorphan hydrobromide",LIQUID,ORAL,20170410,,OTC MONOGRAPH FINAL,part341,Richmond Division of Wyeth,ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE,650; 20,mg/20mL; mg/20mL,,
0031-8751_7f429c9f-e3a5-410c-817d-6fe106f16126,0031-8751,HUMAN OTC DRUG,Robitussin Severe Multi-Symptom Cough Cold Flu,,"acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride",LIQUID,ORAL,20150501,,OTC MONOGRAPH FINAL,part341,Richmond Division of Wyeth,ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE,650; 20; 400; 10,mg/20mL; mg/20mL; mg/20mL; mg/20mL,,
0031-8752_a0ce06c6-44b6-49ba-8ffd-cb20f232109d,0031-8752,HUMAN OTC DRUG,Robitussin Severe Multi-Symptom Cough Cold Flu Nighttime,,"acetaminophen, diphenhydramine hydrochloride, phenylephrine hydrochloride",SOLUTION,ORAL,20150701,,OTC MONOGRAPH FINAL,part341,Richmond Division of Wyeth,ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE,650; 25; 10,mg/20mL; mg/20mL; mg/20mL,,
0031-8753_adf0f894-ec19-49ea-8ee4-061e14ab22bd,0031-8753,HUMAN OTC DRUG,Robitussin 12 Hour Cough Relief,,dextromethorphan polistirex,"SUSPENSION, EXTENDED RELEASE",ORAL,20150701,,ANDA,ANDA091135,Richmond Division of Wyeth,DEXTROMETHORPHAN HYDROBROMIDE,30,mg/5mL,,
0031-8754_adf0f894-ec19-49ea-8ee4-061e14ab22bd,0031-8754,HUMAN OTC DRUG,Robitussin 12 Hour Cough Relief,,dextromethorphan polistirex,"SUSPENSION, EXTENDED RELEASE",ORAL,20160705,,ANDA,ANDA091135,Richmond Division of Wyeth,DEXTROMETHORPHAN HYDROBROMIDE,30,mg/5mL,,
0031-8755_adf0f894-ec19-49ea-8ee4-061e14ab22bd,0031-8755,HUMAN OTC DRUG,Robitussin 12 Hour Cough Relief,,dextromethorphan polistirex,"SUSPENSION, EXTENDED RELEASE",ORAL,20160705,,ANDA,ANDA091135,Richmond Division of Wyeth,DEXTROMETHORPHAN HYDROBROMIDE,30,mg/5mL,,
0032-1203_fad6450d-3caf-165a-db06-011b14e9f469,0032-1203,HUMAN PRESCRIPTION DRUG,Creon,,Pancrelipase,"CAPSULE, DELAYED RELEASE",ORAL,20090430,,NDA,NDA020725,AbbVie Inc.,PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE,15000; 3000; 9500,[USP'U]/1; [USP'U]/1; [USP'U]/1,,
0032-1206_fad6450d-3caf-165a-db06-011b14e9f469,0032-1206,HUMAN PRESCRIPTION DRUG,Creon,,Pancrelipase,"CAPSULE, DELAYED RELEASE PELLETS",ORAL,20090430,,NDA,NDA020725,AbbVie Inc.,PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE,30000; 6000; 19000,[USP'U]/1; [USP'U]/1; [USP'U]/1,,
0032-1212_fad6450d-3caf-165a-db06-011b14e9f469,0032-1212,HUMAN PRESCRIPTION DRUG,Creon,,Pancrelipase,"CAPSULE, DELAYED RELEASE PELLETS",ORAL,20090430,,NDA,NDA020725,AbbVie Inc.,PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE,60000; 12000; 38000,[USP'U]/1; [USP'U]/1; [USP'U]/1,,
0032-1224_fad6450d-3caf-165a-db06-011b14e9f469,0032-1224,HUMAN PRESCRIPTION DRUG,Creon,,Pancrelipase,"CAPSULE, DELAYED RELEASE PELLETS",ORAL,20090430,,NDA,NDA020725,AbbVie Inc.,PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE; PANCRELIPASE AMYLASE,24000; 76000; 120000,[USP'U]/1; [USP'U]/1; [USP'U]/1,,
0032-1708_6339e30d-a5d3-09b0-852a-84ef2e8c2a83,0032-1708,HUMAN PRESCRIPTION DRUG,Prometrium,,Progesterone,CAPSULE,ORAL,20100730,20180930,NDA,NDA019781,AbbVie Inc.,PROGESTERONE,100,mg/1,"Progesterone [Chemical/Ingredient],Progesterone [EPC]",
0032-1711_6339e30d-a5d3-09b0-852a-84ef2e8c2a83,0032-1711,HUMAN PRESCRIPTION DRUG,Prometrium,,Progesterone,CAPSULE,ORAL,20100730,20180731,NDA,NDA019781,AbbVie Inc.,PROGESTERONE,200,mg/1,"Progesterone [Chemical/Ingredient],Progesterone [EPC]",
0032-3016_fad6450d-3caf-165a-db06-011b14e9f469,0032-3016,HUMAN PRESCRIPTION DRUG,Creon,,Pancrelipase,"CAPSULE, DELAYED RELEASE PELLETS",ORAL,20130314,,NDA,NDA020725,AbbVie Inc.,PANCRELIPASE LIPASE; PANCRELIPASE AMYLASE; PANCRELIPASE PROTEASE,36000; 180000; 114000,[USP'U]/1; [USP'U]/1; [USP'U]/1,,
0037-0022_90fd7e8f-c3ea-4843-a13c-32e2269843a5,0037-0022,HUMAN PRESCRIPTION DRUG,sfRowasa,Sulfite-Free Formulation,mesalamine,SUSPENSION,RECTAL,20160329,,NDA,NDA019618,Meda Pharmaceuticals,MESALAMINE,4,g/60mL,"Aminosalicylate [EPC],Aminosalicylic Acids [Chemical/Ingredient]",
0037-0066_25b355a1-136b-42d5-bc09-214387ac6784,0037-0066,HUMAN PRESCRIPTION DRUG,Rowasa,,mesalamine,SUSPENSION,RECTAL,20160329,,NDA,NDA019618,Meda Pharmaceuticals,MESALAMINE,4,g/60mL,"Aminosalicylate [EPC],Aminosalicylic Acids [Chemical/Ingredient]",
0037-0083_bbeb4b69-54f5-40e8-8c29-680d5fe02acd,0037-0083,HUMAN PRESCRIPTION DRUG,PreferaOB plus DHA,,prenatal/postnatal multivitamin/multimineral,KIT,ORAL,20150201,,UNAPPROVED DRUG OTHER,,MEDA Pharmaceuticals,,,,,
0037-0084_d8af88e4-06e1-41f4-9af1-f5bc9a254f67,0037-0084,HUMAN PRESCRIPTION DRUG,PreferaOB,,"Cholecalciferol, .alpha.-tocopherol succinate, d-, thiamine mononitrate, riboflavin, niacinamide, pyridoxine hydrochloride, folic acid, cyanocobalamin, biotin, calcium pantothenate, d-, iron sucrose, heme iron polypeptide, potassium iodide, zinc oxide, sodium selenate, cupric sulfate","TABLET, COATED",ORAL,20150428,,UNAPPROVED DRUG OTHER,,MEDA Pharmaceuticals,"CHOLECALCIFEROL; .ALPHA.-TOCOPHEROL SUCCINATE, D-; THIAMINE MONONITRATE; RIBOFLAVIN; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; FOLIC ACID; CYANOCOBALAMIN; BIOTIN; CALCIUM PANTOTHENATE; IRON SUCROSE; HEME IRON POLYPEPTIDE; POTASSIUM IODIDE; ZINC OXIDE; SODIUM SELENATE; CUPRIC SULFATE",400; 10; 1.5; 1.6; 17; 50; 1; 12; 30; 10; 28; 6; 250; 4.5; 65; .8,[iU]/1; [iU]/1; mg/1; mg/1; mg/1; mg/1; mg/1; ug/1; ug/1; mg/1; mg/1; mg/1; ug/1; mg/1; ug/1; mg/1,"Vitamin D [Chemical/Ingredient],Vitamin D [EPC],Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient],Vitamin B 12 [Chemical/Ingredient],Vitamin B12 [EPC],Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [Chemical/Ingredient],Cations, Divalent [Chemical/Ingredient],Iron [Chemical/Ingredient],Parenteral Iron Replacement [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA]",
0037-0086_88559f4c-25b8-4db1-a840-ea8fd5ac2ab6,0037-0086,HUMAN PRESCRIPTION DRUG,PreferaOB ONE,,"ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, niacinamide, pyridoxine hydrochloride, folic acid, cyanocobalamin, biotin, calcium pantothenate, d-, iron sucrose, heme iron polypeptide, potassium iodide, zinc oxide, schizochytrium dha oil","CAPSULE, LIQUID FILLED",ORAL,20150428,,UNAPPROVED DRUG OTHER,,MEDA Pharmaceuticals,"ASCORBIC ACID; CHOLECALCIFEROL; .ALPHA.-TOCOPHEROL ACETATE, DL-; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; FOLIC ACID; CYANOCOBALAMIN; BIOTIN; CALCIUM PANTOTHENATE; IRON SUCROSE; HEME IRON POLYPEPTIDE; POTASSIUM IODIDE; ZINC OXIDE; SCHIZOCHYTRIUM DHA OIL",25; 400; 10; 17; 50; 1; 12; 30; 10; 22; 6; 175; 15; 200,mg/1; [iU]/1; [iU]/1; mg/1; mg/1; mg/1; ug/1; ug/1; mg/1; mg/1; mg/1; ug/1; mg/1; mg/1,"Vitamin D [Chemical/Ingredient],Vitamin D [EPC],Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient],Vitamin B 12 [Chemical/Ingredient],Vitamin B12 [EPC],Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [Chemical/Ingredient],Cations, Divalent [Chemical/Ingredient],Iron [Chemical/Ingredient],Parenteral Iron Replacement [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA]",
0037-0113_12c5233f-f5d2-4e73-bbfe-abc1f5b0fdcc,0037-0113,HUMAN PRESCRIPTION DRUG,Butisol Sodium,,Butabarbital Sodium,TABLET,ORAL,19390801,,NDA,NDA000793,Meda Pharmaceuticals Inc.,BUTABARBITAL SODIUM,30,mg/1,,CIII
0037-0243_98263b8c-1476-4df0-b663-f5cb946b2fd8,0037-0243,HUMAN PRESCRIPTION DRUG,Astepro,,Azelastine Hydrochloride,"SPRAY, METERED",NASAL,20091012,,NDA,NDA022203,Meda Pharmaceuticals Inc.,AZELASTINE HYDROCHLORIDE,205.5,ug/1,"Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC]",
0037-0245_5dcc069a-8179-4896-a1fe-2da45254a757,0037-0245,HUMAN PRESCRIPTION DRUG,DYMISTA,,Azelastine Hydrochloride and Fluticasone Propionate,"SPRAY, METERED",NASAL,20120501,,NDA,NDA202236,Meda Pharmaceuticals Inc.,AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE,137; 50,ug/1; ug/1,"Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC]",
0037-0430_1f3aad90-0bde-11e1-be50-0800200c9a66,0037-0430,HUMAN PRESCRIPTION DRUG,Felbatol,,felbamate,TABLET,ORAL,19930729,,NDA,NDA020189,Meda Pharmaceuticals Inc.,FELBAMATE,400,mg/1,"Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]",
0037-0431_1f3aad90-0bde-11e1-be50-0800200c9a66,0037-0431,HUMAN PRESCRIPTION DRUG,Felbatol,,felbamate,TABLET,ORAL,19930729,,NDA,NDA020189,Meda Pharmaceuticals Inc.,FELBAMATE,600,mg/1,"Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]",
0037-0442_1f3aad90-0bde-11e1-be50-0800200c9a66,0037-0442,HUMAN PRESCRIPTION DRUG,Felbatol,,felbamate,SUSPENSION,ORAL,19930729,,NDA,NDA020189,Meda Pharmaceuticals Inc.,FELBAMATE,600,mg/5mL,"Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]",
0037-0678_11c11f0c-1a0e-45a9-98d8-1b521d6351c1,0037-0678,HUMAN PRESCRIPTION DRUG,Gastrocrom,,cromolyn sodium,LIQUID,ORAL,20150501,,NDA,NDA020479,MEDA Pharmaceuticals,CROMOLYN SODIUM,20,mg/mL,"Decreased Histamine Release [PE],Mast Cell Stabilizer [EPC]",
0037-1221_70568880-5589-40c0-88f8-1721eef4a8a0,0037-1221,HUMAN PRESCRIPTION DRUG,Cesamet,,Nabilone,CAPSULE,ORAL,20100301,,NDA,NDA018677,Meda Pharmaceuticals Inc.,NABILONE,1,mg/1,"Cannabinoid [EPC],Cannabinoids [Chemical/Ingredient]",CII
0037-2001_427ef120-7164-11e2-bcfd-0800200c9a66,0037-2001,HUMAN PRESCRIPTION DRUG,Soma,,Carisoprodol,TABLET,ORAL,19590701,,NDA,NDA011792,Meda Pharmaceuticals Inc.,CARISOPRODOL,350,mg/1,"Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC]",CIV
0037-2250_427ef120-7164-11e2-bcfd-0800200c9a66,0037-2250,HUMAN PRESCRIPTION DRUG,Soma,,Carisoprodol,TABLET,ORAL,20070901,,NDA,NDA011792,Meda Pharmaceuticals Inc.,CARISOPRODOL,250,mg/1,"Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC]",CIV
0037-3500_496d41cf-a858-45e5-a9c7-1a85eee7fd16,0037-3500,HUMAN PRESCRIPTION DRUG,Demadex,,Torsemide,TABLET,ORAL,20150101,,NDA,NDA020136,Meda Pharmaceuticals,TORSEMIDE,100,mg/1,"Increased Diuresis at Loop of Henle [PE],Loop Diuretic [EPC]",
0037-3505_496d41cf-a858-45e5-a9c7-1a85eee7fd16,0037-3505,HUMAN PRESCRIPTION DRUG,Demadex,,Torsemide,TABLET,ORAL,20150101,,NDA,NDA020136,Meda Pharmaceuticals,TORSEMIDE,5,mg/1,"Increased Diuresis at Loop of Henle [PE],Loop Diuretic [EPC]",
0037-3510_496d41cf-a858-45e5-a9c7-1a85eee7fd16,0037-3510,HUMAN PRESCRIPTION DRUG,Demadex,,Torsemide,TABLET,ORAL,20150101,20190630,NDA,NDA020136,Meda Pharmaceuticals,TORSEMIDE,10,mg/1,"Increased Diuresis at Loop of Henle [PE],Loop Diuretic [EPC]",
0037-3520_496d41cf-a858-45e5-a9c7-1a85eee7fd16,0037-3520,HUMAN PRESCRIPTION DRUG,Demadex,,Torsemide,TABLET,ORAL,20150101,20181130,NDA,NDA020136,Meda Pharmaceuticals,TORSEMIDE,20,mg/1,"Increased Diuresis at Loop of Henle [PE],Loop Diuretic [EPC]",
0037-4401_8afdaf40-dcb8-11e1-baf1-0002a5d5c51b,0037-4401,HUMAN PRESCRIPTION DRUG,Depen,,Penicillamine,TABLET,ORAL,19781130,,NDA,NDA019854,Meda Pharmaceuticals Inc.,PENICILLAMINE,250,mg/1,Antirheumatic Agent [EPC],
0037-4801_3bb82240-2510-430d-b707-c4c0977c110a,0037-4801,HUMAN PRESCRIPTION DRUG,ELESTRIN,,ESTRADIOL,"GEL, METERED",TOPICAL,20140602,,NDA,NDA021813,Meda Pharmaceuticals,ESTRADIOL,0.52,mg/.87g,"Estradiol Congeners [Chemical/Ingredient],Estrogen [EPC],Estrogen Receptor Agonists [MoA]",
0037-6010_e1c9f570-33d4-11e4-8c21-0800200c9a66,0037-6010,HUMAN PRESCRIPTION DRUG,Edluar,,Zolpidem Tartrate,TABLET,ORAL,20090724,,NDA,NDA021997,Meda Pharmaceuticals Inc.,ZOLPIDEM TARTRATE,10,mg/1,"gamma-Aminobutyric Acid-ergic Agonist [EPC],GABA A Agonists [MoA],Pyridines [Chemical/Ingredient],Central Nervous System Depression [PE]",CIV
0037-6050_e1c9f570-33d4-11e4-8c21-0800200c9a66,0037-6050,HUMAN PRESCRIPTION DRUG,Edluar,,Zolpidem Tartrate,TABLET,ORAL,20090724,,NDA,NDA021997,Meda Pharmaceuticals Inc.,ZOLPIDEM TARTRATE,5,mg/1,"gamma-Aminobutyric Acid-ergic Agonist [EPC],GABA A Agonists [MoA],Pyridines [Chemical/Ingredient],Central Nervous System Depression [PE]",CIV
0037-6072_7481aaf9-2cb5-42bb-b95c-e7027328c578,0037-6072,HUMAN PRESCRIPTION DRUG,Natelle One,,"doconexent, icosapent, calcium, iron, ascorbic acid, pyridoxine, .alpha.-tocopherol, folic acid","CAPSULE, GELATIN COATED",ORAL,20150201,,UNAPPROVED DRUG OTHER,,MEDA Pharmaceuticals,DOCONEXENT; ICOSAPENT; CALCIUM; IRON; ASCORBIC ACID; PYRIDOXINE; .ALPHA.-TOCOPHEROL; FOLIC ACID,250; .625; 102; 28; 30; 25; 30; 1,mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; [iU]/1; mg/1,"Calcium [Chemical/Ingredient],Calcium [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA],Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient]",
0037-6321_37b31a99-1a32-4e7f-9363-7061e1a20019,0037-6321,HUMAN PRESCRIPTION DRUG,URELLE,,"hyoscyamine sulfate, methenamine, methylene blue, phenyl salicylate, and sodium phosphate, monobasic, monohydrate",TABLET,ORAL,20150112,,UNAPPROVED DRUG OTHER,,Meda Pharmaceuticals Inc.,"HYOSCYAMINE SULFATE; METHENAMINE; METHYLENE BLUE; PHENYL SALICYLATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE",.12; 81; 10.8; 32.4; 40.8,mg/1; mg/1; mg/1; mg/1; mg/1,"Oxidation-Reduction Agent [EPC],Oxidation-Reduction Activity [MoA]",
0037-6631_17e55d0e-8126-4472-9333-d363612b422d,0037-6631,HUMAN PRESCRIPTION DRUG,AVC,,sulfanilamide,CREAM,VAGINAL,20141201,,NDA,NDA006530,Meda Pharmaceuticals,SULFANILAMIDE,15,g/100g,,
0037-6820_ad34d2e0-1e98-11e4-8c21-0800200c9a66,0037-6820,HUMAN PRESCRIPTION DRUG,COLYTE,,peg-3350 and electrolytes,"POWDER, FOR SOLUTION",NASOGASTRIC,20140805,,NDA,NDA018983,MEDA Pharmaceuticals,POLYETHYLENE GLYCOL 3350; SODIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM SULFATE,240; 5.84; 2.98; 6.72; 22.72,g/4L; g/4L; g/4L; g/4L; g/4L,"Osmotic Activity [MoA],Osmotic Laxative [EPC],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA]",
0037-6822_6881933a-d72c-4a9c-83e0-2b523b801020,0037-6822,HUMAN PRESCRIPTION DRUG,PROCTOFOAM,HC,pramoxine hydrochloride hydrocortisone acetate,"AEROSOL, FOAM",TOPICAL,20140815,,ANDA,ANDA086195,Meda Pharmaceuticals,PRAMOXINE HYDROCHLORIDE; HYDROCORTISONE ACETATE,100; 100,mg/10g; mg/10g,"Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]",
0037-6823_cddc8d80-21b8-11e4-8c21-0800200c9a66,0037-6823,HUMAN OTC DRUG,PROCTOFOAM,NS,pramoxine hydrochloride,"AEROSOL, FOAM",RECTAL,20140818,,OTC MONOGRAPH FINAL,part346,MEDA PHARMACEUTICALS INC.,PRAMOXINE HYDROCHLORIDE,150,mg/15g,,
0037-6824_b22b8b40-2f1e-11e4-8c21-0800200c9a66,0037-6824,HUMAN PRESCRIPTION DRUG,EPIFOAM,,pramoxine hydrochloride and hydrocortisone acetate,"AEROSOL, FOAM",TOPICAL,20140825,,ANDA,ANDA086457,MEDA Pharmaceuticals,PRAMOXINE HYDROCHLORIDE; HYDROCORTISONE ACETATE,100; 100,mg/10g; mg/10g,"Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]",
0037-6830_27acd0c3-12c4-484d-bcb4-08dfc6d21efc,0037-6830,HUMAN PRESCRIPTION DRUG,Cortifoam,,hydrocortisone acetate,"AEROSOL, FOAM",TOPICAL,20150615,,NDA,NDA017351,Meda Pharmaceuticals,HYDROCORTISONE ACETATE,1500,mg/15g,"Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]",
0037-6860_43f6c437-5c6a-4171-893a-c5669a8fa082,0037-6860,HUMAN PRESCRIPTION DRUG,Dipentum,,olsalazine sodium,"CAPSULE, GELATIN COATED",ORAL,20150515,,NDA,NDA019715,MEDA Pharmaceuticals,OLSALAZINE SODIUM,250,mg/1,"Aminosalicylate [EPC],Aminosalicylic Acids [Chemical/Ingredient]",
0037-6885_3dbec270-2747-4c24-a288-9e80ba23ecd9,0037-6885,HUMAN PRESCRIPTION DRUG,BiferaRx,,"folic acid, cyanocobalamin, iron dextran and heme iron polypeptide",TABLET,ORAL,20121031,,UNAPPROVED DRUG OTHER,,Meda Pharmaceuticals,FOLIC ACID; CYANOCOBALAMIN; IRON DEXTRAN; HEME IRON POLYPEPTIDE,1; 25; 22; 6,mg/1; ug/1; mg/1; mg/1,"Vitamin B 12 [Chemical/Ingredient],Vitamin B12 [EPC],Iron [Chemical/Ingredient],Parenteral Iron Replacement [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA]",
0037-7025_64c2811b-d917-11e2-a28f-0800200c9a66,0037-7025,HUMAN PRESCRIPTION DRUG,Optivar,,Azelastine Hydrochloride,SOLUTION/ DROPS,INTRAOCULAR,20000522,,NDA,NDA021127,Meda Pharmaceuticals Inc.,AZELASTINE HYDROCHLORIDE,0.5,mg/mL,"Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC]",
0037-7590_a393a752-c252-403a-82b0-2f580b328252,0037-7590,HUMAN PRESCRIPTION DRUG,Aerospan,,flunisolide,"AEROSOL, METERED",RESPIRATORY (INHALATION),20120301,,NDA,NDA021247,Meda Pharmaceuticals,FLUNISOLIDE,80,ug/1,"Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]",
0037-8110_c180c801-b12e-4c8e-9577-440cd7456189,0037-8110,HUMAN PRESCRIPTION DRUG,MUSE,,Alprostadil,SUPPOSITORY,URETHRAL,20110722,,NDA,NDA020700,Meda Pharmaceuticals Inc.,ALPROSTADIL,125,ug/1,"Genitourinary Arterial Vasodilation [PE],Prostaglandin Analog [EPC],Prostaglandin E1 Agonist [EPC],Prostaglandin Receptor Agonists [MoA],Prostaglandins [Chemical/Ingredient],Venous Vasodilation [PE]",
0037-8120_c180c801-b12e-4c8e-9577-440cd7456189,0037-8120,HUMAN PRESCRIPTION DRUG,MUSE,,Alprostadil,SUPPOSITORY,URETHRAL,20110722,,NDA,NDA020700,Meda Pharmaceuticals Inc.,ALPROSTADIL,250,ug/1,"Genitourinary Arterial Vasodilation [PE],Prostaglandin Analog [EPC],Prostaglandin E1 Agonist [EPC],Prostaglandin Receptor Agonists [MoA],Prostaglandins [Chemical/Ingredient],Venous Vasodilation [PE]",
0037-8130_c180c801-b12e-4c8e-9577-440cd7456189,0037-8130,HUMAN PRESCRIPTION DRUG,MUSE,,Alprostadil,SUPPOSITORY,URETHRAL,20110722,,NDA,NDA020700,Meda Pharmaceuticals Inc.,ALPROSTADIL,500,ug/1,"Genitourinary Arterial Vasodilation [PE],Prostaglandin Analog [EPC],Prostaglandin E1 Agonist [EPC],Prostaglandin Receptor Agonists [MoA],Prostaglandins [Chemical/Ingredient],Venous Vasodilation [PE]",
0037-8140_c180c801-b12e-4c8e-9577-440cd7456189,0037-8140,HUMAN PRESCRIPTION DRUG,MUSE,,Alprostadil,SUPPOSITORY,URETHRAL,20110722,,NDA,NDA020700,Meda Pharmaceuticals Inc.,ALPROSTADIL,1000,ug/1,"Genitourinary Arterial Vasodilation [PE],Prostaglandin Analog [EPC],Prostaglandin E1 Agonist [EPC],Prostaglandin Receptor Agonists [MoA],Prostaglandins [Chemical/Ingredient],Venous Vasodilation [PE]",
0037-9001_d11e402c-c7a8-4252-bc56-f78acb75b74c,0037-9001,HUMAN PRESCRIPTION DRUG,Levsin,,HYOSCYAMINE SULFATE,"INJECTION, SOLUTION",SUBCUTANEOUS,20081201,,UNAPPROVED DRUG OTHER,,Meda Pharmaceuticals,HYOSCYAMINE SULFATE,0.5,mg/mL,,
0039-0051_4c824136-526b-434d-be05-2489719d61dc,0039-0051,HUMAN PRESCRIPTION DRUG,DiaBeta,,glyburide,TABLET,ORAL,20090601,,NDA,NDA017532,Sanofi-Aventis U.S. LLC,GLYBURIDE,2.5,mg/1,"Sulfonylurea [EPC],Sulfonylurea Compounds [Chemical/Ingredient]",
0039-0052_4c824136-526b-434d-be05-2489719d61dc,0039-0052,HUMAN PRESCRIPTION DRUG,DiaBeta,,glyburide,TABLET,ORAL,20090601,,NDA,NDA017532,Sanofi-Aventis U.S. LLC,GLYBURIDE,5,mg/1,"Sulfonylurea [EPC],Sulfonylurea Compounds [Chemical/Ingredient]",
0039-0053_4c824136-526b-434d-be05-2489719d61dc,0039-0053,HUMAN PRESCRIPTION DRUG,DiaBeta,,glyburide,TABLET,ORAL,20090601,,NDA,NDA017532,Sanofi-Aventis U.S. LLC,GLYBURIDE,1.25,mg/1,"Sulfonylurea [EPC],Sulfonylurea Compounds [Chemical/Ingredient]",
0039-0060_0980536d-7652-41a6-a618-8a708d9ac695,0039-0060,HUMAN PRESCRIPTION DRUG,Lasix,,furosemide,TABLET,ORAL,19660701,,NDA,NDA016273,Sanofi-Aventis U.S. LLC,FUROSEMIDE,40,mg/1,"Increased Diuresis at Loop of Henle [PE],Loop Diuretic [EPC]",
0039-0066_0980536d-7652-41a6-a618-8a708d9ac695,0039-0066,HUMAN PRESCRIPTION DRUG,Lasix,,furosemide,TABLET,ORAL,19660701,,NDA,NDA016273,Sanofi-Aventis U.S. LLC,FUROSEMIDE,80,mg/1,"Increased Diuresis at Loop of Henle [PE],Loop Diuretic [EPC]",
0039-0067_0980536d-7652-41a6-a618-8a708d9ac695,0039-0067,HUMAN PRESCRIPTION DRUG,Lasix,,furosemide,TABLET,ORAL,19660701,,NDA,NDA016273,Sanofi-Aventis U.S. LLC,FUROSEMIDE,20,mg/1,"Increased Diuresis at Loop of Henle [PE],Loop Diuretic [EPC]",